| 1666006 | Active | (E)-Thiothixene (100 mg) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1379456 | Active | (Z)-N'-Methylmeloxicam (30 mg) ((Z)-N-(3,5-dimethylthiazol-2(3H)-ylidene)-4-hydroxy-2-methyl-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1213148 | Active | 1,2-Dinitroglycerin (2 ampules x 1 mL) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1213159 | Active | 1,3-Dinitroglycerin (2 ampules x 1 mL) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1445571 | Active | 1-Mononitroglycerin (2 ampules x 1 mL) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1201002 | Active | 17alpha-Dihydroequilin (50 mg) (Estra-1,3,5(10),7-tetraene-3,17alpha-diol) | Reference Standard | Impurity | Steroids | Enquire
|
| 1211254 | Active | 2,3-Dimethylaniline (50 mg) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1187954 | Active | 2,4-Dichlorophenol (100 mg) | Reference Standard | Impurity | Antiseptics | Enquire
|
| 1223005 | Active | 2,4-Disulfamyl-5-Trifluoromethylaniline (50 mg) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1022808 | Active | 2-Amino-5-chlorobenzophenone (25 mg) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1112208 | Active | 2-Chloroadenine (25 mg) (2-Chloro-7H-purin-6-amine) | Reference Standard | Impurity | Oncology | Enquire
|
| 1265526 | Active | 2-Ethylhexan-1-ol (1.5 mL) (DISCONTINUED) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1445584 | Active | 2-Mononitroglycerin (2 ampules x 1 mL) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1685500 | Active | 2-[N-(2,2,2-Trifluoroethyl)amino-5]-chlorobenzophenone (25 mg) | Reference Standard | Impurity | Others-Chemical Medicines | Enquire
|
| 1026605 | Active | 3-Amino-2,4,6-triiodobenzoic Acid (50 mg) | Reference Standard | Impurity | Nonradioactive Imaging Agents | Enquire
|
| 1026412 | Active | 3-Aminosalicylic Acid (15 mg) (3-Amino-2-hydroxybenzoic acid) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1112299 | Active | 3-Chlorobenzoic Acid (25 mg) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1391000 | Active | 3-Mercapto-2-methylpropanoic Acid 1,2-Diphenylethylamine Salt (75 mg) | Reference Standard | Impurity | Others-Chemical Medicines | Enquire
|
| 1430509 | Active | 3-O-Methylmethyldopa (50 mg) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1021204 | Active | 4-Aminophenol (100 mg) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1112467 | Active | 4-Chlorobenzophenone (30 mg) (4-Chlorobenzophenone) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1236506 | Active | 4-Epianhydrotetracycline Hydrochloride (50 mg) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1313254 | Active | 4-Hydrazinylbenzenesulfonamide Hydrochloride (25 mg) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1327157 | Active | 4-Hydroxyindole (25 mg) (1H-Indol-4-ol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1379445 | Active | 4-Methoxymeloxicam (30 mg) (4-methoxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1466572 | Active | 4-Nitrobenzoic Acid (50 mg) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1027007 | Active | 5-Amino-2,4,6-triiodo-N-methylisophthalamic Acid (50 mg) | Reference Standard | Impurity | Nonradioactive Imaging Agents | Enquire
|
| 1327328 | Active | 5-Hydroxymethylfurfural (50 mg) (5-(Hydroxymethyl)-2-furaldehyde) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1533308 | Active | 5-Phenylhydantoin (100 mg) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1166535 | Active | 6,7-Dehydronorethindrone Acetate (20 mg) (3-oxo-19-nor-17alpha-pregn-4,6-dien-20-yn-17-yl acetate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1356213 | Active | 6-Ketonorethindrone Acetate (20 mg) (3,6-Dioxo-19-nor-17alpha pregn-4-en-20-yn-17-yl acetate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1121038 | Active | 8-Chlorotheophylline (200 mg) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1424084 | Active | 9-Methylacridine (25 mg) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1000420 | Active | Abacavir Related Compound A (20 mg) ([4-(2,6-diamino-9H-purin-9-yl)cyclopent-2-enyl]methanol) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1000441 | Active | Abacavir Related Compound B (20 mg) ([4-(2,5-diamino-6-chloropyrimidin-4-ylamino)cyclopent-2-enyl]methanol) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1000452 | Active | Abacavir Related Compound C (20 mg) ([(1S,4R)-4-(2-amino-6-chloro-9H-purin-9-yl)cyclopent-2-enyl]methanol hydrochloride) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1000437 | Active | Abacavir Related Compound D (20 mg) (N6-Cyclopropyl-9-{(1R,4S)-4-[(2,5-diamino-6-chloropyrimidin-4-yloxy)methyl]cyclopent-2-enyl}-9H-purine-2,6-diamine) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1000485 | Active | Abacavir Related Compounds Mixture (15 mg) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1000496 | Active | Abacavir Stereoisomers Mixture (15 mg) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1000419 | Active | Abacavir Sulfate Racemic (20 mg) (4-[2-amino-6-(cyclopropylamino)-9H-purin-9yl]-2-cyclopentene-1-methanol sulfate (2:1)) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1000565 | Active | Acamprosate Related Compound A (15 mg) (3-aminopropane-1-sulfonic acid) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1000576 | Active | Acamprosate Related Compound B (20 mg) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1000612 | Active | Acebutolol Related Compound A (20 mg) (N-(3-Acetyl-4-hydroxyphenyl)butyramide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1000623 | Active | Acebutolol Related Compound B (20 mg) (N-{3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl}acetamide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1000699 | Active | Acebutolol Related Compound I (20 mg) (N-{3-Acetyl-4-[3-(ethylamino)-2-hydroxypropoxy]phenyl}butyramide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1002811 | Active | Acetaldehyde (3 x 1.1 mL) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1003010 | Active | Acetaminophen Related Compound A (15 mg) (4-(acetylamino)phenyl acetate) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1003027 | Active | Acetaminophen Related Compound B (30 mg) (N-(4-hydroxyphenyl)propanamide) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1003031 | Active | Acetaminophen Related Compound C (50 mg) (N-(2-hydroxyphenyl)acetamide) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1003042 | Active | Acetaminophen Related Compound D (50 mg) (N-phenylacetamide) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1003064 | Active | Acetaminophen Related Compound F (50 mg) (p-nitrophenol) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1003100 | Active | Acetaminophen Related Compound J (50 mg) (N-(4-chlorophenyl)acetamide) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1005048 | Active | Acetazolamide Related Compound D (25 mg) (5-Amino-1,3,4-thiadiazole-2-sulfonamide) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1005059 | Active | Acetazolamide Related Compound E (25 mg) (5-Acetamido-1,3,4-thiadiazole-2-sulfonic acid potassium salt) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1010208 | Active | Acetyl Simvastatin (30 mg) ((1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-(acetoxy)-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1009038 | Active | Acetylcysteine Related Compound C (20 mg) (2R,2'R)-3,3'-disulfanediylbis(2-acetamidopropanoic acid) | Reference Standard | Impurity | Hepatic | Enquire
|
| 1009049 | Active | Acetylcysteine Related Compound D (20 mg) (N,S-Diacetyl-L-Cysteine) | Reference Standard | Impurity | Hepatic | Enquire
|
| 1011018 | Active | Acitretin Related Compound A (20 mg) ((2Z,4E,6E,8E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1011029 | Active | Acitretin Related Compound B (20 mg) (ethyl (all-E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoate) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1012076 | Active | Acyclovir Related Compound A (50 mg) (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl acetate) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1012054 | Active | Acyclovir Related Compound F (50 mg) (N-[9-[(2-Hydroxyethoxy)methyl]-6-oxo-6,9-dihydro-1H-purin-2-yl]acetamide) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1012087 | Active | Acyclovir Related Compound G (50 mg) (2-{[2-(Acetylamino)-6-oxo-1,6-dihydro-9H-purin-9-yl]methoxy}ethyl acetate) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1011710 | Active | Adapalene Related Compound A (50 mg) (Methyl 6-bromo-2-naphthoate) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1011721 | Active | Adapalene Related Compound B (50 mg) (Methyl 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoate) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1011732 | Active | Adapalene Related Compound C (25 mg) (2-(adamant-1-yl)methoxybenzene) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1011743 | Active | Adapalene Related Compound D (25 mg) (4,4'-dimethoxy-3,3'-di(adamant-1-yl)biphenyl) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1011754 | Active | Adapalene Related Compound E (25 mg) (2,2'-binaphthyl-6,6'-dicarboxylic acid) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1011878 | Active | Adrenalone Hydrochloride (25 mg) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1012554 | Active | Albendazole Related Compound A (25 mg) (5-Propylthiobenzimidazol-2-amine) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1012557 | Active | Albendazole Related Compound D | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1012559 | Active | Albendazole Related Compound F (25 mg) (Methyl (5-methylthiobenzimidazol-2-yl)carbamate) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1012644 | Active | Albuterol Related Compound A (25 mg) (4-[2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2-methylphenol sulfate) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1012655 | Active | Albuterol Related Compound B (10 mg) (2-(tert-butylamino)-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethanone) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1012689 | Active | Albuterol Related Compound E (10 mg) (2,2'-oxybis(methylene)bis{4-[2-(tert-butylamino)-1-hydroxyethyl]phenol} diacetate) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1012611 | Active | Albuterol Related Compound F (15 mg) (4-[2-(tert-Butylamino)-1-ethoxyethyl]-2-(hydroxymethyl)phenol) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1012564 | Active | Albuterol Related Compound I (20 mg) (4-[2-(tert-Butylamino)-1-hydroxyethyl]phenol) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1012746 | Active | Alclometasone Dipropionate Related Compound A (20 mg) (11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1013024 | Active | Allopurinol Related Compound A (25 mg) (3-Amino-4-carboxamidopyrazole Hemisulfate) | Reference Standard | Impurity | Renal | Enquire
|
| 1013013 | Active | Allopurinol Related Compound B (25 mg) (5-(formylamino)-1H-pyrazole-4-carboxamide) | Reference Standard | Impurity | Renal | Enquire
|
| 1013035 | Active | Allopurinol Related Compound C (25 mg) (5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide) | Reference Standard | Impurity | Renal | Enquire
|
| 1013046 | Active | Allopurinol Related Compound D (35 mg) (Ethyl 5-amino-1H-pyrazole-4-carboxylate) | Reference Standard | Impurity | Renal | Enquire
|
| 1013068 | Active | Allopurinol Related Compound E (25 mg) (Ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate) | Reference Standard | Impurity | Renal | Enquire
|
| 1013079 | Active | Allopurinol Related Compound F (25 mg) (ethyl-(E/Z)-3-(2-carbethoxy-2-cyanoethenyl)amino-1H-pyrazole-4-carboxylate) | Reference Standard | Impurity | Renal | Enquire
|
| 1013523 | Active | Almotriptan Related Compound A (20 mg) ({3-[2-(Dimethylamino)ethyl]-5-[(pyrrolidine-1-yl)sulfonylmethyl]-1H-indol-1-yl}methanol) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1013545 | Active | Almotriptan Related Compound B (15 mg) (2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine hemifumarate) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1013556 | Active | Almotriptan Related Compound C (15 mg) (N-methyl-2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1013567 | Active | Almotriptan Related Compound D (15 mg) (1-[({3-[2-(dimethylamino)ethyl]indol-5-yl}methyl)sulfonyl]pyrrolidine N-oxide hydrochloride) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1013818 | Active | Alosetron Related Compound A (25 mg) (5-Methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1015019 | Active | Alprazolam Related Compound A (30 mg) (2-(2-acetylhydrazino)-7-chloro-5-phenyl-3H-1,4-benzodiazepine) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1018516 | Active | Amantadine Related Compound A (25 mg) (1-Chloroadamantane) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1018527 | Active | Amantadine Related Compound B (25 mg) (N-(Adamantan-1-yl)acetamide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1019417 | Active | Amifostine Disulfide (100 mg) (1,3-Propanediamine, N,N-(dithiodi-2,1-ethanediyl)bis, tetrahydrochloride) | Reference Standard | Impurity | Oncology | Enquire
|
| 1019428 | Active | Amifostine Thiol (50 mg) (Ethanethiol, 2-[(3-aminopropyl)amino]-, dihydrochloride) | Reference Standard | Impurity | Oncology | Enquire
|
| 1019712 | Active | Amiloride Related Compound A (30 mg) (Methyl 3,5-diamino-6-chloropyrazine-2-carboxylate) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1020008 | Active | Aminobutanol (500 mg) (1-Butanol, 2-amino-, (+/-)-) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1025726 | Active | Aminolevulinic Acid Related Compound A (25 mg) (3,3'-(Pyrazine-2,5-diyl)dipropionic acid) | Reference Standard | Impurity | Oncology | Enquire
|
| 1025737 | Active | Aminolevulinic Acid Related Compound B (25 mg) (Methyl 5-(1,3-dioxoisoindolin-2-yl)-4-oxopentanoate) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1027346 | Active | Amiodarone Related Compound D (20 mg) ((2-Butylbenzofuran-3-yl)(4-hydroxy-3,5-diiodophenyl)methanone) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1027357 | Active | Amiodarone Related Compound E (25 mg) ((2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1027380 | Active | Amiodarone Related Compound H (20 mg) (2-chloro-N,N-diethylethanamine hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1028019 | Active | Amitraz Related Compound A (40 mg) (N-(2,4-Dimethylphenyl)formamide) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1028028 | Active | Amitraz Related Compound B (40 mg) (N'-(2,4-Dimethylphenyl)-N-methylformimidamide) (COLD SHIPMENT REQUIRED) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1028032 | Active | Amitraz Related Compound C (40 mg) (N,N'-Bis(2,4-dimethylphenyl)formimidamide) (COLD SHIPMENT REQUIRED) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1029013 | Active | Amitriptyline Related Compound A (25 mg) (dibenzosuberone) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1029024 | Active | Amitriptyline Related Compound B (25 mg) (5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenzo[a,d]-cyclohepten-5-ol) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1029512 | Active | Amlodipine Related Compound A (25 mg) (3-Ethyl 5-methyl [2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-3,5-pyridinedicarboxylate] fumarate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1029534 | Active | Amlodipine Related Compound C (25 mg) (Dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1029545 | Active | Amlodipine Related Compound D (25 mg) (3-Ethyl 5-methyl 4-(2-chlorophenyl)-2-{[2-(1,3-dioxoisoindolin-2-yl)ethoxy]methyl}-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1029567 | Active | Amlodipine Related Compound F (25 mg) (Dimethyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate maleate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1029614 | Active | Amlodipine Related Compound K (25 mg) (Ethyl 6-(2-chlorophenyl)-8-methyl-3,4,6,7-tetrahydro-2H-benzo[b][1,4]oxazine-5-carboxylate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1031445 | Active | Amoxapine Related Compound D (50 mg) (2-Chlorodibenzo[b,f]-[1,4]-oxazepin-11-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1031478 | Active | Amoxapine Related Compound G (50 mg) (3-Chloro-11-(piperazin-1-yl)dibenzo[b,f][1,4]oxazepine) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1031514 | Active | Amoxicillin Related Compound A (15 mg) ((2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1031525 | Active | Amoxicillin Related Compound B (15 mg) (L-amoxicillin) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1031536 | Active | Amoxicillin Related Compound C (15 mg) ((4S)-2-[5-(4-hydroxyphenyl)-3,6-dioxopiperazin-2-yl]-5,5-dimethylthiazolidine-4-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1031547 | Active | Amoxicillin Related Compound D (50 mg) ((4S)-2-{[(R)-2-amino-2-(4-hydroxyphenyl)acetamido](carboxy)methyl}-5,5-dimethylthiazolidine-4-carboxylic acid, monosodium salt) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1031569 | Active | Amoxicillin Related Compound F (15 mg) (3-(4-Hydroxyphenyl)pyrazin-2-ol; phenylpyrazinediol) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1031570 | Active | Amoxicillin Related Compound G (15 mg) ((2S,5R,6R)-6-{(R)-2-[(R)-2-Amino-2-(4-hydroxyphenyl)acetamido]-2-(4-hydroxyphenyl)acetamido}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1031616 | Active | Amoxicillin Related Compound H (15 mg) ((R)-2-(4-hydroxyphenyl)-2-pivalamidoacetic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1031591 | Active | Amoxicillin Related Compound I (25 mg) ((R)-2-Amino-2-(4-hydroxyphenyl)acetic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1031605 | Active | Amoxicillin Related Compound J (15 mg) (Mixture of amoxicillin and amoxicillin related compound J (open ring dimer)) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1031558 | Active | Amoxicillin Related Compounds D and E Mixture (15 mg) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1034320 | Active | Amrinone Related Compound A (100 mg) (5-carboxamide[3,4'-bipyridin]-6(1H)-one) (Inamrinone Related Compound A) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1034363 | Active | Amrinone Related Compound C (50 mg) (6-Oxo-1,6-dihydro-[3,4'-bipyridine]-5-carbonitrile) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1034749 | Active | Anagrelide Related Compound A (25 mg) (ethyl 2-(6-amino-2,3-dichlorobenzylamino)acetate) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1034750 | Active | Anagrelide Related Compound B (25 mg) ((2-amino-5,6-dichloroquinazolin-3(4H)-yl)acetic acid) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1034771 | Active | Anagrelide Related Compound C (25 mg) (Ethyl 2-(5,6-dichloro-2-imino-1,2-dihydroquinazolin-3(4H)-yl)acetate) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1034818 | Active | Anastrozole Related Compound A (20 mg) (2,2'-(5-methyl-1,3-phenylene)bis(2-methylpropanenitrile)) | Reference Standard | Impurity | Oncology | Enquire
|
| 1035402 | Active | Anhydro Simvastatin (30 mg) ((1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-[2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate) (COLD SHIPMENT REQUIRED) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1035708 | Active | Anhydrotetracycline Hydrochloride (25 mg) ((4S ,4aS ,12aS )-4-(Dimethylamino)-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide monohydrochloride) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1036110 | Active | Aniline (250 mg) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1038025 | Active | Antazoline Related Compound A (15 mg) (N-(2-Aminoethyl)-2-[benzyl(phenyl)amino]acetamide) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1040016 | Active | Antipyrine Related Compound A (25 mg) (3-Methyl-1-phenyl-1H-pyrazol-5(4H)-one) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1040752 | Active | Apixaban Related Compound D (15 mg) (N-Formyl-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1040763 | Active | Apixaban Related Compound E (15 mg) (Methyl 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1040774 | Active | Apixaban Related Compound F (25 mg) (Ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1040785 | Active | Apixaban Related Compound G (25 mg) (Ethyl 6-[4-(5-bromopentanamido)phenyl]-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1040796 | Active | Apixaban Related Compound H (25 mg) (Ethyl 6-[4-(5-chloropentanamido)phenyl]-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1041915 | Active | Aprepitant Related Compound A (10 mg) (3-[[(2R,3R)-2-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1041926 | Active | Aprepitant Related Compound B (10 mg) (3-[[(2S,3R)-2-[(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1042419 | Active | Argatroban Related Compound A (15 mg) ((2R,4R)-1-[N8-nitro- N2-(3-methylquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1042420 | Active | Argatroban Related Compound B (20 mg) (Ethyl (4R)-1-[N^8-nitro-L-arginyl]-4-methylpiperidine-2-carboxylate dihydrochloride) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1042437 | Active | Argatroban Related Compound C (20 mg) ((2R,4R)-1-[N^8-amino- N^2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1042645 | Active | Aripiprazole Related Compound B (25 mg) (7-(4-hydroxy-butoxy)-3,4-dihydroquinolin-2(1H)-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1042656 | Active | Aripiprazole Related Compound C (25 mg) (1-(2,3-dichlorophenyl)piperazine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1042689 | Active | Aripiprazole Related Compound F (25 mg) (4-(2,3-dichlorophenyl)-1-[4-(2-oxo-1,2,3,4-tetrahydroquinolin-7-yloxy)butyl]piperazin 1-oxide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1042690 | Active | Aripiprazole Related Compound G (25 mg) (7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}quinolin-2(1H)-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1042714 | Active | Aripiprazole Related Compound H (25 mg) (7-(4-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}butoxy)-3,4-dihydroquinolin-2(1H)-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1042805 | Active | Artemether Related Compound B (15 mg) ((3R,5aS,6R,8aS,9R,10R,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1042929 | Active | Articaine Related Compound A (40 mg) (Methyl 4-methyl-3-[2-(propylamino)acetamido]thiophene-2-carboxylate hydrochloride) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1042930 | Active | Articaine Related Compound B (25 mg) (4-methyl-3-{[2-(propylamino)propanoyl]amino}thiophene-2-carboxylic acid) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1042962 | Active | Articaine Related Compound E (40 mg) (Methyl 3-[2-(isopropylamino)propanamido]-4-methylthiophene-2-carboxylate) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1044356 | Active | Atazanavir Related Compound A (25 mg) ((S)-2-[(Methoxycarbonyl)amino]-3,3-dimethylbutanoic acid) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1044254 | Active | Atenolol Related Compound A (50 mg) (2-(4-Hydroxyphenyl)acetamide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1044265 | Active | Atenolol Related Compound B (25 mg) (2-[4-(2,3-Dihydroxypropoxy)phenyl]acetamide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1044276 | Active | Atenolol Related Compound C (25 mg) (2-[4-(Oxiran-2-ylmethoxy)phenyl]acetamide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1044287 | Active | Atenolol Related Compound D (25 mg) (2-[4-(3-Chloro-2-hydroxypropoxy)phenyl]acetamide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1044298 | Active | Atenolol Related Compound E (25 mg) (2,2'-{[(2-Hydroxypropane-1,3-diyl)bis(oxy)]bis(4,1-phenylene)}diacetamide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1044367 | Active | Atenolol Related Compound F (25 mg) (2,2'-[{[(Isopropylazanediyl)bis(2-hydroxypropane-3,1-diyl)]bis(oxy)}bis(4,1-phenylene)]diacetamide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1044470 | Active | Atomoxetine Related Compound A (10 mg) (3-(Methylamino)-1-phenylpropan-1-ol) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1044488 | Active | Atomoxetine Related Compound B (10 mg) ((R)-N-Methyl-3-phenyl-3-(3-tolyloxy)propan-1-amine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1044491 | Active | Atomoxetine Related Compound C (10 mg) (N-methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1044913 | Active | Atomoxetine S-Isomer (10 mg) ((S)-N-Methyl-3-phenyl-3-(2-tolyloxy)propan-1-amine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1044527 | Active | Atorvastatin Related Compound A (20 mg) (Desfluoro impurity, or (3R,5R)-7-[3-(phenylcarbamoyl)-2-isopropyl-4,5-diphenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calcium salt) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1044538 | Active | Atorvastatin Related Compound B (20 mg) (Calcium (3S,5R)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (1:2)) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1044549 | Active | Atorvastatin Related Compound C (20 mg) (Calcium (3R,5R)-7-[2,3-Bis(4-fluorophenyl)-5-isopropyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (1:2)) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1044550 | Active | Atorvastatin Related Compound D (10 mg) (Epoxide Impurity, 3-(4-Fluorobenzoyl)-2-isobutyryl-N,3-diphenyloxirane-2-carboxamide) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1044571 | Active | Atorvastatin Related Compound E (10 mg) (Calcium(3S,5S)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (1:2)) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1044582 | Active | Atorvastatin Related Compound H (20 mg) (Lactone Impurity, 5-(4-Fluorophenyl)-1-{2-[(2R, 4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1044593 | Active | Atorvastatin Related Compound I (20 mg) (tert-Butyl 2-((4R,6R)-6-{2-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]ethyl}-2,2-dimethyl-1,3-dioxan-4-yl)acetate) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1044662 | Active | Atovaquone Related Compound A (25 mg) (cis-2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1045539 | Active | Azacitidine Related Compound A (25 mg) (4-Amino-1,3,5-triazin-2(1H)-one) | Reference Standard | Impurity | Oncology | Enquire
|
| 1045541 | Active | Azacitidine Related Compound B (15 mg) (1-O-Acetyl-2,3,5-tri-O-benzoyl-Beta-D-ribofuranose) | Reference Standard | Impurity | Oncology | Enquire
|
| 1045574 | Active | Azacitidine Related Compound C (15 mg) (1-beta-D-Ribofuranosyl-3-guanylurea picrate) | Reference Standard | Impurity | Oncology | Enquire
|
| 1045600 | Active | Azaerythromycin A (100 mg) (9-Deoxo-9a-aza-9a-homoerythromycin A) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1045993 | Active | Azathioprine Related Compound A (15 mg) (1-Methyl-4-nitro-1H-imidazol-5-amine) | Reference Standard | Impurity | Immunosuppresants | Enquire
|
| 1045938 | Active | Azathioprine Related Compound G (15 mg) (6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purin-2-amine) | Reference Standard | Impurity | Immunosuppresants | Enquire
|
| 1046170 | Active | Azelastine Related Compound B (20 mg) (N'-(1-methylazepan-4-yl)benzohydrazide hydrochloride) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1046191 | Active | Azelastine Related Compound D (20 mg) (4-(4-chlorobenzyl)phthalazin-1(2H)-one) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1046202 | Active | Azelastine Related Compound E (20 mg) (3-(4-chlorobenzylidene)isobenzofuran-1(3H)-one) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1046213 | Active | Azelastine Related Compound F (20 mg) (4-[4-(4-Chlorobenzyl)-1-oxophthalazin-2(1H)-yl]-1-methylazepane 1-oxide) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1046067 | Active | Azithromycin Identity (75 mg) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1046090 | Active | Azithromycin N-Oxide (15 mg) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1046045 | Active | Azithromycin Related Compound F (25 mg) (3'-N-Demethyl-3'-N-formylazithromycin) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1046023 | Active | Azithromycin Related Compound H (15 mg) (3'-N-{[4-(Acetylamino)phenyl]sulfonyl}-3'-N-demethylazithromycin) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1046307 | Active | Aztreonam E-Isomer (15 mg) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1046351 | Active | Azure B (50 mg) (3-(Dimethylamino)-7-(methylamino)phenothiazin-5-ium chloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1048222 | Active | Baclofen Related Compound A (50 mg) (4-(4-Chlorophenyl)-2-pyrrolidinone) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1048266 | Active | Balsalazide Related Compound A (100 mg) ((E)-5-[(p-carboxyphenyl)azo]-2-salicylic acid, disodium salt) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1048277 | Active | Balsalazide Related Compound B (25 mg) ((E)-5-((m-[(2-carboxyethyl)carbamoyl]phenyl)azo)-2-salicylic acid) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1048517 | Active | Beclomethasone Dipropionate Related Compound A (25 mg) (9-Chloro-11Beta,17-dihydroxy-16Beta-methyl-3,20-dioxopregna-1,4-diene-21-yl propionate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1048543 | Active | Beclomethasone Dipropionate Related Compound H (25 mg) (9-Chloro-11Beta,21-dihydroxy-16Beta-methyl-3,20-dioxopregna-1,4-diene-17-yl propionate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1048583 | Active | Bemotrizinol Impurity Mixture (100 mg) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1048620 | Active | Benazepril Related Compound A (25 mg) ((3R)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid, monohydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1048630 | Active | Benazepril Related Compound B (15 mg) (2-[(S)-3-{[(R)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl]acetic acid hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1048641 | Active | Benazepril Related Compound C (50 mg) ((S)-2-{[(S)-1-(Carboxymethyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-yl]amino}-4-phenylbutanoic acid) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1048652 | Active | Benazepril Related Compound D (15 mg) (3-(1-Ethoxycarbonyl-3-cyclohexyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid monohydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1048663 | Active | Benazepril Related Compound E (25 mg) (3-amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid, monohydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1048674 | Active | Benazepril Related Compound F (15 mg) (tert-Butyl-3-amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1048685 | Active | Benazepril Related Compound G (15 mg) (COLD SHIPMENT REQUIRED) ((3-(1-Ethoxycarbonyl-3-phenyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine)-1-acetic acid, ethyl ester) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1065232 | Active | Bendamustine Related Compound A (25 mg) (4-{5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid hydrochloride) | Reference Standard | Impurity | Oncology | Enquire
|
| 1065243 | Active | Bendamustine Related Compound B (20 mg) (4-(1-Methyl-5-morpholino-1H-benzimidazol-2-yl)butanoic acid hydrochloride) | Reference Standard | Impurity | Oncology | Enquire
|
| 1065254 | Active | Bendamustine Related Compound C (20 mg) (Ethyl 4-{5-[bis(2-hydroxyethyl)amino]-1-methyl-1H -benzimidazol-2-yl}butanoate) | Reference Standard | Impurity | Oncology | Enquire
|
| 1065265 | Active | Bendamustine Related Compound D (20 mg) (4-{5-[(2-Chloroethyl)amino]-1-methyl-1H -benzimidazol-2-yl}butanoic acid hydrochloride) | Reference Standard | Impurity | Oncology | Enquire
|
| 1065276 | Active | Bendamustine Related Compound E (20 mg) (4-{5-[(2-Chloroethyl)(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid) | Reference Standard | Impurity | Oncology | Enquire
|
| 1065287 | Active | Bendamustine Related Compound F (20 mg) (Mannitol-1-yl 4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H -benzimidazol-2-yl}butanoate) | Reference Standard | Impurity | Oncology | Enquire
|
| 1065298 | Active | Bendamustine Related Compound G (20 mg) (4-[6-(2-Chloroethyl)-3,6,7,8-tetrahydro-3-methylimidazo[4,5-h][1,4]benzothiazin-2-yl]butanoic acid hydrochloride) | Reference Standard | Impurity | Oncology | Enquire
|
| 1065301 | Active | Bendamustine Related Compound H (25 mg) (4-[5-({2-[(4-{5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoyl)oxy]ethyl}(2-chloroethyl)amino)-1-methyl-1H-benzimidazol-2-yl]butanoic acid) | Reference Standard | Impurity | Oncology | Enquire
|
| 1065312 | Active | Bendamustine Related Compound I (25 mg) (Ethyl 4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoate) | Reference Standard | Impurity | Oncology | Enquire
|
| 1050982 | Active | Benzalkonium Bromide (C12) (150 mg) (Benzyldodecyldimethylammonium bromide) (COLD SHIPMENT REQUIRED) | Reference Standard | Impurity | Steroids | Enquire
|
| 1051602 | Active | Benzhydrol (50 mg) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1056130 | Active | Benzophenone (25 mg) (Diphenylmethanone) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1057507 | Active | Benzothiadiazine Related Compound A (100 mg) (4-Amino-6-chloro-1,3-benzenedisulfonamide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1059014 | Active | Benzphetamine Related Compound A CIII (30 mg) ((R)-N-Benzyl-N-methyl-1-phenylpropan-2-amine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1059058 | Active | Benzphetamine Related Compound E (30 mg) ((1S,2S)-2-[Benzyl(methyl)amino]-1-phenylpropan-1-ol hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1059069 | Active | Benzphetamine Related Compound F (25 mg) ((1S,2S)-2-[Benzyl(methyl)amino]-1-cyclohexylpropan-1-ol hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1061027 | Active | Benztropine Related Compound A (50 mg) ((1R,3r,5S)-3-(Benzhydryloxy)-8-azabicyclo[3.2.1]octane hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1062019 | Active | Benzyl Chloride (3 x 200 mg) ((Chloromethyl)benzene) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1424511 | Active | Beta-Methylcholine Chloride (2 X 25 mg) (2-Hydroxy-N,N,N-trimethylpropan-1-aminium chloride) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1067034 | Active | Betamethasone Acetate Related Compound C (20 mg) (9-Fluoro-11Beta,17,21-trihydroxy-16Beta-methylpregna-1,4-diene-3,20-dione 11,21-diacetate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1067045 | Active | Betamethasone Acetate Related Compound D (20 mg) (9,11Beta-Epoxy-17,21-dihydroxy-16Beta-methylpregna-1,4-diene-3,20-dione 21-acetate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1067726 | Active | Betamethasone Dipropionate Related Compound B (25 mg) (9-Fluoro-11Beta,21-dihydroxy-16Beta-methyl-3,20-dioxopregna-1,4-diene-17-yl propionate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1067737 | Active | Betamethasone Dipropionate Related Compound C (25 mg) (9-Fluoro-11Beta,17-dihydroxy-16Beta-methyl-3,20-dioxopregna-1,4-diene-21-yl propionate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1067760 | Active | Betamethasone Dipropionate Related Compound F (30 mg) (9,11Beta-Epoxy-16Beta-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropionate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1067781 | Active | Betamethasone Dipropionate Related Compound H (30 mg) (6alpha-Bromo-9-fluoro-11Beta-hydroxy-16Beta-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropionate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1069018 | Active | Betamethasone Valerate Related Compound A (50 mg) (9-Fluoro-11beta,17-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-diene-21-yl valerate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1069049 | Active | Betamethasone Valerate Related Compound D (15 mg) (9-Bromo-11Beta,21-dihydroxy-16Beta-methyl-3,20-dioxopregna-1,4-dien-17-yl valerate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1069914 | Active | Betaxolol Related Compound A (20 mg) (1-(4-Ethylphenoxy)-3-(isopropylamino)propan-2-ol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1071151 | Active | Bexarotene Related Compound A (15 mg) (Methyl 4-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalene-2-carbonyl)benzoate) | Reference Standard | Impurity | Oncology | Enquire
|
| 1071213 | Active | Bicalutamide Related Compound A (25 mg) (N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluoro-phenyl)sulfinyl]-2-hydroxy-2-methyl-propanamide) | Reference Standard | Impurity | Oncology | Enquire
|
| 1071224 | Active | Bicalutamide Related Compound B (10 mg) ((RS)-N-(4-Cyano-3-(trifluoromethyl)phenyl)-3-(3-fluorophenylsulfonyl)-2-hydroxy-2-methylpropanamide) | Reference Standard | Impurity | Oncology | Enquire
|
| 1071359 | Active | Bimatoprost Related Compound A (1 mL) ((E)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(S,E)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl]-N-ethylhept-5-enamide) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1075203 | Active | Bis(2-ethylhexyl)maleate (2 g) (Maleic acid, bis(2-ethylhexyl)ester) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1074030 | Active | Bisacodyl Related Compound A (20 mg) (4,4'-(Pyridin-2-ylmethylene)diphenol) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1074042 | Active | Bisacodyl Related Compound B (20 mg) (2,4'-(Pyridin-2-ylmethylene)diphenol) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1074051 | Active | Bisacodyl Related Compound C (20 mg) (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1074073 | Active | Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1075688 | Active | Bisoctrizole Related Compound A (25 mg) (2-(2H-Benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl) phenol) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1075768 | Active | Bisoprolol Related Compound A (50 mg) (1-[4-(Hydroxymethyl)phenoxy]-3-(isopropylamino)propan-2-ol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1075780 | Active | Bisoprolol Related Compound C (50 mg) (1-(Isopropylamino)-3-(4-methylphenoxy)propan-2-ol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1075799 | Active | Bisoprolol Related Compound D (50 mg) (1-(4-{[(2-Isopropoxyethoxy)methoxy]methyl}phenoxy)-3-(isopropylamino)propan-2-ol fumarate (2:1) salt) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1075804 | Active | Bisoprolol Related Compound E (25 mg) (3,3'-(Isopropylazanediyl)bis(1-(4-((2-isopropoxyethoxy)methyl)phenoxy)propan-2-ol)) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1075815 | Active | Bisoprolol Related Compound F (50 mg) (2-Isopropoxyethyl 4-[2-hydroxy-3-(isopropylamino)propoxy]benzoate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1076126 | Active | Bosentan Related Compound A (15 mg) (4-(tert-butyl)-N-[6-chloro-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl] benzenesulfonamide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1076137 | Active | Bosentan Related Compound B (15 mg) (4-(tert-butyl)-N-[6-hydroxy-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl]benzenesulfonamide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1076148 | Active | Bosentan Related Compound C (15 mg) (1,2-bis({6-[4-(tert-butyl)phenylsulfonamido]-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl}oxy)ethane) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1076159 | Active | Bosentan Related Compound D (15 mg) (4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1076160 | Active | Bosentan Related Compound E (15 mg) (4-(tert-butyl)benzenesulfonamide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1076419 | Active | Brimonidine Related Compound A (50 mg) (5-Bromoquinoxalin-6-amine) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1076421 | Active | Brimonidine Related Compound B (50 mg) (1-(5-Bromoquinoxalin-6-yl)thiourea) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1076454 | Active | Brimonidine Related Compound E (15 mg) (2-(5-Bromoquinoxalin-6-yl)guanidine dihydrochloride) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1076374 | Active | Brinzolamide Related Compound A (50 mg) ((S)-4-(Ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e] [1,2]thiazine-6-sulfonamide 1,1-dioxide), (Brinzolamide (S)-Isomer)) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1076385 | Active | Brinzolamide Related Compound B (50 mg) ((R)-4-Amino-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide oxalate) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1078041 | Active | Brivaracetam Related Compound A | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1078074 | Active | Brivaracetam Related Compound D | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1077887 | Active | Bromperidol Decanoate (15 mg) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1078245 | Active | Budesonide Related Compound E (25 mg) (16alpha,17-[butylidenebis(oxy)]-11Beta,21-dihydroxypregna-1,4,14-triene-3,20-dione) | Reference Standard | Impurity | Steroids | Enquire
|
| 1078267 | Active | Budesonide Related Compound G (25 mg) (16alpha,17-[butylidenebis(oxy)]-11beta, 21-dihydroxypregna-4-ene-3,20-dione) | Reference Standard | Impurity | Steroids | Enquire
|
| 1078289 | Active | Budesonide Related Compound L (25 mg) (16alpha,17-[butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione) | Reference Standard | Impurity | Steroids | Enquire
|
| 1078325 | Active | Bumetanide Related Compound A (10 mg) (3-Amino-4-phenoxy-5-sulfamoylbenzoic Acid) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1078336 | Active | Bumetanide Related Compound B (25 mg) (3-Nitro-4-phenoxy-5-sulfamoylbenzoic Acid) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1078518 | Active | Bupivacaine Related Compound A (50 mg) (6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide) (AS) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1078529 | Active | Bupivacaine Related Compound B (50 mg) N-(2,6-Dimethylphenyl)piperidine-2-carboxamide Hydrochloride | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1078711 | Active | Buprenorphine Related Compound A CII (25 mg) ((S)-2-[17-(But-3-en-1-yl)-4,5alpha-epoxy-3-hydroxy-6-methoxy-6alpha,14-ethanomorphinan-7alpha-yl]- 3,3-dimethylbutan-2-ol) | Reference Standard | Impurity | Opioids | Enquire
|
| 1078697 | Active | Buprenorphine Related Compound B CII (25 mg) ((S)-2-(4,5alpha-Epoxy-3-hydroxy-6-methoxy-6alpha,14-ethanomorphinan-7alpha-yl)-3,3-dimethylbutan-2-ol hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1078744 | Active | Bupropion Hydrochloride Related Compound A (15 mg) (2-(tert-butylamino)-4'-chloropropiophenone hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1078755 | Active | Bupropion Hydrochloride Related Compound B (10 mg) (2-(tert-butylamino)-3'-bromopropiophenone hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1078766 | Active | Bupropion Hydrochloride Related Compound C (40 mg) (1-(3-chlorophenyl)-2-hydroxypropan-1-one) (COLD SHIPMENT REQUIRED) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1078799 | Active | Bupropion Hydrochloride Related Compound F (40 mg) (1-(3-chlorophenyl)-1-hydroxypropan-2-one) (COLD SHIPMENT REQUIRED) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1078857 | Active | Bupropion Related Compound G (50 mg) (2-Bromo-1-(3-chlorophenyl)propan-1-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1078573 | Active | Buspirone Related Compound A (2 x 75 mg) (2-(Piperazin-1-yl)pyrimidine) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1078813 | Active | Buspirone Related Compound G (50 mg) (1,4-Di(pyrimidin-2-yl)piperazine) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1078642 | Active | Buspirone Related Compound K (50 mg) (8-azaspiro[4.5]decane-7,9-dione) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1078824 | Active | Buspirone Related Compound L (75 mg x 2) (8-(4-Chlorobutyl)-8-azaspiro[4.5]decane-7,9-dione) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1078835 | Active | Buspirone Related Compound N (50 mg) (8,8'-(Butane-1,4-diyl)bis(8-azaspiro[4.5]decane-7,9-dione) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1082901 | Active | Butyl 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoate (25 mg) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1086063 | Active | Caffeine Related Compound C (20 mg) (1,3,9-Trimethyl-3,9-dihydro-1H-purine-2,6-dione) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1086064 | Active | Caffeine Related Compound D (20 mg) (3,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dione) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1086066 | Active | Caffeine Related Compound F (20 mg) (1,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dione) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1086152 | Active | Calcipotriene Related Compound C (15 mg) ((5E,7E,22E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1alpha,3beta,24-triol) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1087814 | Active | Candesartan Cilexetil Related Compound A (10 mg) (Ethyl 1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-2-ethoxybenzimidazole-7-carboxylate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1087825 | Active | Candesartan Cilexetil Related Compound B (10 mg) (1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 3-({2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl}methyl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1087847 | Active | Candesartan Cilexetil Related Compound D (10 mg) (1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 3-({2'-(2-ethyl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl}methyl)-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1087869 | Active | Candesartan Cilexetil Related Compound F (10 mg) (1-(Cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-{[2'-(2-ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1087870 | Active | Candesartan Cilexetil Related Compound G (10 mg) (1-{[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-2-ethoxybenzimidazole-7-carboxylic acid) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1090717 | Active | Capecitabine Related Compound A (15 mg) (5'-deoxy-5-fluorocytidine) | Reference Standard | Impurity | Oncology | Enquire
|
| 1090728 | Active | Capecitabine Related Compound B (20 mg) (5'-deoxy-5-fluorouridine) | Reference Standard | Impurity | Oncology | Enquire
|
| 1090739 | Active | Capecitabine Related Compound C (10 mg) (2',3'-O-carbonyl-5'-deoxy-5-fluoro-N4-(pentyloxycarbonyl)cytidine) (COLD SHIPMENT REQUIRED) | Reference Standard | Impurity | Oncology | Enquire
|
| 1091221 | Active | Captopril Disulfide (100 mg) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1093012 | Active | Carbamazepine Related Compound A (30 mg) (10,11-dihydrocarbamazepine) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1093023 | Active | Carbamazepine Related Compound B (50 mg) (5H-Dibenz[b,f]azepine) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1095517 | Active | Carbidopa Related Compound A (25 mg) (3-O-Methylcarbidopa) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1096019 | Active | Carbinoxamine Related Compound A (25 mg) ((4-Chlorophenyl)(pyridin-2-yl)methanone) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1096021 | Active | Carbinoxamine Related Compound B (25 mg) ((4-Chlorophenyl)(pyridin-2-yl)methanol) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1096032 | Active | Carbinoxamine Related Compound C (25 mg) (N,N-Dimethyl-2-[phenyl(pyridin-2-yl)methoxy]ethan-1-amine oxalate) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1096510 | Active | Carglumic Acid Related Compound A (30 mg) ((S)-3-(2,5-dioxoimidazolidin-4-yl)propanoic acid) | Reference Standard | Impurity | Hepatic | Enquire
|
| 1096473 | Active | Carglumic Acid Related Compound D (25 mg) ((S)-1-Carbamoyl-5-oxopyrrolidine-2-carboxylic acid) | Reference Standard | Impurity | Hepatic | Enquire
|
| 1096597 | Active | Carisoprodol Related Compound A (10 mg) (2-hydroxymethyl-2-methylpentyl carbamate) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1096735 | Active | Carmustine Related Compound A (25 mg) (1,3-bis(2-chloroethyl)urea) | Reference Standard | Impurity | Oncology | Enquire
|
| 1096702 | Active | Carprofen Related Compound A (50 mg) (Carbazole) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1096859 | Active | Carteolol Related Compound F (25 mg) (5-(2-Hydroxy-3-methoxypropoxy)-3,4-dihydroquinolin-2(1H)-one) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1096633 | Active | Carvedilol Related Compound A (15 mg) (1-(4-(2-hydroxy-3-(2-(2-methoxyphenoxy)ethylamino)propoxy)-9H-carbazol-9-yl)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1096644 | Active | Carvedilol Related Compound B (15 mg) (3,3'-(2-(2-methoxyphenoxy)ethylazanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol)) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1096655 | Active | Carvedilol Related Compound C (20 mg) (1-(9H-Carbazol-4-yloxy)-3-(benzyl(2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1096666 | Active | Carvedilol Related Compound D (15 mg) (4-(Oxiran-2-ylmethoxy)-9H-carbazole) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1096677 | Active | Carvedilol Related Compound E (15 mg) (2-(2-Methoxyphenoxy)ethyl amine hydrochloride monohydrate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1096804 | Active | Cathinone Hydrochloride CI (50 mg) (alpha-Aminopropiophenone hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1096917 | Active | Cefaclor Delta-3 Isomer (15 mg) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1097126 | Active | Cefadroxil Related Compound B (25 mg) ((6R,7R)-7-amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1097148 | Active | Cefadroxil Related Compound D (25 mg) ((6R,7R)-7-[(S)-2-Amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1097192 | Active | Cefadroxil Related Compound I (25 mg) ((6R,7R)-7-[(R)-2-amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1097625 | Active | Cefdinir Related Compound A (10 mg) ((2R)-2-[(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetamido]-2-[(2RS,5RS)-5-methyl-7-oxo-2,4,5,7-tetrahydro-1H-furo[3,4-d][1,3]thiazin-2-yl]acetic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1097589 | Active | Cefdinir Related Compound B (10 mg) ((6R,7R)-7-[2-(2-amino-4-thiazolyl)acetamido]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1097680 | Active | Cefepime Related Compound D (20 mg) ((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1097691 | Active | Cefepime Related Compound E (20 mg) (1-{[(6R,7R)-7-Amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}-1-methylpyrrolidin-1-ium chloride) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1097953 | Active | Cefotaxime Related Compound E (15 mg) ((Z)-2-(2-aminothiazol-4-yl)-N-{(5aR,6R)-1,7-dioxo-1,3,4,5a,6,7-hexahydroazeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl}-2-(methoxyimino)acetamide) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1098108 | Active | Cefoxitin System Suitability Mixture (15 mg) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1098049 | Active | Cefprozil (E)-Isomer (50 mg) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1098050 | Active | Cefprozil (Z)-Isomer (200 mg) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1097997 | Active | Cefprozil L-Epimer (30 mg) ((6R,7R)-7-[(S)-2-amino-2-(4-hydroxyphenyl)acetamido]-8-oxo-3-[(Z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1097986 | Active | Cefprozil Related Compound D (30 mg) ((6R,7R)-7-amino-8-oxo-3-[(Z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1098129 | Active | Ceftazidime Delta-3-Isomer (15 mg) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1098195 | Active | Ceftriaxone Sodium E-Isomer (25 mg) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1098231 | Active | Cefuroxime Axetil Delta-3-Isomers (10 mg) ((1RS,6R,7R)-1-Acetoxyethyl 3-[(carbamoyloxy)methyl]-7-[(Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylate) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1098253 | Active | Cefuroxime Axetil E-isomers (15 mg) ((1RS,6R,7R)-1-Acetoxyethyl 3-[(carbamoyloxy)methyl]-7-[(E)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1098515 | Active | Celecoxib Related Compound A (10 mg) (4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1098526 | Active | Celecoxib Related Compound B (10 mg) (4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1098537 | Active | Celecoxib Related Compound C (25 mg) (4-[5-(2,4-Dimethylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1098570 | Active | Celecoxib Related Compound D (25 mg) ((E)-4-{2-[1-(p-Tolyl)ethylidene]hydrazineyl}benzenesulfonamide) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1099041 | Active | Cephalexin Related Compound D (25 mg) (3-Hydroxy-4-methylthiophen-2(5H)-one) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1099063 | Active | Cephalexin Related Compound F (25 mg) ((6R,7R)-7-[(R)-2-Amino-2-phenylacetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1102930 | Active | Cetirizine Related Compound A (20 mg) ((RS)-2-[2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic acid ethyl ester oxalate) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1102941 | Active | Cetirizine Related Compound B (25 mg) (2-(4-Benzhydrylpiperazin-1-yl)ethan-1-ol dihydrochloride) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1102952 | Active | Cetirizine Related Compound C (25 mg) (2-(2-{4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl}ethoxy)acetamide) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1102963 | Active | Cetirizine Related Compound G (50 mg) (2-{4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl}ethanol dihydrochloride) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1104265 | Active | Cevimeline trans-Isomer (15 mg) ((2RS,2'SR)-2'-Methyl-4-azaspiro{bicyclo[2.2.2]octane-2,5'-[1,3]oxathiolane} hydrochloride hemihydrate) | Reference Standard | Impurity | Others-Chemical Medicines | Enquire
|
| 1107503 | Active | Chloramphenicol Palmitate Polymorph A (100 mg) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1110020 | Active | Chlordiazepoxide Related Compound A (25 mg) (7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one 4-Oxide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1112311 | Active | Chlorobenzhydryl Piperazine (75 mg) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1115705 | Active | Chloromethyl Isopropyl Carbonate (100 mg) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1117020 | Active | Chloropropiophenone (10 mg) (1-(3-Chlorophenyl)propan-1-one) (COLD SHIPMENT REQUIRED) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1117110 | Active | Chloropropyl Vanillin (25 mg) (4-(3-Chloropropoxy)-3-methoxybenzaldehyde) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1118328 | Active | Chloroquine Related Compound A (15 mg) (4,7-dichloroquinoline) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1118350 | Active | Chloroquine Related Compound D (15 mg) (7-Chloro-4-{[4-(ethylamino)-1-methylbutyl] amino} quinoline) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1118361 | Active | Chloroquine Related Compound E (10 mg) (N4-(5-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine oxalate) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1118394 | Active | Chloroquine Related Compound G (15 mg) (4-((7-chloroquinolin-4-yl)amino)-N,N-diethylpentan-1-amine oxide sulfate) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1122722 | Active | Chloroxylenol Related Compound A (25 mg) (2-chloro-3,5-dimethylphenol) | Reference Standard | Impurity | Antiseptics | Enquire
|
| 1123135 | Active | Chlorpheniramine Related Compound B (25 mg) (di(pyridin-2-yl)amine) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1123146 | Active | Chlorpheniramine Related Compound C (10 mg) (3-(4-chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1-amine maleate) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1119309 | Active | Chlorthalidone Related Compound A (10 mg) (4'-Chloro-3'-sulfamoyl-2-benzophenone Carboxylic Acid) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1130527 | Active | Chlorzoxazone Related Compound A (50 mg) (2-Amino-4-chlorophenol) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1132001 | Active | Cholesteryl Caprylate (200 mg) | Reference Standard | Impurity | Steroids | Enquire
|
| 1134029 | Active | Ciclopirox Related Compound A (25 mg) (3-Cyclohexyl-4,5-dihydro-5-methyl-5-isoxazolyl acetic acid) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1134040 | Active | Ciclopirox Related Compound B (25 mg) (6-Cyclohexyl-4-methyl-2-pyrone) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1134084 | Active | Ciclopirox Related Compound C (10 mg) (6-Cyclohexyl-4-methylpyridin-2(1H)-one) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1133864 | Active | Cidofovir Enantiomer (15 mg) (1-[(R)-3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine dihydrate) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1133875 | Active | Cidofovir Related Compound A (15 mg) (1-[(S)-3-Hydroxy-2-(O-ethylphosphonomethoxy)propyl]cytosine) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1133886 | Active | Cidofovir Related Compound B (15 mg) (1-[(S)-3-Hydroxy-2-(O,O-diethylphosphonomethoxy)propyl]cytosine hydrochloride) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1134164 | Active | Cilostazol Related Compound A (50 mg) (6-hydroxy-3,4-dihydro-1H-quinolin-2-one) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1134175 | Active | Cilostazol Related Compound B (50 mg) (6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1H-quinolin-2-one) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1134186 | Active | Cilostazol Related Compound C (50 mg) (1-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1133922 | Active | Cinacalcet Related Compound C (50 mg) ((R)-N-[1-(Naphthalen-1-yl)ethyl]-3-[4-(trifluoromethyl)phenyl]propan-1-amine hydrochloride) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1133966 | Active | Cinacalcet Related Compound D (50 mg) ((S)-N-[1-(Naphthalen-1-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1133831 | Active | Cinacalcet Related Compound E | Reference Standard | Impurity | Endocrine | Enquire
|
| 1134324 | Active | Ciprofloxacin Ethylenediamine Analog (25 mg) (1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-[(2-aminoethyl)amino]-3-quinolinecarboxylic acid hydrochloride) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1134459 | Active | Ciprofloxacin Formamide (25 mg) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1134346 | Active | Ciprofloxacin Related Compound A (25 mg) (7-Chloro-1-cyclopropyl-4-oxo-6-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride salt) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1134244 | Active | Citalopram Related Compound A (25 mg) (1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1134255 | Active | Citalopram Related Compound B (25 mg) (1-(3-Dimethylaminopropyl)-1-(4-fluorophenyl)-3-hydroxy-1,3-dihydroisobenzofuran-5-carbonitrile oxalate) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1134266 | Active | Citalopram Related Compound C (25 mg) (3-(3-Dimethylaminopropyl)-3-(4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1134277 | Active | Citalopram Related Compound D (15 mg) (1-(4-Fluorophenyl)-1-(3-methylaminopropyl)-1,3-dihydroisobenzofuran-5-carbonitrile hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1134288 | Active | Citalopram Related Compound E (25 mg) (1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile-N-oxide hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1134299 | Active | Citalopram Related Compound F (200 mg) (dimethyl-(1-methyl-3,3-diphenyl-allyl)-amine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1134197 | Active | Citalopram Related Compound G (25 mg) (1-(4'-fluorophenyl)-1-(3-dimethylaminopropyl)-5-chlorophthalane hydrobromide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1134222 | Active | Citalopram Related Compound H (25 mg) (1-(4'-fluorophenyl)-1-(3-dimethylaminopropyl)-5-bromophthalane hydrobromide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1134211 | Active | Cladribine Related Compound A (20 mg) (2-methoxy-2'-deoxyadenosine) | Reference Standard | Impurity | Oncology | Enquire
|
| 1134390 | Active | Clarithromycin Identity (10 mg) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1134619 | Active | Clarithromycin Impurity D (10 mg) (N-desmethyl clarithromycin) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1134620 | Active | Clarithromycin Impurity H (10 mg) (3"-N-Demethyl-3"-N-formyl-6-O-methylerythromycin A) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1134631 | Active | Clarithromycin Impurity Q (10 mg) (Clarithromycin N-oxide) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1134642 | Active | Clarithromycin Impurity R (10 mg) (3"-N-Demethylerythromycin A) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1134380 | Active | Clarithromycin Related Compound A (25 mg) (6,11-di-O-methylerythromycin A) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1134404 | Active | Clavam-2-carboxylate Potassium (2 mg) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1134696 | Active | Clenbuterol Related Compound B (10 mg) (1-(4-amino-3,5-dichlorophenyl)-2-tert-butylaminoethanone hydrochloride) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1135021 | Active | Clidinium Bromide Related Compound A (250 mg) (3-Hydroxy-1-methylquinuclindinium Bromide) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1135892 | Active | Clindamycin 2,3-Dipalmitate (25 mg) (Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside 2,3-dipalmitate monohydrochloride) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1138212 | Active | Clioquinol Related Compound A (25 mg) (5-Chloroquinolin-8-ol) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1138223 | Active | Clioquinol Related Compound B (25 mg) (5,7-Dichloroquinolin-8-ol) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1138314 | Active | Clobazam Related Compound A (25 mg) (8-Chloro-1-phenyl-1,5-dihydro-2H-benzo[b][1,4]diazepine-2,4(3H)-dione) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1138347 | Active | Clobazam Related Compound E (25 mg) (N-[4-Chloro-2-(phenylamino)phenyl]-N-methylacetamide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1138369 | Active | Clobazam Related Compound G (25 mg) (6-Chloro-2,3-dimethyl-1-phenyl-1H-benzimidazol-3-ium chloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1138427 | Active | Clobetasol Propionate Related Compound A (50 mg) (9-alpha-fluoro-11-beta-hydroxy-16-beta-methyl-3-oxoandrosta-1,4-diene-17(R)-spiro-2'-[4'-chloro-5'-ethylfuran-3'(2'H)-one]) | Reference Standard | Impurity | Steroids | Enquire
|
| 1138926 | Active | Clofazimine Related Compound B (25 mg) (5-(4-Chlorophenyl)-3-(isopropylimino)-N-phenyl-3,5-dihydrophenazin-2-amine) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1140101 | Active | Clomiphene Related Compound A (25 mg) ((E,Z)-2-[4-(1,2-Diphenylethenyl)phenoxy]-N,N-diethylethanamine hydrochloride) | Reference Standard | Impurity | Steroids | Enquire
|
| 1140258 | Active | Clomipramine Related Compound A (25 mg) (N1-[3-(3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]-N1,N3,N3-trimethylpropane-1,3-diamine dihydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1140269 | Active | Clomipramine Related Compound C (15 mg) (3-(3-Chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride, monohydrate) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1140270 | Active | Clomipramine Related Compound D (15 mg) (3-(3,7-Dichloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1140292 | Active | Clomipramine Related Compound F (15 mg) (3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepine) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1140327 | Active | Clonazepam Related Compound A (25 mg) (3-Amino-4-(2-chlorophenyl)-6-nitrocarbostyril) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1140338 | Active | Clonazepam Related Compound B (25 mg) (2-Amino-2'-chloro-5-nitrobenzophenone) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1140349 | Active | Clonazepam Related Compound C (25 mg) (2-bromo-2'-(2-chlorobenzoyl)-4'-nitroacetanilide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1140418 | Active | Clonidine Related Compound A (25 mg) (1-Acetyl-2-(2,6-dichlorophenylimino)-imidazolidine) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1140429 | Active | Clonidine Related Compound B (25 mg) (2-[(E)-2,6-dichlorophenylimino]-1-(1-{2-[(E)-2,6-dichlorophenylimino]-imidazolidin-1-yl}-ethyl)-imidazolidine) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1140445 | Active | Clonidine Related Compound C (15 mg) (Methyl N'-(2,6-dichlorophenyl)carbamimidothioate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1140586 | Active | Clopidogrel Related Compound A (20 mg) ((+)-(S)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid, hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1140597 | Active | Clopidogrel Related Compound B (20 mg) (Methyl(+/-)-(o-chlorophenyl)-4,5-dihydrothieno[2,3-c]pyridine-6(7H)-acetate, hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1140600 | Active | Clopidogrel Related Compound C (20 mg) (methyl (-)-(R)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate, hydrogen sulfate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1141024 | Active | Clotrimazole Related Compound A (25 mg) ((o-chlorophenyl)diphenylmethanol) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1144951 | Active | Cloxacillin Related Compound D (15 mg) (3-(2-Chlorophenyl)-5-methylisoxazole-4-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1143802 | Active | Codeine N-Oxide CI (30 mg) | Reference Standard | Impurity | Opioids | Enquire
|
| 1150513 | Active | Cromolyn Related Compound A (25 mg) (1,3-bis(2-acetyl-3-hydroxyphenoxy) propan-2-ol) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1150524 | Active | Cromolyn Related Compound B (25 mg) (diethyl 5,5'-[(2-hydroxypropane-1,3-diyl)bis(oxy)]bis(4-oxo-4H-chromene-2-carboxylate)) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1152596 | Active | Cyclam (25 mg) (1,4,8,11-Tetraazacyclotetradecane) | Reference Standard | Impurity | Oncology | Enquire
|
| 1154015 | Active | Cyclizine Related Compound A (50 mg) (1-methylpiperazine) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1154514 | Active | Cyclobenzaprine Related Compound A (10 mg) (5-[3-(dimethylamino)propyl]-5H-dibenzo[a,d]-cyclohepten-5-ol) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1154525 | Active | Cyclobenzaprine Related Compound B (10 mg) (3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-1-propanamine, hydrochloride) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1156167 | Active | Cyclopentylpropanoic Acid (25 mg) (3-Cyclopentylpropanoic acid) | Reference Standard | Impurity | Steroids | Enquire
|
| 1157002 | Active | Cyclophosphamide (500 mg) | Reference Standard | Impurity | Oncology | Enquire
|
| 1157013 | Active | Cyclophosphamide Related Compound A (25 mg) (bis(2-chloroethyl)amine hydrochloride) | Reference Standard | Impurity | Oncology | Enquire
|
| 1157024 | Active | Cyclophosphamide Related Compound B (25 mg) (3-(2-chloroethyl)-2-oxo-2-hydroxy-1,3,6,2-oxadiazaphosphonane) | Reference Standard | Impurity | Oncology | Enquire
|
| 1157035 | Active | Cyclophosphamide Related Compound C (25 mg) (3-aminopropyl dihydrogen phosphate) | Reference Standard | Impurity | Oncology | Enquire
|
| 1157046 | Active | Cyclophosphamide Related Compound D (25 mg) (3-[2-(2-chloroethylamino)ethylamino]propyl dihydrogen phosphate dihydrochloride) | Reference Standard | Impurity | Oncology | Enquire
|
| 1161010 | Active | Cyproheptadine Related Compound A (40 mg) (5H-dibenzo[a,d]cycloheptene) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1161032 | Active | Cyproheptadine Related Compound C (25 mg) (5-(1-methyl-piperidin-4-yl)-5H-dibenzo[a,d]cyclohepten-5-ol) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1096564 | Active | D-Carglumic Acid (30 mg) (N-Carbamoyl-D-glutamic acid) | Reference Standard | Impurity | Hepatic | Enquire
|
| 1707817 | Active | D-Valacyclovir (25 mg) (D-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy] ethyl ester) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1708015 | Active | D-Valganciclovir (10 mg) (2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-methoxy]-3-hydroxypropyl D-valine ester monohydrochloride) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1087520 | Active | D-camphor sulfonic acid (100 mg) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1162240 | Active | Dabigatran Etexilate Related Compound A (15 mg) (Ethyl 3-(2-{[(4-{[(hexyloxy)carbonyl]carbamoyl}phenyl)amino]methyl}-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1162251 | Active | Dabigatran Etexilate Related Compound B | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1162262 | Active | Dabigatran Etexilate Related Compound C (15 mg) (Ethyl 3-(2-{[(4-{N'-[(2-ethylbutoxy)carbonyl]carbamimidoyl}phenyl)amino]methyl}-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1162320 | Active | Dacarbazine Related Compound A (50 mg) (5-aminoimidazole-4-carboxamide hydrochloride) | Reference Standard | Impurity | Oncology | Enquire
|
| 1162330 | Active | Dacarbazine Related Compound B (50 mg) (2-Azahypoxanthine monohydrate) | Reference Standard | Impurity | Oncology | Enquire
|
| 1162545 | Active | Dalfampridine Related Compound A (25 mg) (4-Aminopyridine 1-oxide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1162556 | Active | Dalfampridine Related Compound B (50 mg) (3,5-Dibromopyridin-4-amine) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1162567 | Active | Dalfampridine Related Compound C (25 mg) (1,3-Di(pyridin-4-yl)urea) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1163162 | Active | Dantrolene Related Compound A (50 mg) (1,2-Bis{[5-(4-nitrophenyl)furan-2-yl]methylene}hydrazine) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1163173 | Active | Dantrolene Related Compound B (50 mg) (5-(4-nitrophenyl)-2-furaldehyde-(2-carboxymethyl) semicarbazone) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1163184 | Active | Dantrolene Related Compound C (50 mg) (5-(4-Nitrophenyl)furan-2-carbaldehyde) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1163264 | Active | Dapagliflozin Related Compound A (15 mg) ((2S,3R,4R,5S,6R)-2-[4-Bromo-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1164211 | Active | Darifenacin Chiral Peak ID Mixture (25 mg) (See USP Certificate for full Chemical Name) | Reference Standard | Impurity | Renal | Enquire
|
| 1164222 | Active | Darifenacin Peak ID Mixture (25 mg) (A mixture consisting of Darifenacin Hydrobromide (99%), Dealkyl darifenacin (0.3%), Ketodarifenacin (0.2%), and 7-Bromo darifenacin (0.3%)) | Reference Standard | Impurity | Renal | Enquire
|
| 1164233 | Active | Darifenacin Related Compound G (25 mg) (5-(2-Bromoethyl)-2,3-dihydrobenzofuran) | Reference Standard | Impurity | Renal | Enquire
|
| 1164697 | Active | Daunorubicinone (25 mg) ((8S,10S)-8-Acetyl-6,8,10,11-tetrahydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione) | Reference Standard | Impurity | Oncology | Enquire
|
| 1471958 | Active | Deacetylnorgestimate (25 mg) ((E)- and (Z)-17-deacetyl norgestimate mixture) (PLANNED TO BE DISCONTINUED) | Reference Standard | Impurity | Steroids | Enquire
|
| 1165215 | Active | Decitabine Related Compound A (25 mg) (1-O-Acetyl-3,5-di-O-(4-chlorobenzoyl)-2-deoxy-D-ribofuranose) | Reference Standard | Impurity | Oncology | Enquire
|
| 1165248 | Active | Decitabine Related Compound D (25 mg) (Methyl 4-chlorobenzoate) | Reference Standard | Impurity | Oncology | Enquire
|
| 1165259 | Active | Decitabine Related Compound E (25 mg) (4-Amino-1-(2-deoxy-alpha-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one) | Reference Standard | Impurity | Oncology | Enquire
|
| 1165226 | Active | Decitabine Related Compounds B and C Mixture (25 mg) (4-Amino-1-(3,5-di-O-(4-chlorobenzoyl)-2-deoxy-Beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one and 4-Amino-1-(3,5-di-O-(4-chlorobenzoyl)-2-deoxy-a-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one) | Reference Standard | Impurity | Oncology | Enquire
|
| 1165690 | Active | Deferasirox Related Compound F (25 mg) (4-Hydrazinylbenzoic acid) | Reference Standard | Impurity | Antidotes & Chelators | Enquire
|
| 1166400 | Active | Dehydrocarteolol Hydrochloride (100 mg) (5-[3-(tert-Butylamino)-2-hydroxypropoxy]quinolin-2(1H)-one hydrochloride) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1171397 | Active | Depramine (20 mg) (3-(5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1171706 | Active | Desacetyl Diltiazem Hydrochloride (50 mg) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1171819 | Active | Desbenzyl Donepezil Hydrochloride (20 mg) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1041992 | Active | Desfluoro Aprepitant (15 mg) (5-{[(2R,3S)-2-{(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-3-phenylmorpholino]methyl}-2H-1,2,4-triazol-3(4H)-one) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1171910 | Active | Desflurane Related Compound A (0.1 mL) (Bis-(1,2,2,2-tetrafluoroethyl)ether) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1173053 | Active | Desloratadine Related Compound A (20 mg) (8-Bromo-6,11-dihydro-11-(piperidin-4-ylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1173086 | Active | Desloratadine Related Compound B (20 mg) (8-chloro-11-(1,2,3,6-tetrahydropyridin-4-yl)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine hydrochloride) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1173064 | Active | Desloratadine Related Compound F (50 mg) (8-Chloro-6,11-dihydro-11-(N-formyl-4-piperidinylidene) -5H-benzo[5,6]cyclohepta[1,2-b]pyridine) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1173246 | Active | Desogestrel Related Compound A (15 mg) (13-Ethyl-11-methylene-18,19-dinor-5alpha,17alpha-pregn-3-en-20-yn-17-ol) | Reference Standard | Impurity | Steroids | Enquire
|
| 1173257 | Active | Desogestrel Related Compound B (25 mg) (13-Ethyl-3-hydroxy-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol) | Reference Standard | Impurity | Steroids | Enquire
|
| 1173268 | Active | Desogestrel Related Compound C (25 mg) (13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol-3-one) | Reference Standard | Impurity | Steroids | Enquire
|
| 1173279 | Active | Desogestrel Related Compound D (25 mg) (13-Ethyl-11-methylenegon-4-en-17-one) | Reference Standard | Impurity | Steroids | Enquire
|
| 1173315 | Active | Desonide Impurities Mixture (25 mg) (See long description for full chemcial name) | Reference Standard | Impurity | Steroids | Enquire
|
| 1173326 | Active | Desonide Related Compound A (15 mg) (17Beta-(2,2-Dihydroxyacetyl)-11Beta-hydroxy-16alpha,17-[(1-methylethylidene)bis(oxy)]-androsta-1,4-dien-3-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1173337 | Active | Desonide Related Compound B (15 mg) (11Beta,21-Dihydroxypregna-1,4,16-triene-3,20-dione) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1046078 | Active | Desosaminylazithromycin (15 mg) ((2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-Ethyl-3,4,10,13-tetrahydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-dimethylamino-Beta-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1173519 | Active | Desoximetasone Related Compound A (25 mg) (9-Fluoro-11Beta,21-dihydroxy-16Alpha-methylpregna-4-ene-3,20-dione) | Reference Standard | Impurity | Steroids | Enquire
|
| 1175784 | Active | Desvenlafaxine Related Compound A (25 mg) (4-[1-(Cyclohex-1-en-1-yl)-2-(dimethylamino)ethyl]phenol) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1175795 | Active | Desvenlafaxine Related Compound B (25 mg) (4-[1-(1-Hydroxycyclohexyl)-2-(methylamino)ethyl]phenol) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1179118 | Active | Dexketoprofen Tromethamine (200 mg) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1176000 | Active | Dexmedetomidine Related Compound A (25 mg) ((2,3-Dimethylphenyl)(1H-imidazol-4-yl)methanone) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1176001 | Active | Dexmedetomidine Related Compound B (25 mg) (4-[1-(2,3-Dimethylphenyl)vinyl]-1H-imidazole) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1176002 | Active | Dexmedetomidine Related Compound C (25 mg) (5-[1-(2,3-Dimethylphenyl)ethyl]-1-ethyl-1H-imidazole) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1180015 | Active | Dextroamphetamine Related Compound A (25 mg) (1-Phenyl-2-propanol) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1180026 | Active | Dextroamphetamine Related Compound B CII (25 mg) (Phenyl acetone) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1181040 | Active | Dextromethorphan Related Compound C (30 mg) (3-Methoxy-17-methyl-9 Alpha,13 Alpha,14 Alpha-morphinan-10-one) | Reference Standard | Impurity | Cough and Cold | Enquire
|
| 1182000 | Active | Diacetylfluorescein (200 mg) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1184027 | Active | Diatrizoic Acid Related Compound A (50 mg) (5-Acetamido-3-amino-2,4,6-triiodobenzoic Acid) | Reference Standard | Impurity | Nonradioactive Imaging Agents | Enquire
|
| 1184118 | Active | Diaveridine (25 mg) (5-(3,4-Dimethoxybenzyl)pyrimidine-2,4-diamine) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1185020 | Active | Diazepam Related Compound A (25 mg) (2-methylamino-5-chlorobenzophenone) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1023403 | Active | Diazepam Related Compound B (25 mg) (3-Amino-6-chloro-1-methyl-4-phenylcarbostyril) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1185063 | Active | Diazepam Related Compound E (25 mg) (6-Chloro-1-methyl-4-phenylquinazolin-2(1H)-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1187229 | Active | Dichloroaniline (15 mg) (3,4-Dichloroaniline) | Reference Standard | Impurity | Oncology | Enquire
|
| 1188811 | Active | Diclofenac Related Compound A (25 mg) (N-(2,6-dichlorophenyl)indolin-2-one) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1189053 | Active | Dicloxacillin Related Compound D (15 mg) (3-(2,6-Dichlorophenyl)-5-methylisoxazole-4-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1191011 | Active | Dicyclomine Related Compound A (40 mg) ([1,1'-Bi(cyclohexane)]-1-carboxylic acid) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1191226 | Active | Didanosine Related Compound A (25 mg) (Hypoxanthine) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1191237 | Active | Didanosine Related Compound B (25 mg) (2',3'-dideoxyadenosine) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1197018 | Active | Diethyltoluamide Related Compound A (25 mg) (N,N-Diethyl-4-toluamide) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1200881 | Active | Dihydrodaunorubicin Hydrochloride (20 mg) ((8S,10S)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride) | Reference Standard | Impurity | Oncology | Enquire
|
| 1200917 | Active | Dihydrodutasteride (25 mg) (N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5alpha-androst-1-ene-17Beta-carboxamide) | Reference Standard | Impurity | Renal | Enquire
|
| 1204339 | Active | Diiodothyronine (15 mg) (O-(4-Hydroxylphenyl)-3,5-diiodo-L-tyrosine) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1204383 | Active | Diiodotyrosine (15 mg) (3,5-Diiodo-L-tyrosine) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1205014 | Active | Diltiazem Related Compound A (AS) (25 mg) (trans-diltiazem hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1353113 | Active | Diluted Isosorbide Mononitrate Related Compound A (150 mg) (1,4:3,6-Dianhydro-D-glucitol 2-nitrate in lactose) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1206017 | Active | Dimenhydrinate Related Compound E (15 mg) (8-chloro-3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1210229 | Active | Dimethyl Fumarate Related Compound A (15 mg) ((E)-4-Methoxy-4-oxobut-2-enoic acid) | Reference Standard | Impurity | Immunosuppresants | Enquire
|
| 1211006 | Active | Dimethyl Sulfoxide (3 g) | Reference Standard | Impurity | Others-Chemical Medicines | Enquire
|
| 1211200 | Active | Dimethylamine Solution (6 x 3 mL) (International Restricted Sales Item) | Reference Standard | Impurity | Oncology | Enquire
|
| 1213136 | Active | Dinoprostone Related Compound C (20 mg) ((E)-7-{(1R,2R,3R)-3-Hydroxy-2-[(S,E)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl}hept-5-enoic acid) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1218050 | Active | Diphenhydramine N-Oxide (25 mg) (2-(benzhydryloxy)-N,N-dimethylethan-1-amine oxide hydrochloride) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1218016 | Active | Diphenhydramine Related Compound A (25 mg) (2-(Diphenylmethoxy)-N-methylethanamine hydrochloride) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1218027 | Active | Diphenhydramine Related Compound B (20 mg) (3-(benzhydryloxy)propane-1,2-diol) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1219019 | Active | Diphenoxylate Related Compound A CI (25 mg) (1-(3-Cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1220357 | Active | Dipivefrin Related Compound E (25 mg) (4-[(Methylamino)acetyl]-1,2-phenylene dipivalate hydrochloride) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1220517 | Active | Dipyridamole Related Compound A (25 mg) (2,2'-{[4,6,8-Tri(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl]azanediyl}diethanol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1220528 | Active | Dipyridamole Related Compound B (25 mg) (2,2',2'',2''',2'''',2'''''-{[8-(Piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,4,6-triyl]tris(azanetriyl)}hexaethanol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1220539 | Active | Dipyridamole Related Compound C (25 mg) (2,2'-{[6-chloro-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl]azanediyl}diethanol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1220540 | Active | Dipyridamole Related Compound D (25 mg) (2,2'-({6-[(2-Hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl}azanediyl)diethanol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1220559 | Active | Dipyridamole Related Compound E (25 mg) (2,2',2'',2'''-{[6,8-Di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,4-diyl]bis(azanetriyl)}tetraethanol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1220561 | Active | Dipyridamole Related Compound F (25 mg) (2,2',2'',2'''-({4-[(2-Hydroxyethyl)amino]-8-(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl}bis(azanetriyl))tetraethanol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1224530 | Active | Dobutamine Related Compound C (50 mg) (N-(3,4-Dimethoxyphenethyl)-4-(4-methoxyphenyl)butan-2-amine hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1224562 | Active | Docetaxel Identification (50 mg) | Reference Standard | Impurity | Oncology | Enquire
|
| 1224948 | Active | Dofetilide Related Compound A (25 mg) (N-[4-(2-{2-[4-(Methanesulfonamido)phenoxy]ethylamino}ethyl)phenyl]methanesulfonamide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1225011 | Active | Dofetilide Related Compound B (25 mg) (N-Methyl-N-[4-(methylsulfonamido)phenethyl]-2-[4-(methylsulfonamido)phenoxy]ethan-1-amine oxide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1225044 | Active | Dofetilide Related Compound D (25 mg) (4-{2-[(4-Aminophenethyl)(methyl)amino]ethoxy}aniline) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1224960 | Active | Dolasetron Mesylate Related Compound A (25 mg) (Hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3 (4H)-one, hydrochloride) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1224992 | Active | Donepezil Related Compound A (25 mg) ((E)-2-[(1-benzylpiperidin-4-yl)methylene]-5,6-dimethoxyindan-1-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1224970 | Active | Donepezil-N-Oxide (20 mg) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1225215 | Active | Dopamine Related Compound A (30 mg) (5-(2-Aminoethyl)-2-methoxyphenol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1225226 | Active | Dopamine Related Compound B (30 mg) (4-(2-Aminoethyl)-2-methoxyphenol hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1225237 | Active | Dopamine Related Compound C (100 mg) (2-(3,4-Dimethoxyphenyl)ethan-1-amine) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1225292 | Active | Dorzolamide Hydrochloride Related Compound A (20 mg) ((4R,6R)-4-(ethylamino)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-2-sulfonamide-7,7-dioxide, monohydrochloride) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1225317 | Active | Dorzolamide Related Compound B (15 mg) ((4RS,6SR)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1225306 | Active | Dorzolamide Related Compound D (30 mg) ((4S,6S)-4-Amino-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1225022 | Active | Doxapram Related Compound B (25 mg) (1-Ethyl-4-{2-[(2-hydroxyethyl)amino]ethyl}-3,3-diphenylpyrrolidin-2-one, hydrochloride) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1225420 | Active | Doxazosin Related Compound A (20 mg) (N-1,4-Benzodioxane-2-carbonyl piperazine hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1225441 | Active | Doxazosin Related Compound B (20 mg) (6,7-dimethoxyquinazoline-2,4-dione) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1225452 | Active | Doxazosin Related Compound C (20 mg) (2-chloro-4-amino-6,7-dimethoxyquinazoline) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1225463 | Active | Doxazosin Related Compound D (20 mg) (1,4-benzodioxane-2-carboxylic acid) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1225474 | Active | Doxazosin Related Compound E (20 mg) (2,4-dichloro-6,7-dimethoxyquinazoline) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1225485 | Active | Doxazosin Related Compound F (15 mg) (N,N'-bis(1,4-benzodioxane-2-carbonyl)piperazine) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1225496 | Active | Doxazosin Related Compound G (15 mg) (4-Amino-6,7-dimethoxyquinazolin-2(1H)-one hydrochloride) (COLD SHIPMENT REQUIRED) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1225511 | Active | Doxepin Related Compound A (50 mg) (dibenzo[b,e]oxepin-11(6H)-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1225522 | Active | Doxepin Related Compound B (50 mg) ((11RS)-11-[3-(dimethylamino)propyl]-6,11-dihydrodibenzo[b,e]oxepin-11-ol) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1225533 | Active | Doxepin Related Compound C (25 mg) ((E,Z)-3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1225758 | Active | Doxorubicinone (25 mg) ((8S,10S)-6,8,10,11-Tetrahydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione) | Reference Standard | Impurity | Oncology | Enquire
|
| 1226014 | Active | Doxycycline Related Compound A (10 mg) ((4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide, monohydrochloride) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1228029 | Active | Drometrizole Trisiloxane Related Compound A (25 mg) (2-(2H-Benzotriazol-2-yl)-6-(isobuten-1-yl)-p-cresol) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1228031 | Active | Drometrizole Trisiloxane Related Compound B (25 mg) (2-(2H-Benzotriazol-2-yl)-6-(isobuten-3-yl)-p-cresol) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1228042 | Active | Drometrizole Trisiloxane Related Compound C (150 mg) (2-(2H-Benzotriazol-2-yl)-6-(isobuten-1-yl)-O1-[bis(trimethylsiloxy)methylsilyl]-p-cresol) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1228053 | Active | Drometrizole Trisiloxane Related Compound D (25 mg) (2-(2H-Benzotriazol-2-yl)-6-isobutyl-p-cresol) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1228064 | Active | Drometrizole Trisiloxane Related Compound E (150 mg) (2-(2H-Benzotriazol-2-yl)-6-{3-[bis(trimethylsiloxy)methylsilyl]isobutyl}-O1-[bis(trimethylsiloxy)methylsilyl]-p-cresol) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1228541 | Active | Dronedarone Related Compound A (25 mg) (N-{2-Butyl-3-[4-(3-butylaminopropoxy)benzoyl]benzofuran-5-yl}methanesulfonamide, hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1228552 | Active | Dronedarone Related Compound B (20 mg) ((5-Amino-2-butylbenzofuran-3-yl){4-[3-(dibutylamino)propoxy]phenyl}methanone, dihydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1228563 | Active | Dronedarone Related Compound C (20 mg) ((5-Amino-2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1228574 | Active | Dronedarone Related Compound D (20 mg) ((2-Butyl-5-nitrobenzofuran-3-yl)(4-hydroxyphenyl)methanone) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1229410 | Active | Drospirenone Related Compound A (15 mg) (17-Hydroxy-6beta,7beta:15beta,16beta-dimethylene-3-oxo-17beta-pregn-4-ene-21-carboxylic acid, gamma-lactone) | Reference Standard | Impurity | Steroids | Enquire
|
| 1229611 | Active | Droxidopa Erythro Isomer (15 mg) ((2RS,3RS)-2-Amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1229622 | Active | Droxidopa Threo Isomer (15 mg) ((2R,3S)-2-Amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1229828 | Active | Duloxetine Related Compound A (10 mg) ((R)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1229872 | Active | Duloxetine Related Compound F (10 mg) ((S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1229883 | Active | Duloxetine Related Compound H (30 mg) ((S)-4-{Methyl[3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]amino}-4-oxobutanoic acid) (COLD SHIPMENT REQUIRED) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1231615 | Active | Ecamsule Related Compound A (50 mg) (1,4-Phenylenedimethanol) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1231626 | Active | Ecamsule Related Compound B (50 mg) (4-(Hydroxymethyl)benzoic acid) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1231637 | Active | Ecamsule Related Compound C (50 mg) (terephthalic acid) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1231648 | Active | Ecamsule Related Compound D (50 mg) (((1SR,4RS)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1231659 | Active | Ecamsule Related Compound E (25 mg) (sodium ((1SR,4SR,E)-3-(4-(hydroxymethyl)benzylidene)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1231660 | Active | Ecamsule Related Compound F (25 mg) (4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzoic acid) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1231681 | Active | Ecamsule Related Compound G (25 mg) (4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzaldehyde, sodium salt) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1231604 | Active | Ecamsule Triethanolamine (200 mg) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1231830 | Active | Econazole Related Compound A (15 mg) (1-(2,4-Dichlorophenyl)-2-(1H-imidazole-1-yl)ethanol) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1231841 | Active | Econazole Related Compound B (15 mg) (2-[(4-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethanamine nitrate) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1231852 | Active | Econazole Related Compound C (15 mg) (1-(4-Chlorobenzyl)-3-[(2RS)-2-[(4-chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]imidazolium chloride) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1234114 | Active | Efavirenz Racemic (20 mg) ((+/-)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1234125 | Active | Efavirenz Related Compound A (20 mg) ((S)-2-(2-amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-ol) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1234147 | Active | Efavirenz Related Compound B (10 mg) ((S,E)-6-Chloro-4-(2-Cyclopropylvinyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1234136 | Active | Efavirenz Related Compound C (20 mg) (6-chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1234475 | Active | Eletriptan Related Compound B (20 mg) ((R)-5-Bromo-3-[(1-methylpyrrolidin-2-yl)methyl]-1H-indole) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1234522 | Active | Eletriptan S-Enantiomer (20 mg) ((S)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-indole, monohydrobromide) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1235332 | Active | Enalapril Related Compound D (25 mg) ((S)-Ethyl 2-[(3S,8aS)-3-methyl-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-4-phenylbutanoate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1235365 | Active | Enalapril Related Compound H (25 mg) (1-{N-[(S)-1-Ethoxycarbonyl-3-cyclohexylpropyl]-L-alanyl}-L-proline, maleate (1:1)) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1235398 | Active | Enanthic Acid (100 mg) (Heptanoic Acid) | Reference Standard | Impurity | Steroids | Enquire
|
| 1235911 | Active | Enrofloxacin Related Compound Mixture (50 mg) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1235944 | Active | Entacapone Related Compound A (25 mg) ((Z)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1235977 | Active | Entecavir Related Compound A (15 mg) (9-[(1S,3R,4S)-4-Dimethylphenylsilyl-3-(benzyloxymethyl)-2-methylenecyclopentyl]guanine) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1236801 | Active | Epilactose (200 mg) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1236890 | Active | Epinastine Related Compound A (25 mg) ((6,11-Dihydro-5H-dibenzo[b,e]azepin-6-yl)methanamine fumarate) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1237611 | Active | Epoprostenol Related Compound A (15 mg) (7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(S,E)-3-hydroxyoct-1-enyl]cyclopentyl}-6-oxoheptanoic acid) (COLD SHIPMENT REQUIRED) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1237622 | Active | Epoprostenol Related Compound B (15 mg) (Sodium 5-(diphenylphosphinoyl)pentanoate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1238228 | Active | Eprosartan Related Compound A (20 mg) ((E)-3-(2-butyl-1H-imidazol-5-yl)-2-(thiophen-2-ylmethyl)acrylic acid hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1238239 | Active | Eprosartan Related Compound B (15 mg) (3-(thiophen-2-yl)propanoic acid) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1238240 | Active | Eprosartan Related Compound C (25 mg) (2-(thiophen-2-ylmethyl)malonic acid) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1238251 | Active | Eprosartan Related Compound D (15 mg) (4-(bromomethyl)benzoic acid) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1238262 | Active | Eprosartan Related Compound E (15 mg) (4-(hydroxymethyl)benzoic acid) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1241550 | Active | Ergotaminine (100 mg) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1241619 | Active | Erlotinib Related Compound A (25 mg) (4-(3-{[6,7-Bis(2-methoxyethoxy) quinazolin-4-yl]amino}phenyl)-2-methyl-3-butyn-2-ol hydrochloride) | Reference Standard | Impurity | Oncology | Enquire
|
| 1242032 | Active | Erythromycin Related Compound N (50 mg) (N-Demethylerythromycin A) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1249417 | Active | Escitalopram Related Compound A (10 mg) ((S)-4-[4-dimethylamino-1-(4-fluoropheny)-1-hydroxy-1-butyl]-3-hydroxymethylbenzonitrile hemi(+)-di-toluoyltartrate) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1249916 | Active | Estazolam Related Compound A (10 mg) (5-Chloro-2-(3-chloromethyl-4H-1,2,4-triazol-4-yl)-benzophenone) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1250020 | Active | Estradiol Related Compound B (10 mg) (1,3,5(10),6-estratetraen-3,17beta-diol) | Reference Standard | Impurity | Steroids | Enquire
|
| 1250041 | Active | Estradiol Related Compound C (15 mg) (1,3,5(10)-estratrien-3,17beta-diol-6-one) | Reference Standard | Impurity | Steroids | Enquire
|
| 1254031 | Active | Estradiol Valerate Identification Mixture (15 mg) | Reference Standard | Impurity | Steroids | Enquire
|
| 1254519 | Active | Estriol Related Compound A (25 mg) (Estra-1,3,5(10),9(11)-tetraene-3,16alpha,17Beta-triol) | Reference Standard | Impurity | Steroids | Enquire
|
| 1255861 | Active | Eszopiclone Related Compound A (10 mg) (6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo [3,4,b] pyrazin-5-yl 4-methylpiperazine-1-carboxylate 4-oxide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1256015 | Active | Ethacrynic Acid Related Compound A (25 mg) ((4-Butyryl-2,3-dichlorophenoxy)acetic acid) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1256037 | Active | Ethacrynic Acid Related Compound C (25 mg) ({4-[2-(4-(Carboxymethoxy)-2,3-dichlorobenzoyl)-2,5-diethyl-3,4-dihydro-2H-pyran-6-yl]-2,3-dichlorophenoxy}acetic acid) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1257018 | Active | Ethambutol Related Compound A (15 mg) ((2R,2'S)-2,2'-[ethane-1,2-diylbis(azanediyl)]dibutan-1-ol)dihydrochloride) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1257029 | Active | Ethambutol Related Compound B (15 mg) (((2R,2'R)-2,2'-[Ethane-1,2-diylbis(azanediyl)]dibutan-1-ol) dihydrochloride) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1260012 | Active | Ethinyl Estradiol Related Compound A (20 mg) (19-Nor-17alpha-pregna-1,3,5(10)-trien-20-yne-3,17-diol-6-one) | Reference Standard | Impurity | Steroids | Enquire
|
| 1260023 | Active | Ethinyl Estradiol Related Compound B (20 mg) (19-Nor-17alpha-pregna-1,3,5(10),9(11)-tetraen-20-yne-3,17-diol monohydrate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1262823 | Active | Ethopabate Related Compound A (25 mg) (Methyl-4-acetamido-2-hydroxybenzoate) | Reference Standard | Impurity | Veterinary | Enquire
|
| 1264013 | Active | Ethosuximide Related Compound A (50 mg) (2-Ethyl-2-methylsuccinic acid) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1021077 | Active | Ethyl 3-Aminocrotonate (2 x 200 mg) (Ethyl (Z)-3-aminobut-2-enoate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1265300 | Active | Ethyl 4-nitrobenzoate (40 mg) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1265479 | Active | Ethyl Benzoate (100 mg) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1265548 | Active | Ethylhexyl Triazone Related Compound A (20 mg) (2-ethylhexyl 4-aminobenzoate) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1268513 | Active | Etidronate Disodium Related Compound A (300 mg) (Sodium phosphite dibasic pentahydrate) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1268892 | Active | Etodolac Peak Identification Mixture (15 mg) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1268728 | Active | Etodolac Related Compound A (25 mg) ((+/-)-8-Ethyl-1-methyl-1,3,4,9-tetrahydropyrano [3,4-b]-indole-1-acetic acid) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1268769 | Active | Etodolac Related Compound H (25 mg) (2-(7-Ethyl-1H-indol-3-yl)ethan-1-ol) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1268794 | Active | Etonogestrel Related Compound A (10 mg) (13-Ethyl-11-methylenegon-4-ene-3,17-dione) | Reference Standard | Impurity | Steroids | Enquire
|
| 1268839 | Active | Etonogestrel Related Compound B (10 mg) (13-Ethyl-6Beta,17Beta-dihydroxy-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one) | Reference Standard | Impurity | Steroids | Enquire
|
| 1268841 | Active | Etonogestrel Related Compound C (10 mg) (13-Ethyl-17Beta-hydroxy-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-3,6-dione) | Reference Standard | Impurity | Steroids | Enquire
|
| 1268943 | Active | Etonogestrel Related Compound D (10 mg) (17Beta-Hydroxy-11-methylene-19-nor-17alpha-pregn-4-en-20-yn-3-one) | Reference Standard | Impurity | Steroids | Enquire
|
| 1268954 | Active | Etonogestrel Related Compound E (10 mg) (13-Ethyl-17Beta-hydroxy-11-methylene-18,19-dinor-17alpha-pregn-5-en-20-yn-3-one) | Reference Standard | Impurity | Steroids | Enquire
|
| 1269061 | Active | Exemestane Related Compound A (15 mg) (6-Methyleneandrosta-4-ene-3,17-dione) | Reference Standard | Impurity | Oncology | Enquire
|
| 1269072 | Active | Exemestane Related Compound B (15 mg) (6-hydroxymethylandrostra-1,4-diene-3,17-dione) | Reference Standard | Impurity | Oncology | Enquire
|
| 1269083 | Active | Exemestane Related Compound C CIII (15 mg) (androsta-1,4-diene-3,17-dione) | Reference Standard | Impurity | Oncology | Enquire
|
| 1090014 | Active | Exo-tetrahydrocannabinol (1 mL) ((6aR,10aR)-6,6-Dimethyl-9-methylene-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1-ol) | Reference Standard | Impurity | Psychoactives | Enquire
|
| 1269174 | Active | Famciclovir Related Compound A (20 mg) (2-[2-(2-Amino-9H-purin-9-yl)ethyl]propane-1,3-diol] hydrochloride) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1269185 | Active | Famciclovir Related Compound B (20 mg) (4-(2-Amino-9H-purin-9-yl)-2-(hydroxymethyl)butyl acetate) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1269196 | Active | Famciclovir Related Compound C (20 mg) (4-(2-amino-9H-purin-9-yl)-2-methylbutyl acetate) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1269130 | Active | Famciclovir Related Compound E (25 mg) (2-aminopurine) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1269141 | Active | Famciclovir Related Compound F (25 mg) (2-Amino-6-chloropurine) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1269221 | Active | Famotidine Related Compound B (25 mg) (3,5-Bis[2-[[2-[(diaminomethylene)amino]thiazol-4-yl]methylthio]ethyl]-4H-1,2,4,6-thiatriazine 1,1-dioxide) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1269232 | Active | Famotidine Related Compound C (25 mg) (3-[[2-(Diaminomethyleneamino)thiazol-4-yl]methylthio]-N-sulfamoylpropanamide hydrochloride) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1269243 | Active | Famotidine Related Compound D (25 mg) (3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanamide) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1269254 | Active | Famotidine Related Compound E (25 mg) (2,2'-[4,4'-disulfanediylbis(methylene)bis(thiazole-4,2-diyl)]diguanidine) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1269265 | Active | Famotidine Related Compound F (25 mg) (3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanoic acid) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1269367 | Active | Febantel Related Compound A (15 mg) (Methyl [[2-[(methoxyacetyl)amino]-4-(phenylthio)phenyl]carbamimidoyl]carbamate) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1269378 | Active | Febantel Related Compound B (15 mg) (2-(Methoxymethyl)-5-(phenylthio)-1H-benzimidazole) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1269323 | Active | Felbamate Related Compound A (25 mg) (3-Hydroxy-2-phenylpropyl carbamate) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1269334 | Active | Felbamate Related Compound B (25 mg) (Phenethyl carbamate) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1269390 | Active | Felodipine Related Compound A (15 mg) (3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1269414 | Active | Fenbendazole Related Compound A (30 mg) (Methyl (1H-benzimidazole-2-yl)carbamate) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1269425 | Active | Fenbendazole Related Compound B (30 mg) (Methyl [5(6)-chlorobenzimidazole-2-yl]carbamate) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1269607 | Active | Fenofibrate Related Compound A (25 mg) ((4-Chlorophenyl)(4-hydroxyphenyl)methanone) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1269618 | Active | Fenofibrate Related Compound B (25 mg) (2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1269629 | Active | Fenofibrate Related Compound C (25 mg) (1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl]oxy]-2-methylpropanoate) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1269469 | Active | Fenoldopam Related Compound A (20 mg) (N-Methyl-6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1269470 | Active | Fenoldopam Related Compound B (20 mg) (1-(4-Hydroxyphenyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol methanesulfonate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1269913 | Active | Fentanyl Related Compound A (100 mg) ((2-bromoethyl)benzene) | Reference Standard | Impurity | Opioids | Enquire
|
| 1269924 | Active | Fentanyl Related Compound B (10 mg) (4-Anilinopiperidine) | Reference Standard | Impurity | Opioids | Enquire
|
| 1269946 | Active | Fentanyl Related Compound D (10 mg) (N-Phenyl-1-(phenylmethyl)-4-piperidinamine) | Reference Standard | Impurity | Opioids | Enquire
|
| 1269957 | Active | Fentanyl Related Compound E CII (10 mg) (N-Phenyl-1-(2-phenylethyl)-4-piperidinamine) | Reference Standard | Impurity | Opioids | Enquire
|
| 1269979 | Active | Fentanyl Related Compound G CI (10 mg) (N-(1-Phenethylpiperidin-4-yl)-N-phenylacetamide) | Reference Standard | Impurity | Opioids | Enquire
|
| 1270388 | Active | Fexofenadine Related Compound A (25 mg) (2-(4-{4-[4-(Hydroxydiphenylmethyl)piperidin-1-yl]butanoyl}phenyl)-2-methylpropanoic acid) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1270399 | Active | Fexofenadine Related Compound B (25 mg) (2-(3-{1-Hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl}phenyl)-2-methylpropanoic acid hydrochloride monohydrate) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1270446 | Active | Fexofenadine Related Compound C (25 mg) (4-[4-(Hydroxydiphenylmethyl)piperidin-1-yl]-1-(4-isopropylphenyl)butan-1-ol hydrochloride) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1270719 | Active | Flavoxate Related Compound A (25 mg) (3-methylflavone-8-carboxylic acid) | Reference Standard | Impurity | Renal | Enquire
|
| 1270720 | Active | Flavoxate Related Compound B (20 mg) (Methyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate) | Reference Standard | Impurity | Renal | Enquire
|
| 1270731 | Active | Flavoxate Related Compound C (20 mg) (3-Methylflavone-8-carboxylic acid ethyl ester) | Reference Standard | Impurity | Renal | Enquire
|
| 1270821 | Active | Flecainide Related Compound A (75 mg) (3-[2,5-Bis(2,2,2-trifluoroethoxy)phenyl]-1,5,6,7,8,8alpha-hexahydroimidazo-[1,5alpha]pyridine hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1271711 | Active | Fluconazole Related Compound A (10 mg) (2-[2-fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ol) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1271722 | Active | Fluconazole Related Compound B (10 mg) (2-(4-fluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ol) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1271733 | Active | Fluconazole Related Compound C (10 mg) (1,1'-(1,3-phenylene)di(1H-1,2,4-triazole)) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1272918 | Active | Fludeoxyglucose Related Compound A (15 mg) (4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane) | Reference Standard | Impurity | Radiopharmaceuticals | Enquire
|
| 1272929 | Active | Fludeoxyglucose Related Compound B (10 mg) (2-chloro-2-deoxy-D-glucose) | Reference Standard | Impurity | Radiopharmaceuticals | Enquire
|
| 1273819 | Active | Flumazenil Related Compound A (20 mg) (8-Fluoro-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylic acid) | Reference Standard | Impurity | Antidotes & Chelators | Enquire
|
| 1273820 | Active | Flumazenil Related Compound B (20 mg) (Ethyl 8-hydroxy-5,6-dihydro-5-methyl-6-oxo-4H-imidazol-[1,5-a][1,4]benzodiazepine-3-carboxylate) | Reference Standard | Impurity | Antidotes & Chelators | Enquire
|
| 1273841 | Active | Flumazenil Related Compound C (500 mg) (N,N-Dimethylformamide diethyl acetal) | Reference Standard | Impurity | Antidotes & Chelators | Enquire
|
| 1274629 | Active | Flunixin Related Compound A (15 mg) (2-Chloronicotinic acid) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1274630 | Active | Flunixin Related Compound B (25 mg) (2-Methyl-3-(trifluoromethyl)aniline) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1274631 | Active | Flunixin Related Compound C (50 mg) (Ethyl 2-chloronicotinate) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1277037 | Active | Fluorescein Related Compound C (25 mg) (2-(2,4-Dihydroxybenzoyl)benzoic acid) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1278018 | Active | Fluorometholone Related Compound A (15 mg) (11Beta,17alpha-Dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione) | Reference Standard | Impurity | Steroids | Enquire
|
| 1278302 | Active | Fluoroquinolonic Acid (150 mg) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1279019 | Active | Fluorouracil Related Compound A (25 mg) (Pyrimidine-2,4,6(1H,3H,5H)-trione) | Reference Standard | Impurity | Oncology | Enquire
|
| 1279021 | Active | Fluorouracil Related Compound B (25 mg) (Dihydropyrimidine-2,4,5(3H)-trione) | Reference Standard | Impurity | Oncology | Enquire
|
| 1279054 | Active | Fluorouracil Related Compound E (25 mg) (5-Chloropyrimidine-2,4(1H,3H)-dione) | Reference Standard | Impurity | Oncology | Enquire
|
| 1279065 | Active | Fluorouracil Related Compound F (25 mg) (2-Ethoxy-5-fluoropyrimidin-4(1H)-one) | Reference Standard | Impurity | Oncology | Enquire
|
| 1279815 | Active | Fluoxetine Related Compound A (15 mg) (N-methyl-3-phenyl-3-[(alpha, alpha, alpha-trifluoro-m-tolyl)oxy]propylamine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1279826 | Active | Fluoxetine Related Compound B (5 mL of a 0.01N HCl Solution, approx. 2 mg/mL) (N-Methyl-3-phenylpropan-1-amine) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1279837 | Active | Fluoxetine Related Compound C (15 mg) (4-(methyl{3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl}amino)-4-oxobutanoic acid) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1282015 | Active | Fluphenazine Related Compound A (50 mg) (10-{3-[4-(2-Hydroxyethyl)piperazin-1-yl]propyl}-2-(trifluoromethyl)-10H-phenothiazine 5-oxide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1282026 | Active | Fluphenazine Related Compound B (50 mg) (10-{3-[4-(2-Hydroxyethyl)piperazin-1-yl]propyl}-2-(trifluoromethyl)-10H-phenothiazine 5,5-dioxide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1285308 | Active | Flurazepam Related Compound C (50 mg) (5-Chloro-2-(2-diethylaminoethylamino)-2'-fluorobenzophenone hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1285603 | Active | Flurazepam Related Compound F (50 mg) (7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1285760 | Active | Flurbiprofen Related Compound A (100 mg) (2-(4-Biphenylyl)propionic Acid) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1285997 | Active | Flutamide Related Compound A (20 mg) (4-nitro-3-(trifluoromethyl)aniline) | Reference Standard | Impurity | Oncology | Enquire
|
| 1285986 | Active | Flutamide Related Compound B (20 mg) (N-[4-nitro-3-(trifluoromethyl)phenyl]acetamide) | Reference Standard | Impurity | Oncology | Enquire
|
| 1285829 | Active | Fluticasone Propionate Related Compound D (15 mg) (S-methyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha-methyl-3-oxo-17alpha-propionyloxyandrosta-1,4-diene-17beta-carbothioate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1285818 | Active | Fluticasone Propionate Related Compound J (15 mg) (6alpha, 9alpha-difluoro-11beta,17alpha-dihydroxy-16alpha-methyl-3-oxoandrosta-1,4-diene-17beta-carboxylic acid) | Reference Standard | Impurity | Steroids | Enquire
|
| 1285840 | Active | Fluticasone Propionate Related Compounds Mixture (25 mg) | Reference Standard | Impurity | Steroids | Enquire
|
| 1285964 | Active | Fluvastatin Related Compound B (15 mg) ([R*,S*-E]-(+/-)-7-[3-(4-fluorophenyl)-1-methylethyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid 1,1, dimethylethyl ester) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1042351 | Active | Formoterol Related Compound A (30 mg) (2-Amino-4-(1-hydroxy-2-((1-(4-methoxyphenyl)propan-2-yl)amino)ethyl)phenol) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1042373 | Active | Formoterol Related Compound C (30 mg) (N-(2-Hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethyl)phenyl)acetamide fumarate) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1286141 | Active | Formoterol Related Compound D (30 mg) (N-(2-Hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl](methyl)amino}ethyl)phenyl)formamide fumarate) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1286184 | Active | Formoterol Related Compound I (25 mg) (N-(2-hydroxy-5-[(RS)-1-hydroxy-2-{[(SR)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl)formamide) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1286311 | Active | Formyl Penicillamine (25 mg) (2-Formamido-3-mercapto-3-methylbutanoic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1283379 | Active | Fosamprenavir Related Compound A (10 mg) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1283313 | Active | Foscarnet Related Compound B (10 mg) (disodium (ethoxyoxidophosphanyl)formate) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1283324 | Active | Foscarnet Related Compound D (0.27 mL) (O,O-diethyl ethoxycarbonylphosphonate) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1283415 | Active | Fosinopril Related Compound A (25 mg) ((4S)-4-cyclohexyl-[(4-phenylbutyl)phosphinyl]acetyl-L-proline) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1283426 | Active | Fosinopril Related Compound B (25 mg) ((4S)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-D-proline propionate (ester), hemibarium salt, sesquihydrate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1283437 | Active | Fosinopril Related Compound C (15 mg) ((4S)-4-cyclohexyl-1-[(RS)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]-acetyl-L-proline propionate (ester), sodium salt) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1283448 | Active | Fosinopril Related Compound D (15 mg) ((4R)-4-cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-L-proline propionate (ester), sodium salt) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1283459 | Active | Fosinopril Related Compound E (15 mg) ((4S)-4-phenyl-1-[(R)-[(S)-1-hydroxy-2-methyl-propoxy](4-phenylbutyl)phospinyl]acetyl-L-proline propionate (ester), sodium salt) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1283460 | Active | Fosinopril Related Compound F (15 mg) ((4S)-4-cyclohexyl-1-[(R)-[(S)-1-hydroxypropoxy](4-phenylbutyl)phosphinyl]acetyl-L-proline propionate(ester), sodium salt) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1283470 | Active | Fosinopril Related Compound G (15 mg) ((4-phenylbutyl)phosphinyl acetic acid, disodium salt) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1283481 | Active | Fosinopril Related Compound H (25 mg) (4-phenylbutyl phosphonic acid) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1286402 | Active | Frovatriptan Racemate (15 mg) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1286424 | Active | Frovatriptan Related Compound A (20 mg) ((R)-3-Amino-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1287020 | Active | Furosemide Related Compound A (50 mg) (2-Chloro-4-N-furfurylamino-5-sulfamoylbenzoic Acid) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1287030 | Active | Furosemide Related Compound B (100 mg) (4-Chloro-5-sulfamoylanthranilic Acid) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1287325 | Active | Gabapentin Related Compound A (50 mg) (2-Azaspiro[4.5]decan-3-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1287347 | Active | Gabapentin Related Compound B (30 mg) ((1-cyanocyclohexyl)acetic acid) (COLD SHIPMENT REQUIRED) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1287358 | Active | Gabapentin Related Compound D (10 mg) ([1-(3-Oxo-2-aza-spiro[4.5]dec-2-ylmethyl)cyclohexyl]acetic acid) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1287369 | Active | Gabapentin Related Compound E (25 mg) (carboxymethyl-cyclohexanecarboxylic acid) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1287518 | Active | Gadodiamide Related Compound A (25 mg) (Gadolinium sodium diethylenetriamine pentaacetic acid monomethylamide) | Reference Standard | Impurity | Nonradioactive Imaging Agents | Enquire
|
| 1287529 | Active | Gadodiamide Related Compound B (50 mg) (Gadolinium disodium diethylenetriamine pentaacetic acid) | Reference Standard | Impurity | Nonradioactive Imaging Agents | Enquire
|
| 1287642 | Active | Gadoteridol Related Compound A (50 mg) (10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid) | Reference Standard | Impurity | Nonradioactive Imaging Agents | Enquire
|
| 1287653 | Active | Gadoteridol Related Compound B (50 mg) (Gadolinium(III) 2,2',2''-(1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate dihydrate) | Reference Standard | Impurity | Nonradioactive Imaging Agents | Enquire
|
| 1287664 | Active | Gadoteridol Related Compound C (50 mg) (1,4,7,10-Tetraaza-11-oxo-bicyclo[8.2.2]tetradecane-4,7-diacetic acid) | Reference Standard | Impurity | Nonradioactive Imaging Agents | Enquire
|
| 1287766 | Active | Galantamine Hydrobromide Racemic (15 mg) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1287777 | Active | Galantamine Hydrobromide Related Compounds Mixture (25 mg) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1020023 | Active | Gamma-Aminobutyric Acid (50 mg) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1288339 | Active | Ganciclovir Mono-N-methyl Valinate (10 mg) (2-(RS)-[(Guanin-9-yl)methoxy]-3-hydroxypropyl N-methyl-L-valinate hydrochloride) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1288317 | Active | Ganciclovir Related Compound A (15 mg) ((RS)-2-Amino-9-(2,3-dihydroxy-propoxymethyl)-1,9-dihydro-purin-6-one) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1288419 | Active | Gatifloxacin Related Compound A (15 mg) (1-Cyclopropyl-6-fluoro-8-hydroxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1288441 | Active | Gatifloxacin Related Compound D (15 mg) (1-Cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1288452 | Active | Gatifloxacin Related Compound E (15 mg) (1-Cyclopropyl-6-fluoro-8-methoxy-7-(2-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid monohydrochloride) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1289116 | Active | Gefitinib Related Compound A (25 mg) (7-Methoxy-6-(3-morpholinopropoxy)quinazolin-4(3H)-one) | Reference Standard | Impurity | Oncology | Enquire
|
| 1289127 | Active | Gefitinib Related Compound B (25 mg) (N-(4-Chloro-3-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine) | Reference Standard | Impurity | Oncology | Enquire
|
| 1288510 | Active | Gemfibrozil Related Compound A (20 mg) ((E,Z)-2,2-dimethyl-5-[2,5-dimethyl-4-(propene-1-yl)phenoxy]valeric acid) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1288634 | Active | Gemifloxacin Related Compound B (15 mg) (7-[3-(Aminomethyl)-4-hydroxypyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid monomethanesulfonate) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1288645 | Active | Gemifloxacin Related Compound C (15 mg) (7-[3-(Aminomethyl)-4-oxopyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid monomethanesulfonate) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1292314 | Active | Glimepiride Related Compound A (20 mg) (1-[[p-[2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl]phenyl]sulfonyl]-3-(cis-4-methylcyclohexyl)urea) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1292325 | Active | Glimepiride Related Compound B (20 mg) (glimepiride sulfonamide, or 3-Ethyl-4-methyl-2-oxo-N-(4-sulfamoylphenethyl)-2,5-dihydro-1H-pyrrole-1-carboxamide) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1292336 | Active | Glimepiride Related Compound C (20 mg) ((Methyl ({4-[2-(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamido)ethyl]phenyl}sulfonyl)carbamate) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1292347 | Active | Glimepiride Related Compound D (20 mg) (Glimepiride 3-isomer, or 1-[[m-[2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl]phenyl]sulfonyl]-3-(trans-4-methylcyclohexyl)urea) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1292609 | Active | Glipizide Related Compound A (25 mg) (N-{2-[(4-aminosulfonyl)phenyl]ethyl}-5-methyl-pyrazinecarboxamide) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1292610 | Active | Glipizide Related Compound B (15 mg) (6-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1292631 | Active | Glipizide Related Compound C (15 mg) (1-cyclohexyl-3-[[4-[2-[[(6-methylpyrazin-2-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]urea) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1295516 | Active | Glyburide Related Compound A (25 mg) (4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzenesulfonamide) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1295527 | Active | Glyburide Related Compound B (25 mg) (methyl-[[4-[2-[(5-chloro-2-methoxybenzoyl)-amino]ethyl]phenyl]sulfonyl]carbamate) (AS) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1296010 | Active | Glycopyrrolate Erythro Isomer (25 mg) ((RS)-3-[(RS)-2-cyclopentyl-2-hydroxy-2-phenylacetoxy]-1,1-dimethylpyrrolidinium bromide) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1296029 | Active | Glycopyrrolate Related Compound A (50 mg) (5-Nitrobenzene-1,3-dicarboxylic acid) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1296031 | Active | Glycopyrrolate Related Compound B (50 mg) (1-Methylpyrrolidin-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate Hydrochloride) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1296042 | Active | Glycopyrrolate Related Compound C (25 mg) (2-Cyclopentyl-2-hydroxy-2-phenylacetic acid) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1296086 | Active | Glycopyrrolate Related Compound I (15 mg) ((RS)-3-[(SR)-2-(4-Chlorophenyl)-2-cyclopentyl-2-hydroxyacetoxy]-1,1-dimethylpyrrolidin-1-ium bromide) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1296100 | Active | Glycopyrrolate Related Compound L (50 mg) (Methyl 2-cyclopentyl-2-hydroxy-2-phenylacetate) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1298117 | Active | Granisetron Related Compound A (15 mg) (2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2H-indazole-3-carboxamide) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1298128 | Active | Granisetron Related Compound B (15 mg) (N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1298139 | Active | Granisetron Related Compound C (15 mg) (N-[(1R,3r,5S)-9-azabicyclo[3.3.1]non-3-yl]-1-methyl-1H-indazole-3-carboxamide hydrochloride) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1298140 | Active | Granisetron Related Compound D (15 mg) (1-Methyl-1H-indazole-3-carboxylic acid) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1298150 | Active | Granisetron Related Compound E (15 mg) ((1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine acetate) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1299200 | Active | Griseofulvin Permeability Diameter (2 g) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1300004 | Active | Guaiacol (1 g) (2-Methoxyphenol) | Reference Standard | Impurity | Cough and Cold | Enquire
|
| 1302156 | Active | Guanine (100 mg) | Reference Standard | Impurity | Oncology | Enquire
|
| 1303013 | Active | Haloperidol Related Compound A (10 mg) (4,4'-Bis[4-(p-chlorophenyl)-4-hydroxypiperidino]-butyrophenone) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1303024 | Active | Haloperidol Related Compound B (10 mg) (4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(2-fluorophenyl)butan-1-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1228075 | Active | Heptamethyl Trisiloxane (150 mg) (1,1,1,3,5,5,5-Heptamethyltrisiloxane) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1162273 | Active | Hexyl Methanesulfonate (50 mg) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1315012 | Active | Hydrocodone Related Compound A CII (70 mg) (4-hydroxy-3-methoxy-17-methylmorphinan-6-one) | Reference Standard | Impurity | Opioids | Enquire
|
| 1323019 | Active | Hydromorphone N-Oxide Hydrochloride CII (15 mg) (4,5alpha-Epoxy-3-hydroxy-17-methylmorphinan-6-one N-oxide, hydrochloride) | Reference Standard | Impurity | Opioids | Enquire
|
| 1323021 | Active | Hydromorphone Related Compound A CII (10 mg) (7,8-didehydro-4,5alpha-epoxy-3-hydroxy-17-methylmorphinan-6-one perchlorate) | Reference Standard | Impurity | Opioids | Enquire
|
| 1333058 | Active | Hydroxyzine Related Compound A (25 mg) (1-[(4-Chlorophenyl)phenylmethyl]piperazine) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1335010 | Active | Hyoscyamine Related Compound A (10 mg) (Norhyoscyamine Sulfate) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1335428 | Active | Ibandronate Related Compound A (25 mg) (3-[Methyl(pentyl)amino]propanoic acid hydrochloride) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1335541 | Active | Ibuprofen Related Compound C (0.2 mL/ampule; 3 ampules) (4-isobutylacetophenone) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1335596 | Active | Ibuprofen Related Compound J (25 mg) (2-(4-Isobutyrylphenyl)propanoic acid) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1335621 | Active | Ibutilide Related Compound A (20 mg) (N-Ethyl-N-heptyl-4-[4-(methylsulfonamido)phenyl]-4-oxobutanamide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1335632 | Active | Ibutilide Related Compound B (20 mg) (N-Ethyl-N-heptyl-4-hydroxy-4-[4-(methylsulfonamido)phenyl]butanamide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1336250 | Active | Iloperidone Related Compound A (20 mg) ([4'-(3-Chloropropoxy)-3'-methoxy]acetophenone) (DISCONTINUED) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1336500 | Active | Imidazole (200 mg) (1H-Imidazole) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1337004 | Active | Iminodibenzyl (25 mg) (10,11-Dihydro-5H-dibenzo[b,f]azepine) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1338324 | Active | Imiquimod Related Compound A (25 mg) (1-Isobutyl-1H-imidazo[4,5-c]quinoline) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1338335 | Active | Imiquimod Related Compound B (25 mg) (1-Isobutyl-1H-imidazo[4,5-c]quinoline 5-oxide) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1338346 | Active | Imiquimod Related Compound C (25 mg) (4-Chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1338357 | Active | Imiquimod Related Compound D (25 mg) (1-Propyl-1H-imidazo[4,5-c]quinolin-4-amine) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1034341 | Active | Inamrinone Related Compound B (100 mg) (2-Hydroxy-N-(6-oxo-1,6-dihydro-[3,4'-bipyridin]-5-yl)propanamide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1338812 | Active | Indapamide Related Compound A (50 mg) (4-chloro-N-(2-methyl-1H-indol-1-yl)-3-sulfamoylbenzamide) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1340086 | Active | Indole (25 mg) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1417113 | Active | Indomethacin Related Compound A (25 mg) (2-(5-methoxy-2-methyl-1H-indol-3-yl)acetic acid) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1112423 | Active | Indomethacin Related Compound B (25 mg) (4-chlorobenzoic acid) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1343540 | Active | Iodixanol Related Compound C (25 mg) (5-[Acetyl[3-[[3,5-bis[[(2,3-dihydroxypropyl)amino]carbonyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide) | Reference Standard | Impurity | Nonradioactive Imaging Agents | Enquire
|
| 1343550 | Active | Iodixanol Related Compound D (50 mg) (5-[Acetyl(2-hydroxy-3-methoxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide) | Reference Standard | Impurity | Nonradioactive Imaging Agents | Enquire
|
| 1343561 | Active | Iodixanol Related Compound E (25 mg) (5-{N-[3-(N-{3-carbamoyl-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl}acetamido)-2-hydroxypropyl]acetamido}-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide) | Reference Standard | Impurity | Nonradioactive Imaging Agents | Enquire
|
| 1344622 | Active | Iohexol Related Compound A (100 mg) (5-(acetylamino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide) | Reference Standard | Impurity | Nonradioactive Imaging Agents | Enquire
|
| 1344644 | Active | Iohexol Related Compound B (50 mg) (5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide) | Reference Standard | Impurity | Nonradioactive Imaging Agents | Enquire
|
| 1344666 | Active | Iohexol Related Compound C (50 mg) (N,N'-Bis(2,3-dihydroxypropyl)-5-nitro-1,3- benzenedicarboxamide) | Reference Standard | Impurity | Nonradioactive Imaging Agents | Enquire
|
| 1344724 | Active | Iopamidol Related Compound A (50 mg) (N,N'-Bis-(1,3-dihydroxy-2-propyl)-5-amino-2,4,6-triiodoisophthalamide) | Reference Standard | Impurity | Nonradioactive Imaging Agents | Enquire
|
| 1344735 | Active | Iopamidol Related Compound B (50 mg) (5-Glycolamido-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodoisophthalamide) | Reference Standard | Impurity | Nonradioactive Imaging Agents | Enquire
|
| 1344746 | Active | Iopamidol Related Compound C (40 mg) (4-chloro-N1, N3-bis(1,3-dihydroxypropan-2-yl)-5-(S)-lactamido-2,6-diiodoisophthalamide) | Reference Standard | Impurity | Nonradioactive Imaging Agents | Enquire
|
| 1344826 | Active | Iopromide Related Compound A (50 mg) (5-Amino-N1,N3-Bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-N1-methylisophthalamide) | Reference Standard | Impurity | Nonradioactive Imaging Agents | Enquire
|
| 1344837 | Active | Iopromide Related Compound B (50 mg) (5-(Acetylamino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methyl-1,3-benzenedicarboxamide) | Reference Standard | Impurity | Nonradioactive Imaging Agents | Enquire
|
| 1345126 | Active | Ioversol Related Compound B (50 mg) (N,N'-Bis(2,3-dihydroxypropyl)-5-{[N-(2-hydroxyethyl)amino]-2-oxoethoxy}-2,4,6-triiodoisophthalamide) | Reference Standard | Impurity | Nonradioactive Imaging Agents | Enquire
|
| 1345228 | Active | Ioxilan Related Compound A (100 mg) (5-amino-2,4,6-triiodo-3 N-(2-hydroxyethyl)carbamoyl benzoic acid) (PLANNED TO BE DISCONTINUED) | Reference Standard | Impurity | Nonradioactive Imaging Agents | Enquire
|
| 1347518 | Active | Ipratropium Bromide Related Compound A (10 mg) ((1R,3r,5S,8r)-3-Hydroxy-8-isopropyl-8-methyl-8-azabicyclo[3.2.1]octan-8-ium bromide) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1347529 | Active | Ipratropium Bromide Related Compound B (10 mg) ((1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane, bromide) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1347530 | Active | Ipratropium Bromide Related Compound C (15 mg) ((2-RS)-3-hydroxy-2-phenylpropanoic acid) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1347711 | Active | Irbesartan Related Compound A (25 mg) (1-pentanoylamino-cyclopentanecarboxylic acid [2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1347610 | Active | Irinotecan Related Compound A (10 mg) ((S)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione) | Reference Standard | Impurity | Oncology | Enquire
|
| 1347631 | Active | Irinotecan Related Compound B (10 mg) ((S)-4,11-diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione) | Reference Standard | Impurity | Oncology | Enquire
|
| 1347642 | Active | Irinotecan Related Compound C (10 mg) (11-Ethyl-4-hydroxy-4-methyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl (1,4'-bipiperidine)- 1'-carboxylate hydrochloride) | Reference Standard | Impurity | Oncology | Enquire
|
| 1347653 | Active | Irinotecan Related Compound D (15 mg) ((R)-9-[(1,4'-Bipiperidine)-1'-carbonyloxy]-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline hydrochloride, trihydrate) | Reference Standard | Impurity | Oncology | Enquire
|
| 1347664 | Active | Irinotecan Related Compound E (15 mg) ((S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione) | Reference Standard | Impurity | Oncology | Enquire
|
| 1193378 | Active | Iscotrizinol Related Compound B (25 mg) (4-[(4-{[4-(tert-butylcarbamoyl)phenyl]amino}-6-[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)amino]-1,3,5-triazin-2-yl)amino]benzoic acid) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1193389 | Active | Iscotrizinol Related Compound C (25 mg) (2-Ethylhexyl 4-[(4-{[4-(tert-butylcarbamoyl)phenyl]amino}-6-chloro-1,3,5-triazin-2-yl)amino]benzoate) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1193390 | Active | Iscotrizinol Related Compound D (25 mg) (2-Ethylhexyl 4-[(4,6-bis{[4-(tert-butylcarbamoyl)phenyl]amino}-1,3,5-triazin-2-yl)amino]benzoate) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1193414 | Active | Iscotrizinol Related Compound F (25 mg) (Bis(2-ethylhexyl) 4,4'-({6-[(4-carbamoylphenyl)amino]-1,3,5-triazine-2,4-diyl}bis(azanediyl))dibenzoate) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1193425 | Active | Iscotrizinol Related Compound G (25 mg) (2-Ethylhexyl 4-{4-[(4-{[4-(tert-butylcarbamoyl)phenyl]amino}-6-[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)amino]-1,3,5-triazin-2-yl)amino]benzamido}benzoate) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1193447 | Active | Iscotrizinol Related Compound I (25 mg) (Bis(2-ethylhexyl) 4,4'-{[6-({4-[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)carbamoyl]phenyl}amino)-1,3,5-triazine-2,4-diyl]bis(azanediyl)}dibenzoate) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1350625 | Active | Iso-propyl p-Toluenesulfonate (50 mg) (Isopropyl toluene-4-sulfonate) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1349014 | Active | Isoflurane Related Compound A (0.1 mL) (1-Chloro-2,2,2-trifluoroethyl chlorodifluoromethyl ether) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1349025 | Active | Isoflurane Related Compound B (0.1 mL) (2,2,2-Trifluoroethyl difluoromethyl ether) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1349149 | Active | Isoguaifenesin (30 mg) | Reference Standard | Impurity | Cough and Cold | Enquire
|
| 1349604 | Active | Isomalathion (50 mg) (Diethyl 2-{[methoxy(methylthio)phosphoryl]thio}succinate) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1351016 | Active | Isoproterenol Related Compound A (25 mg) (1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethan-1-one hydrochloride) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1354218 | Active | Isradipine Related Compound A (15 mg) (Isopropyl methyl 4-(4-benzofurazanyl)-2,6-dimethyl-3,5-pyridinedicarboxylate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1356020 | Active | Ketamine Related Compound A (50 mg) (1-[(2-Chlorophenyl)(methylimino)methyl]cylcopentanol) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1356643 | Active | Ketoprofen Related Compound A (25 mg) (alpha-methyl-3-(4-methylbenzoyl) benzeneacetic acid) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1356552 | Active | Ketoprofen Related Compound C (20 mg) (2-(3-carboxyphenyl)propionic acid) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1356563 | Active | Ketoprofen Related Compound D (20 mg) (3-Acetylbenzophenone) (COLD SHIPMENT REQUIRED) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1356585 | Active | Ketoprofen Related Compound F (20 mg) (3-(1-Cyanoethyl)benzophenone) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1356315 | Active | Ketorolac Related Compound A (20 mg) (5-Benzoyl-N-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)-2,3-dihydro-1H-pyrrolizine-1-carboxamide) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1356326 | Active | Ketorolac Related Compound B (20 mg) (5-benzoyl-2,3-dihydro-1H-pyrrolizin-1-ol) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1356337 | Active | Ketorolac Related Compound C (20 mg) (5-benzoyl-2,3-dihydro-1H-pyrrolizin-1-one) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1356348 | Active | Ketorolac Related Compound D (20 mg) (5-benzoyl-2,3-dihydro-1H-pyrrolizine) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1356417 | Active | Ketotifen Related Compound A (30 mg) (4-(4H-Benzo[4,5]cyclohepta[1,2-b]thiophen-4-ylidene)-1-methylpiperidine fumarate) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1356472 | Active | Ketotifen Related Compound G (30 mg) (4-(1-Methylpiperidin-4-ylidene)-4H-benzo[4,5]cyclohepta[1,2-b]thiophene-9,10-dione fumarate) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1356745 | Active | Labetalol Cyclohexyl Analog (25 mg) (5-{2-[(4-Cyclohexylbutan-2-yl)amino]-1-hydroxyethyl}-2-hydroxybenzamide hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1356719 | Active | Labetalol Related Compound A (25 mg) (2-Hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzoic acid hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1356723 | Active | Labetalol Related Compound F (15 mg) (2-Hydroxy-5-[(4-phenylbutan-2-yl)glycyl]benzamide hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1357125 | Active | Lacosamide Related Compound B (30 mg) (2-Acetamido-3-(benzylamino)-3-oxopropyl acetate) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1357147 | Active | Lacosamide Related Compound D (30 mg) (2-Amino-N-benzyl-3-methoxypropanamide oxalate) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1357170 | Active | Lacosamide Related Compound F (30 mg) (2-Acetamido-N-benzyl-3-hydroxypropanamide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1357158 | Active | Lacosamide S-Enantiomer (30 mg) ((S)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1356778 | Active | Lamotrigine Related Compound B (20 mg) (2,3-dichlorobenzoic acid) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1356789 | Active | Lamotrigine Related Compound C (10 mg) (3-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-5(4H)-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1356790 | Active | Lamotrigine Related Compound D (10 mg) (N-[5-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl]-2,3-dichlorobenzamide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1356905 | Active | Lanolin Alcohols (5 g) | Reference Standard | Impurity | Others-Chemical Medicines | Enquire
|
| 1356927 | Active | Lansoprazole Related Compound A (25 mg) (2-({[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl}sulfonyl)benzimidazole) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1356931 | Active | Lansoprazole Related Compound B (25 mg) (2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-pyridin-2-yl]methyl]sulfanyl]-1H-benzimidazole monohydrate) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1357486 | Active | Latanoprost Related Compound A (50 mg) (Isopropyl (E)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}-5-heptenoate) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1357497 | Active | Latanoprost Related Compound B (25 mg) (Isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3S)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoate) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1357522 | Active | Latanoprost Related Compound D (25 mg) (COLD SHIPMENT REQUIRED) (Isopropyl (Z)-7-{(1R,2R,3R,5S)-2-[(R)-5-phenyl-3-(triethylsilyloxy)pentyl]-3,5-bis(triethylsilyloxy)cyclopentyl}hept-5-enoate) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1357533 | Active | Latanoprost Related Compound E (25 mg) ((Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}-5-heptenoic acid) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1357045 | Active | Leflunomide Related Compound A (100 mg) (4-(trifluoromethyl)aniline) | Reference Standard | Impurity | Immunosuppresants | Enquire
|
| 1357056 | Active | Leflunomide Related Compound B (20 mg) (Z)-2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)but-2-enamide | Reference Standard | Impurity | Immunosuppresants | Enquire
|
| 1357067 | Active | Leflunomide Related Compound C (10 mg) (N-(3'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide) | Reference Standard | Impurity | Immunosuppresants | Enquire
|
| 1356982 | Active | Letrozole Related Compound A (25 mg) (4,4'-(1H-1,3,4-triazol-1-ylmethylene)dibenzonitrile) | Reference Standard | Impurity | Oncology | Enquire
|
| 1358795 | Active | Levalbuterol Related Compound A (30 mg) (4-(2-tert-Butylamino-ethyl)-2-hydroxymethyl-phenol) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1358809 | Active | Levalbuterol Related Compound B (20 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-methyl-benzenemethanol) (DISCONTINUED) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1358810 | Active | Levalbuterol Related Compound C (30 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-(methoxymethyl)-benzenemethanol) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1358820 | Active | Levalbuterol Related Compound D (30 mg) (5-[2-(tert-Butylamino)-1-hydroxyethyl]-2-hydroxybenzaldehyde sulfate (2:1) (salt)) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1358831 | Active | Levalbuterol Related Compound E (30 mg) (4-(2-(tert-Butylamino)-1-hydroxyethyl)-2-(ethoxymethyl)phenol) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1358842 | Active | Levalbuterol Related Compound F (30 mg) ((R)-1-[4-(Benzyloxy)-3-(hydroxymethyl)phenyl]-2-(tert-butylamino)ethan-1-ol) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1358864 | Active | Levalbuterol Related Compound H (10 mg) (4-[2-(tert-Butylamino)-1-methoxyethyl]-2-(hydroxymethyl)phenol acetate) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1359415 | Active | Levetiracetam Racemic Mixture (15 mg) (1:1 mixture of levetiracetam S-enantiomer-(2S)-2-(2-oxopyrrolidin-1-yl)butanamide and levetiracetam R-enantiomer (2R)-2-(2-oxopyrrolidin-1-yl)butanamide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1359426 | Active | Levetiracetam Related Compound A (20 mg) ((S)-N-(1-amino-1-oxobutan-2-yl)-4-chlorobutanamide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1359437 | Active | Levetiracetam Related Compound B (20 mg) ((S)-2-aminobutanamide hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1359867 | Active | Levocabastine Related Compound A (50 mg) (1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic acid hydrochloride) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1359958 | Active | Levocetirizine Amide (75 mg) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1361010 | Active | Levodopa Related Compound A (50 mg) (3-(2,4,5-Trihydroxyphenyl)-L-alanine) (COLD SHIPMENT REQUIRED) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1420006 | Active | Levodopa Related Compound B (50 mg) (3-methoxytyrosine) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1362114 | Active | Levofloxacin Related Compound A (25 mg) ((S)-9-fluoro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1362125 | Active | Levofloxacin Related Compound B (35 mg) ((S)-9,10,difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1362136 | Active | Levofloxacin Related Compound C (25 mg) ((S)-ethyl 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylate) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1362158 | Active | Levofloxacin Related Compound E (25 mg) ((S)-9-Fluoro-2,3-dihydro-3-methyl-10-[2-(methylamino)ethylamino]-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid hydrochloride) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1362169 | Active | Levofloxacin Related Compound F (25 mg) ((S)-2,3-Dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1179344 | Active | Levomedetomidine (25 mg) ((R)-4-[1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole hydrochloride) (25 mg) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1366080 | Active | Lidocaine Related Compound H (50 mg) (2-Chloro-N-(2,6-dimethylphenyl)acetamide) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1367515 | Active | Lindane Related Compound A (25 mg) ((1R,2R,3R,4R,5S,6S)-1,2,3,4,5,6-Hexachlorocyclohexane) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1367639 | Active | Linezolid R-Isomer (20 mg) (N-{[(R)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl}acetamide) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1367570 | Active | Linezolid Related Compound A (20 mg) ((R)-5-(azidomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1367581 | Active | Linezolid Related Compound B (20 mg) ((S)-N-{[3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl]methyl}thioacetamide) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1367592 | Active | Linezolid Related Compound C (20 mg) ((S)-5-(aminomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1367606 | Active | Linezolid Related Compound D (20 mg) ((R)-[3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl]methyl methanesulfonate) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1368610 | Active | Lisinopril Related Compound A (250 mg) ((S)-2-{(3S,8aS)-3-(4-aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-alpha]pyrazin-2(1H)-yl}-4-phenylbutanoic acid) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1369431 | Active | Lomustine Related Compound B (25 mg) (1-(2-Chloroethyl)-3-cyclohexylurea) | Reference Standard | Impurity | Oncology | Enquire
|
| 1369442 | Active | Lomustine Related Compound C (25 mg) (1,3-Dicyclohexylurea) | Reference Standard | Impurity | Oncology | Enquire
|
| 1369453 | Active | Lomustine Related Compound D (25 mg) (3-(2-Chloroethyl)-1-cyclohexyl-1-nitrosourea) | Reference Standard | Impurity | Oncology | Enquire
|
| 1370065 | Active | Loperamide Related Compound F (25 mg) (1r,4s)-4-(4-Chlorophenyl)-1-[4-(dimethylamino)-4-oxo-3,3-diphenylbutyl]-4-hydroxypiperidine 1-oxide hydrate) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1370280 | Active | Loratadine Related Compound A (15 mg) (8-Chloro-5,6-dihydro-11-(piperidin-4-ylidene)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1370291 | Active | Loratadine Related Compound B (15 mg) (8-Chloro-11-(1-methylpiperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1370269 | Active | Loratadine Related Compound C (15 mg) (8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1370327 | Active | Lorazepam Related Compound A (25 mg) (7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-acetoxy-2H-1,4-benzodiazepin-2-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1370338 | Active | Lorazepam Related Compound B (25 mg) (2-Amino-2',5-dichlorobenzophenone) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1370349 | Active | Lorazepam Related Compound C (25 mg) (6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxaldehyde) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1370350 | Active | Lorazepam Related Compound D (25 mg) (6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxylic Acid) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1370360 | Active | Lorazepam Related Compound E (25 mg) (6-Chloro-4-(o-chlorophenyl)-2-quinazoline methanol) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1370473 | Active | Losartan Related Compound A (20 mg) (2-Butyl-4-chloro-1H-imidazole-5-carbaldehyde) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1370484 | Active | Losartan Related Compound B (20 mg) (2-Butyl-4-chloro-(1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methyl acetate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1370495 | Active | Losartan Related Compound C (20 mg) (2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-5-carbaldehyde) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1370509 | Active | Losartan Related Compound D (20 mg) (5-[4'-({2-Butyl-5-[(5-{4'-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-1H-tetrazol-1-yl)methyl]-4-chloro-1H-imidazol-1-yl}methyl)biphenyl-2-yl]tetrazol, potassium salt) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1370510 | Active | Losartan Related Compound E (20 mg) (5-[4'-({2-Butyl-5-[(5-{4'-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-2H-tetrazol-2-yl)methyl]-4-chloro-1H-imidazol-1-yl}methyl)biphenyl-2-yl]tetrazol, potassium salt) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1236833 | Active | Lovastatin Epimer Mixture (25 mg) (Epilovastatin and Lovastatin 1:1 Mixture) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1370655 | Active | Lovastatin Impurity Identification Mixture (30 mg) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1370611 | Active | Lovastatin Related Compound A (20 mg) (4,4a-Dihydrolovastatin) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1370699 | Active | Loxapine N-Oxide (25 mg) (4-(2-Chlorodibenzo[b,f][1,4]oxazepin-11-yl)-1-methylpiperazine 1-oxide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1370713 | Active | Loxapine Related Compound A (20 mg) (3-Chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1370724 | Active | Lufenuron Related Compound B (15 mg) (N-[(2,5-Dichloro-4-hydroxyphenyl)carbamoyl]-2,6-difluorobenzamide) | Reference Standard | Impurity | Veterinary | Enquire
|
| 1370735 | Active | Lufenuron Related Compound C (15 mg) (N-[3-Chloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenylcarbamoyl]-2,6-difluorobenzamide) | Reference Standard | Impurity | Veterinary | Enquire
|
| 1370780 | Active | Lufenuron Related Compound G (15 mg) (2,5-Dichloro-4-[3-(2,6-difluorobenzoyl)ureido]phenyl phenyl carbonate) | Reference Standard | Impurity | Veterinary | Enquire
|
| 1370757 | Active | Lumefantrine Related Compound A (25 mg) ((RS, Z)-2-(Dibutylamino)-2-(2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl)ethanol hydrochloride) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1370848 | Active | Lurasidone Related Compound A (25 mg)((3aR,4S,7R,7aS)-Hexahydro-1H-4,7-methano-2H-isoindole-1,3-dione) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1370859 | Active | Lurasidone Related Compound B (25 mg) (3aR,4S,7R,7aS)-2-{(1S,2S)-2-[4-(1,2-Benzisothiazol-3-yl)piperazin-1-ylmethyl]cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione, hydrochloride | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1370892 | Active | Lurasidone Related Compound C (15 mg) ((3aR,4R,7S,7aS)-2-{(1R,2R)-2-[4-(1,2-Benzisothiazol-3-yl)piperazin-1-ylmethyl]cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione, hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1286209 | Active | Mafenide Related Compound A (50 mg) (4-Formylbenzenesulfonamide) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1375241 | Active | Maprotiline Related Compound D (15 mg) (3-(9,10-dihydro-9,10-ethanoanthracen-9-yl)-N-methylprop-2-en-1-amine, hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1375524 | Active | Mebendazole Related Compound D (15 mg) (Methyl 5-benzoyl-1-methylbenzimidazol-2-ylcarbamate) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1376017 | Active | Mecamylamine Related Compound A (10 mg) (N,1,7,7-Tetramethylbicyclo[2.2.1]heptan-2-amine hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1377010 | Active | Meclizine Related Compound A (15 mg) (4-Chlorobenzhydrol) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1377029 | Active | Meclizine Related Compound B (15 mg) (1-[(4-Chlorophenyl)(phenyl)methyl]-4-(2-methylbenzyl)piperazine dihydrochloride monohydrate) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1378012 | Active | Medroxyprogesterone Acetate Related Compound A (25 mg) (6alpha-Methyl-3,20-dioxopregnan-17-yl acetate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1378023 | Active | Medroxyprogesterone Acetate Related Compound B (25 mg) (17-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione) | Reference Standard | Impurity | Steroids | Enquire
|
| 1379060 | Active | Mefloquine Related Compound A (20 mg) (threo-mefloquine) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1379128 | Active | Megestrol Acetate Related Compound C (20 mg) (6,17a-beta-Dimethyl-3,17-dioxo-17a-homoandrosta-4,6-diene-17a-alpha-yl acetate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1379139 | Active | Megestrol Acetate Related Compound D (20 mg) (6-Methylene-3,20-dioxopregn-4-en-17-yl acetate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1379172 | Active | Megestrol Acetate Related Compound H (20 mg) | Reference Standard | Impurity | Steroids | Enquire
|
| 1379183 | Active | Melamine (250 mg) (2,4,6-Triamino-1,3,5-triazine) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1379265 | Active | Melengestrol Acetate Related Compound A (25 mg) (16-Methylene-3,20-dioxopregn-4-en-17-yl acetate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1379276 | Active | Melengestrol Acetate Related Compound B (25 mg) (6,16-Dimethylene-3,20-dioxopregn-4-en-17-yl acetate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1379412 | Active | Meloxicam Related Compound A (25 mg) (ethyl-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate- 1,1-dioxide) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1379423 | Active | Meloxicam Related Compound B (25 mg) (5-Methylthiazol-2-amine) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1379434 | Active | Meloxicam Related Compound C (30 mg) (Isopropyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate-1,1-dioxide) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1380513 | Active | Memantine Related Compound A (50 mg) (1,3-Dimethyladamantane) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1380524 | Active | Memantine Related Compound B (15 mg) (3,5-Dimethyladamantane-1-ol) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1380535 | Active | Memantine Related Compound C (50 mg) (1-Chloro-3,5-dimethyladamantane) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1380546 | Active | Memantine Related Compound D (50 mg) (1-Bromo-3,5-dimethyladamantane) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1380557 | Active | Memantine Related Compound E (15 mg) (N-3,5-Dimethyladamantan-1-yl formamide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1380568 | Active | Memantine Related Compound F (50 mg) (3-Amino-5,7-dimethyladamantan-1-ol hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1380579 | Active | Memantine Related Compound G (30 mg) (3-Methyladamantan-1-amine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1380580 | Active | Memantine Related Compound H (30 mg) (3,5,7-Trimethyladamantan-1-amine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1380591 | Active | Memantine Related Compound I (30 mg) (3-Ethyladamantan-1-amine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1383000 | Active | Meperidine Related Compound A (50 mg) (Ethyl 1-ethyl-4-phenylpiperidine-4-carboxylate) | Reference Standard | Impurity | Opioids | Enquire
|
| 1392818 | Active | Mesna Related Compound A (50 mg) (2-(Acetylthio)ethane-1-sulfonic acid, potassium salt, crystal adduct with potassium chloride) | Reference Standard | Impurity | Oncology | Enquire
|
| 1392829 | Active | Mesna Related Compound B (50 mg) (2,2'-Disulfanediylbis(ethane-1-sulfonic acid), dipotassium salt, crystal adduct with sodium chloride) | Reference Standard | Impurity | Oncology | Enquire
|
| 1396058 | Active | Metaraminol Enantiomer (25 mg) (3-[(1S,2R)-2-Amino-1-hydroxypropyl]phenol D-tartrate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1396036 | Active | Metaraminol Related Compound A (25 mg) ((E)-1-[3-(benzyloxy)phenyl]-2-(hydroxyimino)propan-1-one) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1396047 | Active | Metaraminol Related Compound B (25 mg) (2-Amino-1-[3-(benzyloxy)phenyl]propan-1-ol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1396150 | Active | Metaxalone Related Compound A (10 mg) (4-((3,5-dimethylphenoxy)methyl)imidazolidin-2-one) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1396168 | Active | Metaxalone Related Compound B (25 mg) (1-amino-3-(3,5-dimethylphenoxy)propan-2-ol) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1396171 | Active | Metaxalone Related Compound C (25 mg) (Bis[2-hydroxy-3-(3,5-dimethylphenoxy)propyl]amine) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1396310 | Active | Metformin Related Compound A (30 mg) (1-Cyanoguanidine) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1396331 | Active | Metformin Related Compound B (25 mg) (1-Methylbiguanide hydrochloride) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1396342 | Active | Metformin Related Compound C (25 mg) (N,N-Dimethyl-[1,3,5]triazine-2,4,6-triamine) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1398020 | Active | Methadone Related Compound B CII (25 mg) (4-(Dimethylamino)-2,2-diphenylpentanenitrile) | Reference Standard | Impurity | Opioids | Enquire
|
| 1398031 | Active | Methadone Related Compound C (25 mg) (4-(Dimethylamino)-3-methyl-2,2-diphenylbutanenitrile 4-toluene sulfonate) | Reference Standard | Impurity | Opioids | Enquire
|
| 1398042 | Active | Methadone Related Compound D CII (25 mg) (6-(Dimethylamino)-5-methyl-4,4-diphenylhexan-3-one hydrochloride) | Reference Standard | Impurity | Opioids | Enquire
|
| 1411016 | Active | Methimazole Related Compound A (3 x 50 mg) (2,2-Dimethoxy-N-methylethanamine) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1411038 | Active | Methimazole Related Compound C (3 x 50 mg) (1-Methyl-2-(methylthio)-1H-imidazole) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1414025 | Active | Methotrexate Related Compound B (75 mg) ((S)-2-{4-[(2,4-diaminopteridin-6-yl)methylamino]benzamido}pentanedioic acid) | Reference Standard | Impurity | Oncology | Enquire
|
| 1414036 | Active | Methotrexate Related Compound C (50 mg) ((S)-2-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl](methyl)amino}benzamido) pentanedioic acid) | Reference Standard | Impurity | Oncology | Enquire
|
| 1414058 | Active | Methotrexate Related Compound E (50 mg) (4-{[(2,4-Diaminopteridin-6-yl)methyl](methyl)amino}benzoic acid, hemihydrochloride) | Reference Standard | Impurity | Oncology | Enquire
|
| 1065345 | Active | Methoxsalen Related Compound A (25 mg) (4-Methoxy-7H-furo[3,2-g]chromen-7-one) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1349740 | Active | Methoxsalen Related Compound B (25 mg) (4,9-Dimethoxy-7H-furo[3,2-g]chromen-7-one) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1418650 | Active | Methoxymethylguanine (20 mg) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1424018 | Active | Methyclothiazide Related Compound A (50 mg) (4-Amino-6-chloro-N-3-methyl-m-benzenedisulfonamide) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1424112 | Active | Methyl Besylate (25 mg) (Methyl Benzenesulfonate) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1424209 | Active | Methylbenzhydrol (50 mg) (2-Methylbenzhydrol) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1427027 | Active | Methyldopa Related Compound B (10 mg) ((S)-2-Amino-3-(4-methoxyphenyl)-2-methylpropanoic acid hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1427038 | Active | Methyldopa Related Compound C (20 mg) ((S)-2-Amino-3-(3,4-dimethoxyphenyl)-2-methylpropanoic acid hydrochloride monohydrate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1428229 | Active | Methylene Simvastatin (30 mg) ((1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbut-3-enoate) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1430724 | Active | Methylnaltrexone Peak Identification Mixture CII (10 mg) (Methylnaltrexone Bromide containing about 0.1% methylnaltrexone related compound A) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1434011 | Active | Methylphenidate Hydrochloride Erythro Isomer Solution (0.5 mL) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1434022 | Active | Methylphenidate Related Compound A (50 mg) (alpha-Phenyl-2-piperidineacetic Acid Hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1437020 | Active | Methylprednisolone Hemisuccinate Related Compound B (50 mg) (11Beta,21-Dihydroxy-6alpha-methyl-3,20-dioxopregna-1,4-dien-17-yl hydrogen succinate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1437042 | Active | Methylprednisolone Hemisuccinate Related Compound D (50 mg) (11Beta,17-Dihydroxy-6alpha-methyl-3,20-dioxopregna-4-en-21-yl hydrogen succinate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1435014 | Active | Methylprednisolone Related Compound A (25 mg) (17,21-Dihydroxy-6alpha-methylpregna-1,4-diene-3,11,20-trione) | Reference Standard | Impurity | Steroids | Enquire
|
| 1435036 | Active | Methylprednisolone Related Compound C (25 mg) (11beta-Hydroxy-6alpha-methylandrosta-1,4-diene-3,17-dione) | Reference Standard | Impurity | Steroids | Enquire
|
| 1440819 | Active | Metoclopramide Related Compound A (15 mg) (4-Acetamido-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1440820 | Active | Metoclopramide Related Compound B (15 mg) (Methyl 4-acetamido-5-chloro-2-methoxybenzoate) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1440841 | Active | Metoclopramide Related Compound D (15 mg) (Methyl 4-acetamido-2-methoxybenzoate) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1268772 | Active | Metomidate Hydrochloride (50 mg) (Methyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate hydrochloride) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1441232 | Active | Metoprolol Related Compound A (20 mg) ((+/-)1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]-propan-2-ol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1441243 | Active | Metoprolol Related Compound B (100 mg) ((+/-)1-Chloro-2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]-propane) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1441254 | Active | Metoprolol Related Compound C (15 mg) (4-[2-Hydroxy-3-(isopropylamino)propoxy]benzaldehyde hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1441265 | Active | Metoprolol Related Compound D (50 mg) ((+/-)N,N-bis-[2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propyl](1-methylethyl)amine hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1443249 | Active | Metyrosine R-Enantiomer | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1443227 | Active | Metyrosine Related Compound A (15 mg) (2-Amino-3-(4-methoxyphenyl)-2-methylpropanenitrile hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1443431 | Active | Miconazole Related Compound C (50 mg) (2-[(2,4-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethan-1-amine hydrochloride) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1443464 | Active | Miconazole Related Compound F (50 mg) (1-{2-[(3,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1443497 | Active | Miconazole Related Compound I (50 mg) (1-{2-[(2-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole mononitrate) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1443715 | Active | Midodrine Related Compound A (40 mg) (1-(2,5 Dimethoxyphenyl)-2-aminoethanol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1443668 | Active | Milnacipran Related Compound A (25 mg) (2-(Aminomethyl)-1-phenylcyclopropane-1-carboxylic acid hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1443679 | Active | Milnacipran Related Compound B (25 mg) (1-Phenyl-3-azabicyclo[3.1.0]hexan-2-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1443680 | Active | Milnacipran Related Compound C (25 mg) ((1RS ,2SR)-2-[(1,3-Dioxoisoindolin-2-yl)methyl]-N,N-diethyl-1-phenylcyclopropane-1-carboxamide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1443919 | Active | Milrinone Related Compound A (50 mg) (1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carboxamide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1444220 | Active | Minoxidil Related Compound E (25 mg) (6-(Piperidin-1-yl)pyrimidine-2,4-diamine) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1444106 | Active | Mirabegron (100 mg) | Reference Standard | Impurity | Renal | Enquire
|
| 1444155 | Active | Mirabegron Racemate (15 mg) | Reference Standard | Impurity | Renal | Enquire
|
| 1444117 | Active | Mirabegron Related Compound A (15 mg) ((R)-2-[(4-Aminophenethyl)amino]-1-phenylethan-1-ol hydrochloride) | Reference Standard | Impurity | Renal | Enquire
|
| 1444285 | Active | Mirtazapine Related Compound A (25 mg) (1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1444235 | Active | Mirtazapine Related Compound B (25 mg) (1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine 2-oxide monohydrate) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1444241 | Active | Mirtazapine Related Compound C (50 mg) (2-Methyl-3,4,10,14b-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-1(2H)-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1444252 | Active | Mirtazapine Related Compound D (50 mg) (2-Methyl-1,2,3,4-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-10(14bH)-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1445018 | Active | Mitotane Related Compound A (25 mg) (2,2-Bis(4-Chlorophenyl)-1,1-dichloroethane) | Reference Standard | Impurity | Oncology | Enquire
|
| 1445346 | Active | Modafinil Related Compound A (20 mg) (2-[(diphenylmethyl)sulfinyl]acetic acid) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1445368 | Active | Modafinil Related Compound C (20 mg) (2-[(diphenylmethyl)sulfenyl]acetamide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1445415 | Active | Modafinil S-enantiomer CIV (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) (30 mg) ((S)-2-(Benzhydrylsulfinyl)acetamide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1445392 | Active | Modafinil Sulfone (30 mg) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1445608 | Active | Moexipril Related Compound A (20 mg) ((3S)-2-{(2S)-N-[(1S)-1-Carboxy-3-phenylpropyl]alanyl}-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1445619 | Active | Moexipril Related Compound B (20 mg) ((S)-ethyl 2-{(3S,11aS)-8,9-dimethoxy-3-methyl-1,4-dioxo-3,4-dihydro-1H-pyrazino[1,2-b]isoquinolin-2(6H,11H,11aH)-yl}-4-phenylbutanoate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1445620 | Active | Moexipril Related Compound C (20 mg) ((S)-tert-butyl 2-{(S)-2-[(S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino]propanoyl}-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate, maleate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1445631 | Active | Moexipril Related Compound D (20 mg) ((S)-2-{(S)-2-[(S)-4-cyclohexyl-1-ethoxy-1-oxobutan-2-ylamino]propanoyl}-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1445642 | Active | Moexipril Related Compound E (20 mg) ((S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1445653 | Active | Moexipril Related Compound F (20 mg) ((S)-2-[(S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino]propanoic acid) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1445664 | Active | Moexipril Related Compound G (20 mg) ((S)-6,7-dimethoxy-2-{(S)-2-[(S)-1-methoxy-1-oxo-4-phenylbutan-2-ylamino]propanoyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1445437 | Active | Molindone Related Compound A (20 mg) (3-Ethyl-2-methyl-1,5,6,7-tetrahydro-4H-indol-4-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1445462 | Active | Mometasone Furoate Related Compound C (15 mg) (21-Chloro-16alpha-methyl-3,11,20-trioxopregna-1,4-dien-17-yl furan-2-carboxylate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1446848 | Active | Montelukast Racemate (20 mg) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1446837 | Active | Montelukast for Peak Identification (20 mg) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1448016 | Active | Morphine Related Compound A CI (20 mg) (7,8-Didehydro-4,5alpha-epoxy-17-methylmorphinan-3,6alpha-diol, N-oxide) | Reference Standard | Impurity | Opioids | Enquire
|
| 1448027 | Active | Morphine Related Compound B CII (20 mg) (2,2'-Bimorphine trihydrate) | Reference Standard | Impurity | Opioids | Enquire
|
| 1448617 | Active | Moxifloxacin Related Compound A (25 mg) (1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1448628 | Active | Moxifloxacin Related Compound B (25 mg) (1-Cyclopropyl-6,8-dimethoxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride monohydrate) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1448639 | Active | Moxifloxacin Related Compound C (25 mg) (1-Cyclopropyl-8-ethoxy-6-fluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride monohydrate) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1448640 | Active | Moxifloxacin Related Compound D (15 mg) (1-Cyclopropyl-8-fluoro-6-methoxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1448655 | Active | Moxifloxacin Related Compound E (25 mg) (1-Cyclopropyl-6-fluoro-8-hydroxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1448661 | Active | Moxifloxacin Related Compound F (25 mg) (1-Cyclopropyl-6-fluoro-8-methoxy-7-(1-methyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1448672 | Active | Moxifloxacin Related Compound G (15 mg) (1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid, monohydrochloride) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1448967 | Active | Mycophenolate Mofetil Related Compound A (15 mg) (2-Morpholinoethyl (E)-6-(1,3-dihydro-4,6-dihydroxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate) | Reference Standard | Impurity | Immunosuppresants | Enquire
|
| 1448978 | Active | Mycophenolate Mofetil Related Compound B (15 mg) [(RS)-7-hydroxy-5-methoxy-4-methyl-6-[2-(5-methyl-2-oxo-tetrahydrofuran-5-yl)ethyl]-3H-isobenzofuranyl-1-one] | Reference Standard | Impurity | Immunosuppresants | Enquire
|
| 1449041 | Active | Myristylpyridinium Chloride (25 mg) (1-Tetradecylpyridinium chloride) | Reference Standard | Impurity | Others-Chemical Medicines | Enquire
|
| 1064122 | Active | N-Benzyl-N-methyl-ethanolamine (3 x 0.2 mL) (2-[benzyl(methyl)amino]ethanol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1046089 | Active | N-Demethylazithromycin (15 mg) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1266802 | Active | N-Ethylpiperazine (0.5 mL) | Reference Standard | Impurity | Oncology | Enquire
|
| 1449530 | Active | Nabumetone Related Compound A (15 mg) (1-(6-methoxy-2-naphthyl)-but-1-en-3-one) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1449711 | Active | Nadolol Related Compound A (25 mg) ((2RS,3SR)-5-(2,3-Dihydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1449722 | Active | Nadolol Related Compound B (25 mg) ((2RS,3SR)-5-(2-Hydroxy-3-methoxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1449733 | Active | Nadolol Related Compound C (25 mg) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1449766 | Active | Nadolol Related Compound F (25 mg) (1-(tert-Butylamino)-3-(naphthalen-1-yloxy)propan-2-ol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1449777 | Active | Nadolol Related Compound G (25 mg) (1-(tert-Butylamino)-3-(5,6,7,8-tetrahydronaphthalen-1-yloxy)propan-2-ol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1453049 | Active | Naloxone Related Compound D CII (25 mg) (4,5alpha-Epoxy-3,14-dihydroxy-17-(prop-2-enyl)morphinan-7-ene-6-one) | Reference Standard | Impurity | Antidotes & Chelators | Enquire
|
| 1453526 | Active | Naltrexone Related Compound A CII (30 mg) (N-(3-butenyl)-noroxymorphone Hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1457017 | Active | Naphazoline Related Compound A (30 mg) (N-(2-Aminoethyl)-2-(naphthalen-1-yl)acetamide) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1457312 | Active | Naproxen Related Compound A (20 mg) (6-methoxy-2-naphthoic acid) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1457356 | Active | Naproxen Related Compound E (25 mg) ((S)-Methyl 2-(6-methoxynaphthalen-2-yl)propanoate) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1457436 | Active | Naproxen Related Compound G (50 mg) ((R)-2-(6-Methoxynaphthalen-2-yl)propanoic acid) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1457414 | Active | Naproxen Related Compound K (50 mg) (1-(6-Methoxynaphthalen-2-yl)ethanol) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1457425 | Active | Naproxen Related Compound L (15 mg) (1-(6-methoxynaphthalen-2-yl)ethanone) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1457618 | Active | Nateglinide Related Compound A (10 mg) (trans-4-isopropylcyclohexanecarboxylic acid) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1457629 | Active | Nateglinide Related Compound B (10 mg) (N-(trans-4-isopropylcyclohexanecarbonyl)-L-phenylalanine) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1457630 | Active | Nateglinide Related Compound C (20 mg) (N-(cis-4-isopropylcyclohexanecarbonyl)-D-phenylalanine) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1457855 | Active | Nebivolol Related Compound A (30 mg) (See USP Certificate for full Chemical Name) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1457866 | Active | Nebivolol Related Compound B (30 mg) (See USP Certificate for full Chemical Name) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1457877 | Active | Nebivolol Related Compound C (100 mg) (COLD SHIPMENT REQUIRED) ((RS)-6-Fluoro-2-[(RS)-oxiran-2-yl]chroman) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1457888 | Active | Nebivolol Related Compound D (100 mg) ((RS)-6-Fluoro-2-[(SR)-oxiran-2-yl]chroman) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1457899 | Active | Nebivolol Related Compound E (30 mg) (1-(Chroman-2-yl)-2-((2-(6-fluorochroman-2-yl)-2-hydroxyethyl)amino)ethanol hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1457797 | Active | Nebivolol Stereoisomer Mixture (15 mg) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1457913 | Active | Nefazodone Related Compound A (25 mg) (1-(3-chlorophenyl)-4-(3-chloropropyl)-piperazine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1457924 | Active | Nefazodone Related Compound B (25 mg) (2-[3-[4-(4-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1458020 | Active | Neomycin A (2.5 mg) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1460328 | Active | Nepafenac Related Compound A (25 mg) (2-{2-Amino-3-[hydroxy(phenyl)methyl]phenyl}acetamide) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1460339 | Active | Nepafenac Related Compound B (25 mg) (7-Benzoylindolin-2-one) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1460725 | Active | Nevirapine Related Compound A (15 mg) (5,11-dihydro-6H-11-ethyl-4-methyl-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1460736 | Active | Nevirapine Related Compound B (10 mg) (5,11-Dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1460747 | Active | Nevirapine Related Compound C (15 mg) (5,11-Dihydro-6H-11-propyl-4-methyl-dipyrido[3,2-b:2',3'-e] [1,4]diazepin-6-one) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1463246 | Active | Nicardipine Related Compound B (20 mg) (3-{2-[Benzyl(methyl)amino]ethyl}5-methyl 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate oxalate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1463268 | Active | Nicardipine Related Compound C (10 mg) (Dimethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1463279 | Active | Nicardipine Related Compound D (10 mg) (Bis{2-[benzyl(methyl)amino]ethyl} 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate dihydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1463326 | Active | Nicotine Related Compound A (20 mg) (1,2,3,6-tetrahydro-2,3'-bipyridine) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1463337 | Active | Nicotine Related Compound B (20 mg) (3-(1-methyl-1H-pyrrol-2-yl)pyridine) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1463348 | Active | Nicotine Related Compound C (20 mg) ((S)-1-methyl-5-(pyridin-3-yl)pyrrolidin-2-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1463359 | Active | Nicotine Related Compound D (20 mg) (3-(4,5-dihydro-3H-pyrrol-2-yl)pyridine fumarate) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1463360 | Active | Nicotine Related Compound E (20 mg) ((1RS,2S)-1-methyl-2-(pyridin-3-yl)pyrrolidine 1-oxide oxalate) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1463371 | Active | Nicotine Related Compound F (20 mg) (3-(pyrrolidin-2-yl)pyridine) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1463382 | Active | Nicotine Related Compound G (20 mg) ((S)-3-(piperidin-2-yl)pyridine) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1463600 | Active | Nifedipine Nitrophenylpyridine Analog (25 mg) (Dimethyl 4-(2-nitrophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1463701 | Active | Nifedipine Nitrosophenylpyridine Analog (25 mg) (Dimethyl 4-(2-nitrosophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1463439 | Active | Nilotinib Related Compound A (25 mg) (3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline) | Reference Standard | Impurity | Oncology | Enquire
|
| 1463440 | Active | Nilotinib Related Compound B (25 mg) (Methyl 3-amino-4-methylbenzoate) | Reference Standard | Impurity | Oncology | Enquire
|
| 1463457 | Active | Nilotinib Related compound C (25 mg) (3-Amino-4-methylbenzoic acid) | Reference Standard | Impurity | Oncology | Enquire
|
| 1463870 | Active | Nimodipine Related Compound A (50 mg) (2-methoxyethyl-1-methylethyl 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1463869 | Active | Nimodipine Related Compound B (50 mg) (bis(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1463949 | Active | Nisoldipine Related Compound C (30 mg) (Isobutyl (Z)-2-(2-nitrobenzylidene)-3-oxobutanoate) (DISCONTINUED) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1464158 | Active | Nisoldipine Related Compound D (30 mg) (3-Isobutyl 5-methyl 2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate) (DISCONTINUED) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1464169 | Active | Nisoldipine Related Compound E (30 mg) (3-Isobutyl 5-methyl 2,6-dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate) (DISCONTINUED) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1464183 | Active | Nisoldipine Related Compound G (30 mg) (Diisobutyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate) (DISCONTINUED) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1463971 | Active | Nitazoxanide Related Compound A (25 mg) (5-Nitrothiazole-2-amine) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1463982 | Active | Nitazoxanide Related Compound B (25 mg) (2-Hydroxy-N-(5-nitrothiazol-2-yl) benzamide) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1021703 | Active | Nitrofurantoin Related Compound A (20 mg) (N-(Aminocarbonyl)-N-[([5-nitro-2-furanyl]-methylene)-amino]-glycine) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1466007 | Active | Nitrofurazone Related Compound A (50 mg) (1,2-Bis[(5-nitrofuran-2-yl)methylene]hydrazine) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1465503 | Active | Nitrofurfural Diacetate (100 mg) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1468465 | Active | Norelgestromin Related Compound A (15 mg) (13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-5(6)-en-20-yn-3-one oxime) | Reference Standard | Impurity | Steroids | Enquire
|
| 1470026 | Active | Norethindrone Related Compound B CIII (30 mg) (Estr-4-ene-3,17-dione) | Reference Standard | Impurity | Steroids | Enquire
|
| 1471517 | Active | Norfloxacin Related Compound A (15 mg) (7-Chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1471550 | Active | Norfloxacin Related Compound E (15 mg) (7-Chloro-1-ethyl-4-oxo-6-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1471583 | Active | Norfloxacin Related Compound H (15 mg) (7-[4-(ethoxycarbonyl)piperazin-1-yl]-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1471619 | Active | Norfloxacin Related Compound K (15 mg) (6-Fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1471925 | Active | Norgestimate Related Compound A (25 mg) (Levonorgestrel acetate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1472043 | Active | Norgestrel Related Compound L (25 mg) (13-Ethylgon-4-ene-3,17-dione) | Reference Standard | Impurity | Steroids | Enquire
|
| 1473002 | Active | Noroxymorphone Hydrochloride CII (50 mg) (4,5alpha-Epoxy-3,14-dihydroxymorphinan-6-one hydrochloride) | Reference Standard | Impurity | Opioids | Enquire
|
| 1473400 | Active | Norscopolamine (20 mg) ((1R ,2R ,4S ,5S ,7s )-3-Oxa-9-azatricyclo[3.3.1.0^2,4]nonan-7-yl (S)-3-hydroxy-2-phenylpropanoate) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1478119 | Active | Ofloxacin Related Compound A (25 mg) (9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1478312 | Active | Olanzapine Related Compound A (15 mg) (5-Methyl-2-((2-nitrophenyl)amino)-3-thiophenecarbonitrile) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1478323 | Active | Olanzapine Related Compound B (15 mg) (2-methyl-10H-thieno-[2,3-b][1,5]benzodiazepin-4[5H]-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1478334 | Active | Olanzapine Related Compound C (5 mg) (2-Methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine 4'-N-oxide) (COLD SHIPMENT REQUIRED) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1478378 | Active | Olmesartan Medoxomil Related Compound A (20 mg) (1-{[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4,4-dimethyl-2-propyl-1H-furo[3,4-d]imidazol-6(4H)-one) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1478425 | Active | Olopatadine Related Compound B (35 mg) ((Z)-3-{2-(carboxymethyl)dibenzo[b,e]oxepin-11(6H)-ylidene}-N,N-dimethylpropan-1-amine oxide) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1478436 | Active | Olopatadine Related Compound C (35 mg) (11-Oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl acetic acid) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1478516 | Active | Omeprazole Related Compound A (15 mg) (5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfonyl]-1H-benzimidazole) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1478480 | Active | Omeprazole Related Compound B (15 mg) (5-Methoxy-1H-benzimidazol-2-thiol) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1478527 | Active | Omeprazole Related Compound E (15 mg) (4-Methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-3,5-dimethylpyridine 1-oxide) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1478561 | Active | Omeprazole Related Compound I (15 mg) (4-Methoxy-2-[[(5-methoxy-1H-benzimidazol-2-yl)sulfonyl]methyl]-3,5-dimethylpyridine 1-oxide) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1478491 | Active | Omeprazole Related Compounds F and G Mixture (25 mg) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1478593 | Active | Ondansetron Related Compound A (50 mg) (3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1478618 | Active | Ondansetron Related Compound C (30 mg) (9-Methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1478629 | Active | Ondansetron Related Compound D (30 mg) (1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1478645 | Active | Ondansetron Related Compound G (15 mg) (3-[(1H-Imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1478811 | Active | Orlistat Related Compound A (25 mg) ((3S,4S)-3-Hexyl-4-[(2R)-2-hydroxytridecyl]-2-oxetanone) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1478822 | Active | Orlistat Related Compound B (20 mg) (Diisopropyl hydrazine-1,2-dicarboxylate) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1478833 | Active | Orlistat Related Compound C (25 mg) (Triphenylphosphine Oxide) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1478844 | Active | Orlistat Related Compound D (10 mg) (N-formyl-L-leucine (3S,4R,6S)-3-hexyl-2-oxo-6-undecyltetrahydro-2H-pyran-4-yl ester) (DISCONTINUED) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1478877 | Active | Orlistat Related Compound D Solution (2 x 1 mL (5 mg/mL)) ((3S,4R,6S)-3-Hexyl-2-oxo-6-undecyltetrahydro-2H-pyran-4-yl formyl-L-leucinate in acetonitrile) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1478855 | Active | Orlistat Related Compound E (10 mg) (N-Formyl (S)-isoleucine (S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1479010 | Active | Orphenadrine Related Compound A (50 mg) ((RS)-N,N-dimethyl-2-[(3-methylphenyl)-phenylmethoxy]ethanamine citrate) (AS) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1479020 | Active | Orphenadrine Related Compound B (20 mg) (N-Ethyl-N,N-dimethyl-2-[phenyl(o-tolyl)methoxy]ethanaminium chloride; also known as N-Ethyl-N,N-dimethyl-2-[phenyl(2-tolyl)methoxy]ethanaminium chloride) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1479031 | Active | Orphenadrine Related Compound C (20 mg) (N-methyl-2-[phenyl(o-tolyl)methoxy]ethanamine hydrochloride) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1479053 | Active | Orphenadrine Related Compound E (50 mg) (N,N-Dimethyl-2-[phenyl(m-tolyl)methoxy]ethanamine) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1479064 | Active | Orphenadrine Related Compound F (50 mg) (N,N-Dimethyl-2-[phenyl(p-tolyl)methoxy]ethanamine citrate) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1479315 | Active | Oseltamivir Related Compound A (10 mg) ((3S,4R,5S)-ethyl 4-acetamido-5-amino-2-azido-3-(pentan-3-yloxy)cyclohexanecarboxylate) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1481044 | Active | Oxacillin Related Compound C (15 mg) (5-Methyl-3-phenylisoxazole-4-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1481215 | Active | Oxaliplatin Related Compound A (100 mg) (Ethanedioic acid, dihydrate) | Reference Standard | Impurity | Oncology | Enquire
|
| 1481226 | Active | Oxaliplatin Related Compound B (15 mg) ([SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N') dinitratoplatinum(II)) | Reference Standard | Impurity | Oncology | Enquire
|
| 1481237 | Active | Oxaliplatin Related Compound C (20 mg) ([1R-trans-(1,2-cyclohexanediamine-N,N')]-trans-dihydroxido-[oxalato(2-)-O,O']platinum(IV)) | Reference Standard | Impurity | Oncology | Enquire
|
| 1481248 | Active | Oxaliplatin Related Compound D (10 mg) (cis-[(1S,2S)-1,2-cyclohexanediamine-N,N'][oxalato(2-)-O,O']platinum) | Reference Standard | Impurity | Oncology | Enquire
|
| 1481260 | Active | Oxaliplatin Related Compound F (25 mg) ([SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N') diiodidoplatinum(II)) | Reference Standard | Impurity | Oncology | Enquire
|
| 1482014 | Active | Oxandrolone Related Compound A CIII (20 mg) (17beta-hydroxy-17alpha-methyl-2-oxa-5alpha-androst-7-en-3-one) | Reference Standard | Impurity | Steroids | Enquire
|
| 1482025 | Active | Oxandrolone Related Compound B CIII (20 mg) (17 beta-hydroxy-17 alpha-methyl-4-oxa-5 alpha-androsta-3-one) | Reference Standard | Impurity | Steroids | Enquire
|
| 1482036 | Active | Oxandrolone Related Compound C CIII (20 mg) (17,17-dimethyl-18-nor-2-oxa-5alpha-androst-13-en-3-one) | Reference Standard | Impurity | Steroids | Enquire
|
| 1483017 | Active | Oxazepam Related Compound A (15 mg) (7-Chloro-5-phenyl-4,5-dihydro-1H-benzodiazepine-2,3-dione) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1483028 | Active | Oxazepam Related Compound B (15 mg) (7-Chloro-2-oxo-5-phenyl-2,3-dihydro-1H-benzodiazepin-3-yl acetate) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1483039 | Active | Oxazepam Related Compound C (15 mg) (6-chloro-4-phenylquinazoline-2-carbaldehyde) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1483163 | Active | Oxcarbazepine Related Compound A (10 mg) (N-Formyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1483174 | Active | Oxcarbazepine Related Compound B (10 mg) (N-Acetyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1483185 | Active | Oxcarbazepine Related Compound C (10 mg) (Acridin-9(10H)-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1483196 | Active | Oxcarbazepine Related Compound D (10 mg) (10-(10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamido)-5H-dibenzo[b,f]azepine-5-carboxamide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1483200 | Active | Oxcarbazepine Related Compound E (10 mg) (10(11H)-Oxo-5H-dibenz[b,f]azepine) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1483436 | Active | Oxiconazole Related Compound A (20 mg) (2',4'-Dichloro-2-imidazol-1-ylacetophenone (E)-[O-(2,4-dichlorobenzyl)oxime]) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1483447 | Active | Oxiconazole Related Compound B (20 mg) ((Z)-1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone oxime) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1483458 | Active | Oxiconazole Related Compound C (20 mg) (1-(2,4-Dichlorophenyl)-2-(1H -imidazol-1-yl)ethan-1-one hydrochloride) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1483469 | Active | Oxiconazole Related Compound D (50 mg) ((2,4-Dichlorophenyl)methanol) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1483470 | Active | Oxiconazole Related Compound E (100 mg) (2,4-Dichlorobenzyl chloride) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1485114 | Active | Oxybutynin Related Compound A (100 mg) (Phenylcyclohexylglycolic Acid) | Reference Standard | Impurity | Renal | Enquire
|
| 1485125 | Active | Oxybutynin Related Compound B (20 mg) (Cyclohexyl Mandelic Acid Methyl Ester) | Reference Standard | Impurity | Renal | Enquire
|
| 1485136 | Active | Oxybutynin Related Compound C (20 mg) (4-(ethylmethylamino)but-2-ynyl(+/-)-2-cyclohexyl-2-hydroxy-2-phenylacetate hydrochloride) | Reference Standard | Impurity | Renal | Enquire
|
| 1485216 | Active | Oxycodone Related Compound A CII (10 mg) (14-hydroxycodeinone) (COLD SHIPMENT REQUIRED) | Reference Standard | Impurity | Opioids | Enquire
|
| 1485227 | Active | Oxycodone Related Compound B CII (15 mg) (oxycodone N-oxide) | Reference Standard | Impurity | Opioids | Enquire
|
| 1485238 | Active | Oxycodone Related Compound C CII (15 mg) (codeinone) | Reference Standard | Impurity | Opioids | Enquire
|
| 1486015 | Active | Oxymetazoline Related Compound A (15 mg) (N-(2-Aminoethyl)-2-[4-(tert-butyl)-3-hydroxy-2,6-dimethylphenyl]acetamide hydrochloride) | Reference Standard | Impurity | Cough and Cold | Enquire
|
| 1487029 | Active | Oxymetholone Related Compound B (25 mg) (17Beta-Hydroxy-1-hydroxymethylene-17alpha-methyl-5alpha-androstan-3-one) | Reference Standard | Impurity | Steroids | Enquire
|
| 1488019 | Active | Oxymorphone Related Compound A CII (25 mg) (4,5alpha-Epoxy-3,14-dihydroxy-17-methylmorphinan-6-one N-oxide) | Reference Standard | Impurity | Opioids | Enquire
|
| 1111908 | Active | P-Chloroaniline (200 mg) | Reference Standard | Impurity | Antiseptics | Enquire
|
| 1491365 | Active | Paclitaxel Impurity Mixture (10 mg) (This mixture contains paclitaxel and paclitaxel benzyl analog) | Reference Standard | Impurity | Oncology | Enquire
|
| 1491343 | Active | Paclitaxel Related Compound A (20 mg) (Cephalomannine) | Reference Standard | Impurity | Oncology | Enquire
|
| 1491354 | Active | Paclitaxel Related Compound B (20 mg) (10-deacetyl-7-epipaclitaxel) | Reference Standard | Impurity | Oncology | Enquire
|
| 1491818 | Active | Paliperidone Related Compound A (20 mg) (3-Ethyl-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-alpha]pyrimidin-4-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1491820 | Active | Paliperidone Related Compound B (20 mg) (6-fluoro-3-(piperidin-4-yl)benzoisoxazole hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1491831 | Active | Paliperidone Related Compound C (20 mg) (3-(2-Chloroethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1491842 | Active | Paliperidone Related Compound D (20 mg) (4-(6-Fluorobenzo[d]isoxazol-3-yl)-1-[2-(9-hydroxy-2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-3-yl)ethyl]piperidine 1-oxide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1491853 | Active | Paliperidone Related Compound E (15 mg) (3-{2-[4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-7,8-dihydro-4H-pyrido[1,2-a]pyrimidine-4,9(6H)-dione trifluoroacetate) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1492211 | Active | Palonosetron Enantiomer (15 mg) ((3aR)-2-[(3R)-Quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1492222 | Active | Palonosetron Related Compound A (15 mg) ((3aS)-1-Oxo-2-[(3S)-quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinoline 1-oxide) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1492233 | Active | Palonosetron Related Compound B (15 mg) ((3S)-3-(1-Oxo-5,6-dihydro-1H-benzo[de]isoquinolin-2(4H)-yl)quinuclidine 1-oxide) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1492244 | Active | Palonosetron Related Compound C (15 mg) ((S)-2-[(3R)-Quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1492255 | Active | Palonosetron Related Compound D (15 mg) ((R)-2-[(3S)-Quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1492266 | Active | Palonosetron Related Compound E (15 mg) (2-[(3S)-Quinuclidin-3-yl]-2,4,5,6-tetrahydro-1H-benzo[de]isoquinolin-1-one hydrochloride) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1492700 | Active | Pamabrom Related Compound A (30 mg) (8-Chlorotheophylline) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1494228 | Active | Pancuronium Bromide Related Compound A (15 mg) (1,1'-(3alpha,17beta-dihydroxy-5alpha-androstan-2beta,16beta-ylene) bis(1-methylpiperidinium) dibromide) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1494239 | Active | Pancuronium Bromide Related Compound B (15 mg) (1,1'-(17beta-Acetoxy-3alpha-hydroxy-5alpha-androstan-2beta,16beta-ylene) bis(1-methylpiperidinium) dibromide) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1494240 | Active | Pancuronium Bromide Related Compound C (15 mg) (1,1'-(3alpha-acetoxy-17beta-hydroxy-5alpha-androstan-2beta,16beta-ylene) bis(1-methylpiperidinium) dibromide) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1494909 | Active | Pantoprazole Related Compound A (25 mg) (5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfonyl]-1H-benzimidazole) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1494910 | Active | Pantoprazole Related Compound B (25 mg) (5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]-1H-benzimidazole) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1494920 | Active | Pantoprazole Related Compound C (20 mg) (5-(difluoromethoxy)-1H-benzimidazole-2-thiol) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1494942 | Active | Pantoprazole Related Compound E (20 mg) (6,6'-Bis(difluoromethoxy)-2,2'-bis[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H,1'H-5,5'-bibenzimidazole) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1494931 | Active | Pantoprazole Related Compounds D and F Mixture (20 mg) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1496802 | Active | Parachlorophenol (500 mg) | Reference Standard | Impurity | Antiseptics | Enquire
|
| 1500230 | Active | Paroxetine Related Compound B (15 mg) ((3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-phenylpiperidine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1500240 | Active | Paroxetine Related Compound C (30 mg) ((3R,4S)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride) OR ((+)-trans-Paroxetine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1500251 | Active | Paroxetine Related Compound D (10 mg) ((3RS,4RS)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride); cis-paroxetine hydrochloride | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1500207 | Active | Paroxetine Related Compound E (50 mg) (4-(4-Fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1500273 | Active | Paroxetine Related Compound F (25 mg) ((3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methylpiperidine) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1500284 | Active | Paroxetine Related Compound G (10 mg) ((+/-)trans-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4''-fluorophenyl-4'-phenyl)piperidine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1501108 | Active | Penicillamine Disulfide (200 mg) (3,3'-Dithiodi-D-valine) | Reference Standard | Impurity | Antidotes & Chelators | Enquire
|
| 1505029 | Active | Pentazocine Related Compound A | Reference Standard | Impurity | Opioids | Enquire
|
| 1505030 | Active | Pentazocine Related Compound B | Reference Standard | Impurity | Opioids | Enquire
|
| 1505041 | Active | Pentazocine Related Compound C | Reference Standard | Impurity | Opioids | Enquire
|
| 1510867 | Active | Pergolide Sulfoxide (50 mg) ((8Beta)-8-[(Methylsulfinyl)methyl]-6-propyl-D-ergoline) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1510890 | Active | Perindopril Related Compound A (20 mg) ((2S,3aS,7aS)-octahydro-1H-indole-2-carboxylic acid) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1510903 | Active | Perindopril Related Compound B (10 mg) ((2S,3aS,7aS)-1-{(S)-2-[(S)-1-carboxybutylamino]propanoyl}octahydro-1H-indole-2-carboxylic acid monohydrate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1510914 | Active | Perindopril Related Compound C (20 mg) ((S)-2-[(3S,5aS,9aS,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl]pentanoic acid) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1510925 | Active | Perindopril Related Compound D (25 mg) ((S)-2-{(3S,5aS,9aS,10aR)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl}pentanoic acid) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1510936 | Active | Perindopril Related Compound E (10 mg) ((2S,3aS,7aS)-1-{(S)-2-[(S)-1-Isopropoxy-1-oxopentan-2-ylamino]propanoyl}octahydro-1H-indole-2-carboxylic acid, tert-butylamine) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1510947 | Active | Perindopril Related Compound F (10 mg) ((S)-ethyl 2-{(3S,5aS,9aS,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl}pentanoate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1510970 | Active | Perindopril Related Compound I (20 mg) (2-Methylpropan-2-amine (2S,3aS,7aS)-1-{(S)-2-[(R)-1-ethoxy-1-oxopentan-2-ylamino]propanoyl}octahydro-1H-indole-2-carboxylate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1510999 | Active | Perindopril Related Compound K (10 mg) ((3S,5aS,9aS,10aS)-3-methyldecahydropyrazino[1,2-a]indole-1,4-dione) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1511473 | Active | Permethrin Related Compound G (25 mg) (3-Phenoxybenzyl 3-(chloroethynyl)-2,2-dimethylcyclopropane-1-carboxylate) | Reference Standard | Impurity | Veterinary | Enquire
|
| 1511021 | Active | Perphenazine Related Compound B (15 mg) (2-{4-[3-(10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1511203 | Active | Perphenazine Sulfoxide (25 mg) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1524012 | Active | Phenobarbital Related Compound A (30 mg) (5-Ethyl-2,6-diimino-5-phenyltetrahydropyrimidin-4(1H)-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1524023 | Active | Phenobarbital Related Compound B (30 mg) (5-Ethyl-6-imino-5-phenyldihydropyrimidine-2,4(1H,3H)-dione) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1525999 | Active | Phenoxybenzamine Alcohol (COLD SHIPMENT REQUIRED) (50 mg) (2-[Benzyl(1-phenoxypropan-2-yl)amino]ethan-1-ol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1526030 | Active | Phenoxybenzamine Nitrile (50 mg) (COLD SHIPMENT REQUIRED) (3-[Benzyl(1-phenoxypropan-2-yl)amino]propanenitrile) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1528512 | Active | Phentermine Related Compound A (30 mg) (N-(2-Methyl-1-phenylpropan-2-yl)formamide) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1528534 | Active | Phentermine Related Compound C (100 mg) ((2-Methylprop-1-en-1-yl)benzene) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1529071 | Active | Phentolamine Keto Analog (25 mg) (N-(3-Hydroxyphenyl)-N-(4-tolyl)-4,5-dihydro-1H-imidazole-2-carboxamide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1529016 | Active | Phentolamine Related Compound A (25 mg) (N-(2-Aminoethyl)-2-[(3-hydroxyphenyl)(4-tolyl)amino]acetamide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1614523 | Active | Phenylbutyrate Related Compound A (25 mg) (4-oxo-4-phenylbutanoic acid) | Reference Standard | Impurity | Renal | Enquire
|
| 1614556 | Active | Phenylbutyrate Related Compound B (100 mg) (3,4-dihydronaphthalen-1(2H)-one) | Reference Standard | Impurity | Renal | Enquire
|
| 1614534 | Active | Phenylbutyrate Related Compound C (25 mg) (4-cyclohexylbutanoic acid) (COLD SHIPMENT REQUIRED) | Reference Standard | Impurity | Renal | Enquire
|
| 1533024 | Active | Phenylephrine Related Compound C (30 mg) (1-(3-Hydroxyphenyl)-2-(methylamino)ethan-1-one hydrochloride) | Reference Standard | Impurity | Renal | Enquire
|
| 1533035 | Active | Phenylephrine Related Compound D (30 mg) ((R)-3-{2-[Benzyl(methyl)amino]-1-hydroxyethyl}phenol) | Reference Standard | Impurity | Renal | Enquire
|
| 1533046 | Active | Phenylephrine Related Compound E (30 mg) (2-[Benzyl(methyl)amino]-1-(3-hydroxyphenyl)ethan-1-one hydrochloride) | Reference Standard | Impurity | Renal | Enquire
|
| 1533261 | Active | Phenylephrine Related Compound F (30 mg) ((R)-2-Methyl-1,2,3,4-tetrahydroisoquinoline-4,8-diol hydrochloride monohydrate) | Reference Standard | Impurity | Renal | Enquire
|
| 1533272 | Active | Phenylephrine Related Compound G (30 mg) ((R)-N-(2-Hydroxy-2-(3-hydroxyphenyl)ethyl)-N-methylglycine) | Reference Standard | Impurity | Renal | Enquire
|
| 1533250 | Active | Phenylethyl Alcohol (1 mL) | Reference Standard | Impurity | Others-Chemical Medicines | Enquire
|
| 1534413 | Active | Phenyltoloxamine Related Compound A (50 mg) (2-(2-benzylphenoxy)ethylmethylamine hydrochloride) | Reference Standard | Impurity | Cough and Cold | Enquire
|
| 1535019 | Active | Phenytoin Related Compound A (50 mg) (2,2-Diphenylglycine) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1535020 | Active | Phenytoin Related Compound B (50 mg) (2,2-Diphenyl-2-ureidoacetic acid) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1535959 | Active | Phthalazine (20 mg) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1535899 | Active | Phthalic Acid (50 mg) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1569326 | Active | Pimobendan Related Compound A (15 mg) (4-[2-(4-Methoxyphenyl)-1H-benzimidazol-5-yl]-3-methyl-4-oxobutanoic acid) | Reference Standard | Impurity | Veterinary | Enquire
|
| 1569337 | Active | Pimobendan Related Compound B (15 mg) (N-[2-Amino-4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl]-4-methoxybenzamide) | Reference Standard | Impurity | Veterinary | Enquire
|
| 1541529 | Active | Piperacillin Related Compound E (25 mg) (1-ethylpiperazine-2,3-dione) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1544348 | Active | Pirfenidone Related Compound A (15 mg) (5-Methylpyridin-2-amine) | Reference Standard | Impurity | Immunosuppresants | Enquire
|
| 1544359 | Active | Pirfenidone Related Compound B (15 mg) (5-Methylpyridin-2(1H)-one) | Reference Standard | Impurity | Immunosuppresants | Enquire
|
| 1544417 | Active | Piroctone Related Compound A (15 mg) ((2-[5-methyl-3-(2,4,4-trimethylpentyl)-4,5-dihydroisoxazol-5-yl]acetic acid) 2-aminoethanol salt) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1544428 | Active | Piroctone Related Compound B (25 mg) (4-methyl-6-(2,4,4-trimethylpentyl)-2H-pyran-2-one) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1544519 | Active | Piroxicam Related Compound A (50 mg) (Pyridin-2-amine) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1544520 | Active | Piroxicam Related Compound B (50 mg) (4-Hydroxy-N-(pyridin-2-yl)-2H-benzothiazine-3-carboxamide 1,1-dioxide) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1544541 | Active | Piroxicam Related Compound D (50 mg) (Methyl 2-[1,1-dioxido-3-oxobenzoisothiazol-2(3H)-yl]acetate) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1544574 | Active | Piroxicam Related Compound G (50 mg) (Methyl 4-hydroxy-2H-benzothiazine-3-carboxylate 1,1-dioxide monohydrate) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1544600 | Active | Piroxicam Related Compound J (50 mg) (Methyl 4-hydroxy-2-methyl-2H-benzothiazine-3-carboxylate 1,1-dioxide) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1372333 | Active | Polyallylamine Hydrochloride (200 mg) (2-Propen-1-amine, hydrochloride (1:1), homopolymer) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1548190 | Active | Potassium Chloride (1 g) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1548258 | Active | Potassium Ferricyanide | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1548269 | Active | Potassium Ferrocyanide | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1551300 | Active | Potassium Trichloroammineplatinate (25 mg) | Reference Standard | Impurity | Oncology | Enquire
|
| 1553768 | Active | Pramipexole Related Compound A (15 mg) ((S)-4,5,6,7-Tetrahydrobenzothiazole-2,6-diamine) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1553815 | Active | Pramipexole Related Compound D (25 mg) ((R)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole dihydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1553837 | Active | Pramipexole Related Compound F (25 mg) ((6S,7R)-2-Amino-6-(propylamino)-4,5,6,7-tetrahydrobenzothiazol-7-ol) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1553848 | Active | Pramipexole Related Compound G (25 mg) ((6S,7S)-2-Amino-6-(propylamino)-4,5,6,7-tetrahydrobenzothiazol-7-ol) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1554148 | Active | Prasugrel Related Compound D (15 mg) (5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1554192 | Active | Pravastatin 1,1,3,3-Tetramethylbutylamine (200 mg) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1554217 | Active | Pravastatin Related Compound A (10 mg) (Sodium (3R,5R)-3,5-dihydroxy-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] heptanoate) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1554228 | Active | Pravastatin Related Compound B (20 mg) (sodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8-((S)-2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1554658 | Active | Praziquantel Related Compound A (20 mg) (2-benzoyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino [2,1-a]isoquinolin-4-one) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1554669 | Active | Praziquantel Related Compound B (50 mg) (2-(cyclohexylcarbonyl)-2,3,6,7-tetrahydro-4H-pyrazino [2,1-a]isoquinolin-4-one) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1554670 | Active | Praziquantel Related Compound C (50 mg) (2-(N-formylhexahydrohippuroyl)-1,2,3,4-tetrahydroisoquinolin-1-one) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1554749 | Active | Prazosin Related Compound D (25 mg) (Furan-2-yl(piperazin-1-yl)methanone) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1554910 | Active | Prednicarbate Related Compound A (20 mg) (1,2-Dihydroprednicarbate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1554920 | Active | Prednicarbate Related Compound B (20 mg) (Prednisolone-17-ethylcarbonate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1554931 | Active | Prednicarbate Related Compound C (20 mg) (prednisolone-21-propionate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1559629 | Active | Pregabalin Related Compound A (25 mg) ((R)-3-(Aminomethyl)-5-methylhexanoic acid) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1559647 | Active | Pregabalin Related Compound C (25 mg) (COLD SHIPMENT REQUIRED) (4-Isobutylpyrrolidin-2-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1561019 | Active | Prilocaine Related Compound A (100 mg) (o-Toluidine hydrochloride) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1561020 | Active | Prilocaine Related Compound B (50 mg) ((RS)-N-(4-methylphenyl)-2-(propylamino)propanamide) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1561518 | Active | Primaquine Related Compound A (15 mg) (8-[(4-Aminopentyl)amino]-6-methoxyquinoline) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1562011 | Active | Primidone Related Compound A (20 mg) (2-Ethyl-2-phenylmalonamide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1562033 | Active | Primidone Related Compound C (20 mg) (2-phenyl butyramide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1563320 | Active | Probucol Related Compound A (25 mg) (2,2',6,6'-tetra-tert-butyldiphenoquinone) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1563331 | Active | Probucol Related Compound B (25 mg) (4,4'-dithio-bis(2,6-di-tert-butylphenol)) (DISCONTINUED) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1563342 | Active | Probucol Related Compound C (25 mg) (4-[(3,5-di-tert-butyl-2-hydroxyphenylthio)isopropylidenethio]-2,6-di-tert-butylphenol) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1565010 | Active | Procarbazine Related Compound A (50 mg) (4-Formyl-N-isopropylbenzamide) | Reference Standard | Impurity | Oncology | Enquire
|
| 1566045 | Active | Prochlorperazine Related Compound A (10 mg) (4-Chloro-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine dihydrochloride) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1568018 | Active | Progesterone Related Compound H (25 mg) (Pregna-4,6-diene-3,20-dione) | Reference Standard | Impurity | Steroids | Enquire
|
| 1568028 | Active | Proguanil Related Compound A (25 mg) (1-cyano-3-isopropylguanidine) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1568051 | Active | Proguanil Related Compound C (25 mg) (1,5-bis(4-chlorophenyl)biguanide hydrochloride) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1568062 | Active | Proguanil Related Compound D (25 mg) (1,5-bis(1-methylethyl)biguanide hydrochloride) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1568073 | Active | Proguanil Related Compound E (25 mg) (1-(4-chlorophenyl)-3-cyanoguanidine) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1568084 | Active | Proguanil Related Compound F (25 mg) (1-(3,4-dichlorophenyl)-5-isopropylbiguanide hydrochloride) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1568095 | Active | Proguanil Related Compound G (25 mg) (1-(3-chlorophenyl)-5-isopropylbiguanide hydrochloride) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1570029 | Active | Promethazine Related Compound B (25 mg) (N,N-Dimethyl-2-(10H-phenothiazin-10-yl)propan-1-amine hydrochloride) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1570315 | Active | Propafenone Related Compound A (20 mg) (N-{2-Hydroxy-3-[2-(3-phenylpropanoyl)phenoxy]propyl}-N-propylformamide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1570326 | Active | Propafenone Related Compound B (50 mg) (RS,E)-1-[2-[2-Hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylprop-2-en-1-one) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1329505 | Active | Propantheline Bromide Related Compound A (50 mg) (9-Hydroxypropantheline bromide) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1572536 | Active | Propofol Related Compound A (25 mg) (3,3',5,5'-Tetraisopropylbiphenyl-4,4'-diol) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1572547 | Active | Propofol Related Compound B (30 mg) (2,6-Diisopropyl-1,4-benzoquinone) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1572558 | Active | Propofol Related Compound C (25 mg) (2,6-diisopropylphenyl isopropyl ether) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1576016 | Active | Propranolol Related Compound A (25 mg) (3-(Naphthalen-1-yloxy)propane-1,2-diol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1578500 | Active | Prostaglandin A1 (25 mg) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1578554 | Active | Prostaglandin B1 (25 mg) ((13E,15S)-15-Hydroxy-9-oxoprosta-8(12),13-dien-1-oic acid) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1584014 | Active | Pyrantel Related Compound A (25 mg) ((Z)-1-Methyl-2-[2-(2-thiophenyl)vinyl]-1,4,5,6-Tetrahydropyrimidine 4,4'-methylenebis[3-hydroxy-2-naphthoate] (1:1)) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1585017 | Active | Pyrazinamide Related Compound A (25 mg) (Pyrazinecarboxylic acid) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1585028 | Active | Pyrazinamide Related Compound B (50 mg) (Pyrazinecarbonitrile) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1586020 | Active | Pyridostigmine Related Compound A (50 mg) (Pyridin-3-yl dimethylcarbamate) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1586031 | Active | Pyridostigmine Related Compound B (10 mg) (3-Hydroxy-1-methylpyridin-1-ium bromide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1589029 | Active | Pyroglutamic Acid (30 mg) ((S)-5-Oxopyrrolidine-2-carboxylic acid) | Reference Standard | Impurity | Hepatic | Enquire
|
| 1592227 | Active | Quazepam Related Compound A (30 mg) (7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1592737 | Active | Quetiapine Related Compound B (15 mg) (11-(Piperazin-1-yl)dibenzo[b,f][1,4]thiazepine dihydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1592781 | Active | Quetiapine Related Compound G (15 mg) (Dibenzo[b,f][1,4]thiazepin-11(10H)-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1592792 | Active | Quetiapine Related Compound H (15 mg) (4-(Dibenzo[b,f][1,4]thiazepin-11-yl)-1-[2-(2-hydroxyethoxy)ethyl]piperazine 1-oxide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1593412 | Active | Quinapril Related Compound A (50 mg) (Ethyl [3S-[(2R*), 3a, 11ab]]-1,3,4,6,11,11a-hexahydro-3-methyl-1,4-dioxo-a-(2-phenylethyl)-2H-pyrazino[1,2-b]isoquinoline-2-acetate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1593423 | Active | Quinapril Related Compound B (50 mg) (3-Isoquinolinecarboxylic acid, 2-[2-[(1-carboxy-3-phenylpropyl)amino]-1-oxopropyl]-1,2,3,4-tetrahydro-,[3S-[2[R*(R*)],3R*]]) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1597504 | Active | Quininone (50 mg) (Cinchonan-9-one, 6'-methoxy-, (8alpha)-) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1413988 | Active | R-Methotrexate (5 mg) (Sodium (R)-2-(4-{[(2,4-Diaminopteridin-6-yl)methyl](methyl)amino}benzamido)pentanedioate) | Reference Standard | Impurity | Oncology | Enquire
|
| 1478083 | Active | R-Ofloxacin (25 mg) ((R)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1478479 | Active | R-Omeprazole (15 mg) (5-Methoxy-2-[(R)-[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole, sodium salt) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1598020 | Active | Rabeprazole Related Compound A (25 mg) (Disodium 1-benzimidazol-2-yl-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylate) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1598031 | Active | Rabeprazole Related Compound B (15 mg) (2-{[(1H-benzo[d]imidazol-2-yl)sulfinyl]methyl}-4-(3-methoxypropoxy)-3-methylpyridine 1-oxide) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1598042 | Active | Rabeprazole Related Compound C (25 mg) (1H-Benzimidazole-2-thiol) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1598053 | Active | Rabeprazole Related Compound D (25 mg) (2-({[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methyl}sulfonyl)benzimidazole) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1598064 | Active | Rabeprazole Related Compound E (25 mg) (2-{[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methylthio}benzimidazole) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1598075 | Active | Rabeprazole Related Compound F (15 mg) (2-{[(4-Chloro-3-methyl-2-pyridyl)methyl]sulfinyl}benzimidazole) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1643281 | Active | Racemic Tamsulosin Hydrochloride (50 mg) | Reference Standard | Impurity | Renal | Enquire
|
| 1667235 | Active | Racemic Tiagabine Hydrochloride Mixture (25 mg) ((S)-(+),(R)-(-)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid, hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1598234 | Active | Raloxifene Related Compound C (20 mg) (1-(2-{4-[6-hydroxy-2-(4-hydroxyphenyl)benzothiophene-3-carbonyl]phenoxy}ethyl)piperidine 1-oxide monohydrate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1598267 | Active | Raltegravir Related Compound E (20 mg) (N-{2-[4-(Benzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]propan-2-yl}-5-methyl-1,3,4-oxadiazole-2-carboxamide) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1598314 | Active | Ramipril Related Compound A (30 mg) ((2S,3aS,6aS)-1-[(S)2-[[(S)-1-(Methoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1598323 | Active | Ramipril Related Compound B (20 mg) ((2S,3aS,6aS)-1-{[(S)-1-Methoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1598338 | Active | Ramipril Related Compound C (20 mg) ((2S,3aS,6aS)-1-{[(S)-4-Cyclohexyl-1-ethoxy-1-oxobutan-2-yl]-L-alanyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1598347 | Active | Ramipril Related Compound D (20 mg) (Ethyl (S)-2-[(3S,5aS,8aS,9aS)-3-methyl-1,4-dioxodecahydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-2-yl]-4-phenylbutanoate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1598507 | Active | Ranitidine Related Compound A (50 mg) (5-{[(2-Aminoethyl)thio]methyl}-N,N-dimethyl-2-furanmethanamine hemifumarate) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1598609 | Active | Ranitidine Related Compound B (50 mg) (N,N'-bis[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-2-nitro-1,1-ethenediamine) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1598700 | Active | Ranitidine Related Compound C (50 mg) (N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]sulfinyl]ethyl]-N-methyl-2-nitro-1,1-ethenediamine) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1598755 | Active | Ranolazine Related Compound A (50 mg) ((+/-)-2-[(2-methoxyphenoxy)methyl]oxirane) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1598766 | Active | Ranolazine Related Compound B (50 mg) (N-(2,6-Dimethylphenyl)-2-[4-(2-hydroxy-3-phenoxypropyl)piperazin-1-yl]acetamide dihydrochloride monohydrate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1598777 | Active | Ranolazine Related Compound C (50 mg) (N-(2,6-Dimethylphenyl)-2-(piperazin-1-yl)acetamide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1598788 | Active | Ranolazine Related Compound D (50 mg) (2,2'-(Piperazine-1,4-diyl)bis[N-(2,6-dimethylphenyl)acetamide]) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1600212 | Active | Regorafenib Related Compound A (15 mg) (4-(4-Amino-3-fluorophenoxy)-N-methylpicolinamide) | Reference Standard | Impurity | Oncology | Enquire
|
| 1600824 | Active | Repaglinide Related Compound A (10 mg) ((S)-3-Methyl-1-[2-(1-piperidinyl)phenyl]butylamine, N-acetyl-L-glutamate salt) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1600835 | Active | Repaglinide Related Compound B (50 mg) (3-Ethoxy-4-ethoxycarbonylphenylacetic acid) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1600846 | Active | Repaglinide Related Compound C (25 mg) ((S)-2-Ethoxy-4-[2-[[2-phenyl-1-[2-(1-piperidinyl)phenyl]ethyl]amino]-2-oxoethyl] benzoic acid) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1600868 | Active | Repaglinide Related Compound E (20 mg) ((R)-2-Ethoxy-4-[2-({3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}amino)-2-oxoethyl]benzoic acid) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1602717 | Active | Ribavirin Related Compound A (15 mg) (1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxylic acid) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1602740 | Active | Ribavirin Related Compound D (15 mg) (1H-1,2,4-triazole-3-carboxamide) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1604202 | Active | Rifampin Quinone (25 mg) (1,4-dideoxy-1,4-dihydro-3-[[[4-methyl-1-piperazinyl]imino]methyl]-1,4-dioxo-rifamycin) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1604199 | Active | Rifampin-N-Oxide (25 mg) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1604348 | Active | Riluzole Related Compound A (25 mg) (4-(Trifluoromethoxy)aniline) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1604621 | Active | Risedronate Related Compound A (20 mg) ([1-Hydroxy-2-(2-pyridinyl)ethylidene]bis(phosphonic acid), monohydrate) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1604632 | Active | Risedronate Related Compound B (20 mg) ([3,6-Bis[(3-pyridinyl)methyl]-2,5-dihydroxy-2,5-dioxido-1,4,2,5-dioxadiphosphorinane-3,6-diyl]bis[phosphonic acid] disodium tetrahydrate salt) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1604643 | Active | Risedronate Related Compound C (20 mg) ([2-(3-pyridinyl)ethylidene-1,1]bis(phosphonic acid)) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1604756 | Active | Risperidone Related Compound G (25 mg) (3-{2-[4-(4-Fluoro-2-hydroxybenzoyl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1604676 | Active | Risperidone Related Compounds Mixture (25 mg) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1604814 | Active | Ritonavir Related Compounds Mixture (50 mg) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1604541 | Active | Rivaroxaban R-enantiomer (20 mg) ((R)-5-Chloro-N-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)thiophene-2-carboxamide) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1604552 | Active | Rivaroxaban Related Compound B (20 mg) ((S)-N-({2-Oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)acetamide) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1604563 | Active | Rivaroxaban Related Compound D (20 mg) (1,3-Bis({(S)-2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)urea) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1604596 | Active | Rivaroxaban Related Compound G (20 mg) ((S)-2-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)isoindoline-1,3-dione) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1604585 | Active | Rivaroxaban Related Compound H (20 mg) ((S)-4,5-Dichloro-N-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)thiophene-2-carboxamide) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1604574 | Active | Rivaroxaban Related Compound J (20 mg) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1604869 | Active | Rivastigmine Related Compound A (15 mg) ((+)-Di-(p-toluoyl)-D-tartaric acid) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1604870 | Active | Rivastigmine Related Compound B (15 mg) ((R,S)-3-[1-(Dimethylamino)ethyl]phenyl dimethylcarbamate) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1604811 | Active | Rivastigmine Related Compound C (15 mg) ((S)-3-[1-(Dimethylamino)ethyl]phenol) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1604825 | Active | Rivastigmine Related Compound D (50 mg) (3-Acetylphenyl ethyl(methyl)carbamate) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1604950 | Active | Rivastigmine Related Compound E (15 mg) ((S)-1-(3-{[Ethyl(methyl)carbamoyl]oxy}phenyl)-N,N,N-trimethylethanaminium chloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1604961 | Active | Rivastigmine Related Compound F (25 mg) (3-Vinylphenyl ethyl(methyl)carbamate) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1604847 | Active | Rivastigmine Tartrate R-Isomer (20 mg) ((R)-3-[1-(Dimethylamino)ethyl]phenyl ethyl(methyl)carbamate, hydrogen tartrate) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1604916 | Active | Rocuronium Peak Identification Mixture (25 mg) (rocuronium bromide spiked with rocuronium related compounds A, B, C, D, E, F, G, and H) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1605023 | Active | Roflumilast Related Compound A (30 mg) (3-(Cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-hydroxybenzamide) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1605034 | Active | Roflumilast Related Compound B (30 mg) (N-(3,5-Dichloropyridin-4-yl)-4-(difluoromethoxy)-3-hydroxybenzamide) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1605045 | Active | Roflumilast Related Compound C (50 mg) (3,5-Dichloropyridin-4-amine) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1605056 | Active | Roflumilast Related Compound D (50 mg) (3-(Cyclopropylmethoxy)-4-(difluoromethoxy)benzoic acid) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1605067 | Active | Roflumilast Related Compound E (30 mg) (N-(3-Bromo-5-chloropyridin-4-yl)-3-(cyclopropylmethoxy)-4-(difluoromethoxy)benzamide) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1605216 | Active | Ropinirole Related Compound A (50 mg) (4-(2-hydroxyethyl)indolin-2-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1605227 | Active | Ropinirole Related Compound B (50 mg) (4-[2-(Dipropylamino)ethyl]indoline-2,3-dione hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1605512 | Active | Ropivacaine Related Compound A (25 mg) (2,6-dimethylaniline hydrochloride) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1605523 | Active | Ropivacaine Related Compound B (50 mg) ((R)-N-(2,6-Dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride monohydrate) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1605828 | Active | Rosiglitazone Related Compound A (25 mg) ((5Z)-5-{[4-({2-[methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methylidene}-1,3-thiazolidine-2,4-dione) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1606059 | Active | Rosuvastatin Enantiomer (25 mg) (Calcium (3S,5R,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate salt (1:2)) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1606026 | Active | Rosuvastatin Related Compound A (25 mg) (Calcium (3R,5S,E)-7-{4-(4-fluorophenyl)-2-[(2-hydroxy-N,2-dimethylpropyl)sulfonamide]-6-isopropylpyrimidin-5-yl}-3,5-dihydroxyhept-6-enoate salt (1:2)) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1606037 | Active | Rosuvastatin Related Compound B (25 mg) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1606048 | Active | Rosuvastatin Related Compound C (25 mg) (tert-Butyl 2-[(4R,6S)-6-{(E)-2-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl]vinyl}-2,2-dimethyl-1,3-dioxan-4-yl]acetate) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1606081 | Active | Rotigotine Racemate (25 mg) ((RS)-6-{Propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1606117 | Active | Rotigotine Related Compound C (25 mg) ((S)-6-{[2-(Thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1606140 | Active | Rotigotine Related Compound G (25 mg) ((S)-6-{Bis[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1606156 | Active | Rotigotine Related Compound H (25 mg) ((S)-5-Methoxy-N-propyl-N-[2-(thiophen-2-yl)ethyl]-1,2,3,4-tetrahydronaphthalen-2-amine) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1202253 | Active | Rotigotine Related Compound K (25 mg) (7,8-Dihydronaphthalen-1-ol) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1606412 | Active | Rufinamide Related Compound A (25 mg) (1-(2-Fluorobenzyl)-1H-1,2,3-triazole-4-carboxamide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1606423 | Active | Rufinamide Related Compound B (25 mg) (Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1609013 | Active | Salicylic Acid Related Compound A (100 mg) (4-hydroxybenzoic acid) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1609024 | Active | Salicylic Acid Related Compound B (100 mg) (4-hydroxyisophthalic acid) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1609614 | Active | Salmeterol Related Compound A (20 mg) (4-[1-Hydroxy-2-(4-phenylbutylamino)ethyl]-2-(hydroxymethyl)phenol) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1609625 | Active | Salmeterol Related Compound B (3 x 1.3 mg) (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2- | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1609680 | Active | Salmeterol Related Compound H (30 mg) (1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid, monohydrate) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1609831 | Active | Saquinavir Related Compound A (25 mg) (N-tert-butyl-decahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-[[N-(2-quinolylcarbonyl)-D-asparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1611944 | Active | Selegiline Related Compound D (15 mg) ((R)-N-(1-Phenylpropan-2-yl)prop-2-yn-1-amine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1612517 | Active | Sertraline Hydrochloride Racemic Mixture (30 mg) ((1RS,4RS)-4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthylamine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1612528 | Active | Sertraline Hydrochloride Related Compound A (25 mg) ((1RS,4SR)-4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthylamine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1612550 | Active | Sevoflurane Related Compound A (0.2 mL) (1,1,1,3,3-Pentafluoroisopropenyl fluoromethyl ether) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1612572 | Active | Sevoflurane Related Compound B (0.2 mL) (1,1,1,3,3,3-hexafluoro-2-methoxy-propane) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1612594 | Active | Sevoflurane Related Compound C (0.2 mL) (1,1,1,3,3,3-hexafluoro-2-propanol) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1612856 | Active | Sibutramine Related Compound A (20 mg) (N-{1-[1-(2-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1612867 | Active | Sibutramine Related Compound B (20 mg) (N-{1-[1-(3-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1612878 | Active | Sibutramine Related Compound C (20 mg) (N-{1-[1-(4-chlorophenyl)cyclobutyl]pentyl}-N,N-dimethylamine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1612889 | Active | Sibutramine Related Compound D (20 mg) (N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N-methylamine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1612685 | Active | Sildenafil Related Compound A (10 mg) (1-{[3-(6,7-Dihydro-1-methyl-7-oxo-3-isobutyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl}-4-methylpiperazine) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1614432 | Active | Sodium Nitrate (200 mg) | Reference Standard | Impurity | Antidotes & Chelators | Enquire
|
| 1614589 | Active | Sodium Picosulfate Related Compound A (20 mg) (4-[(Pyridin-2-yl)(4-hydroxyphenyl)methyl]phenyl sodium sulfate) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1614807 | Active | Sodium Sulfate Anhydrous (1 g) | Reference Standard | Impurity | Antidotes & Chelators | Enquire
|
| 1615311 | Active | Solifenacin Identification Mixture A (15 mg) | Reference Standard | Impurity | Renal | Enquire
|
| 1615322 | Active | Solifenacin Identification Mixture B (20 mg) | Reference Standard | Impurity | Renal | Enquire
|
| 1615887 | Active | Sorafenib Related Compound H (25 mg) (4-(4-{3-[2-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N-methylpicolinamide) | Reference Standard | Impurity | Oncology | Enquire
|
| 1617419 | Active | Sotalol Related Compound A (50 mg) (N-[4-[[(1-Methylethyl)amino]acetyl]phenyl]methanesulfonamide monohydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1617420 | Active | Sotalol Related Compound B (50 mg) (N-(4-Formylphenyl)methanesulfonamide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1617430 | Active | Sotalol Related Compound C (50 mg) (N-{4-[2-(Isopropylamino)ethyl]phenyl}methanesulfonamide hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1619051 | Active | Spironolactone Epimer Mixture (30 mg) (7-Epispironolactone approximately 56% and Spironolactone approximately 39% mixture) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1619017 | Active | Spironolactone Related Compound A (100 mg) ((2'R)-3',4'-Dihydro-5'H-spiro[androst-4,6-diene-17,2'-furan]-3,5'-dione) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1619028 | Active | Spironolactone Related Compound B (30 mg) ((2'R)-7alpha-(Acetylthio)-5'H-spiro[androst-4-ene-17,2'-furan]-3,5'-dione) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1619039 | Active | Spironolactone Related Compound C (30 mg) ((2'R)-3',4'-Dihydro-5'H-spiro[androst-4-ene-17,2'-furan]-3,5'-dione) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1619040 | Active | Spironolactone Related Compound D (30 mg) ((2'R)-7alpha-(Acetyldisulfanyl)-3',4'-dihydro-5'H-spiro[androst-4-ene-17,2'-furan]-3,5'-dione) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1619094 | Active | Spironolactone Related Compound I (30 mg) (S-[17alpha-(Ethoxymethyl)-17-hydroxy-3-oxoandrost-4-en-7alpha-yl]ethanethioate) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1622044 | Active | Stearylpyridinium Chloride (25 mg) (1-Octadecylpyridinium chloride) | Reference Standard | Impurity | Others-Chemical Medicines | Enquire
|
| 1623604 | Active | Succinylmonocholine Chloride (50 mg) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1623749 | Active | Sulbactam Related Compound A (15 mg) ((2S)-2-Amino-3-methyl-3-sulfinobutanoic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1623772 | Active | Sulbactam Related Compound D (15 mg) (Potassium (2S,5R,6R)-6-bromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1623783 | Active | Sulbactam Related Compound E (15 mg) ((2S,5R)-6,6-Dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1623794 | Active | Sulbactam Related Compound F (15 mg) ((2S,5R)-6,6-Dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1623692 | Active | Sulconazole Related Compound A (15 mg) (1-[2-(4-Chlorobenzyl)sulfinyl-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole nitrate) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1629019 | Active | Sulfamethazine Related Compound A (100 mg) (4-Amino-N-carbamimidoylbenzenesulfonamide-, monohydrate) (DISCONTINUED) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1629021 | Active | Sulfamethazine Related Compound B (50 mg) (Mixture containing about 49% of 4-Amino-2-chloro-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide and about 48% of 4-Amino-3-chloro-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide) (DISCONTINUED) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1631500 | Active | Sulfamethoxazole N4-Glucoside (25 mg) (4-(beta-D-glucopyranosylamino)-N-(5-methyl-3-isoxazolyl)-benzenesulfonamide) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1631511 | Active | Sulfamethoxazole Related Compound A (15 mg) (N-{4-[N-(5-methylisoxazol-3-yl)sulfamoyl]phenyl}acetamide) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1631522 | Active | Sulfamethoxazole Related Compound B (15 mg) (4-amino-N-{4-[N-(5-methylisoxazol-3-yl)sulfamoyl]phenyl}benzenesulfonamide) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1631533 | Active | Sulfamethoxazole Related Compound C (15 mg) (5-methylisoxazol-3-amine) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1631566 | Active | Sulfamethoxazole Related Compound F (15 mg) (4-amino-N-(3-methylisoxazol-5-yl)benzenesulfonamide) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1632004 | Active | Sulfanilamide (5 g) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1633506 | Active | Sulfanilic Acid (200 mg) (4-Aminobenzenesulfonic acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1635228 | Active | Sulfaquinoxaline Related Compound A (25 mg) (N1,N2-diquinoxalin-2-ylsulfanilamide) | Reference Standard | Impurity | Veterinary | Enquire
|
| 1636118 | Active | Sulfasalazine Related Compound K (25 mg) (5-{4-[N-(6-Methylpyridin-2-yl)sulfamoyl]phenyldiazenyl}salicylic acid) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1642019 | Active | Sulindac Related Compound A (20 mg) ((E)-2-{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1642020 | Active | Sulindac Related Compound B (20 mg) ((Z)-2-{5-fluoro-2-methyl-1-[4-(methylsulfonyl)benzylidene]-1H-inden-3-yl}acetic acid) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1642031 | Active | Sulindac Related Compound C (20 mg) ((Z)-2-{5-fluoro-2-methyl-1-[4-(methylthio)benzylidene]-1H-inden-3-yl}acetic acid) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1642212 | Active | Sumatriptan Succinate Related Compound A (15 mg) ([3-[2-(dimethylamino)ethyl]-2-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1H-indol-5-yl]-N-methylmethanesulfonamide, succinate salt) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1642223 | Active | Sumatriptan Succinate Related Compound C (50 mg) ([3-[2-(dimethylamino)ethyl]-1-(hydroxymethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide succinate salt) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1642256 | Active | Sumatriptan Succinate Related Impurities (25 mg) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1642824 | Active | Tacrolimus 8-epimer (15 mg) (See USP Certificate for full Chemical Name) | Reference Standard | Impurity | Immunosuppresants | Enquire
|
| 1642835 | Active | Tacrolimus 8-propyl analog (15 mg) (See USP Certificate for full Chemical Name) | Reference Standard | Impurity | Immunosuppresants | Enquire
|
| 1642813 | Active | Tacrolimus Related Compound A (15 mg) (See USP Certificate for full Chemical Name) | Reference Standard | Impurity | Immunosuppresants | Enquire
|
| 1643382 | Active | Tazarotene Related Compound B (30 mg) (Ethyl 6-chloronicotinate) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1643394 | Active | Tazobactam Related Compound A (20 mg) ((2S,3S)-2-Amino-3-methyl-3-sulfino-4-(1H-1,2,3-triazol-1-yl)butyric acid) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1643420 | Active | Telmisartan Related Compound A (20 mg) (1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]imidazole monohydrate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1643437 | Active | Telmisartan Related Compound B (15 mg) (4'-[(1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl)methyl]biphenyl-2-carboxylic acid) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1644319 | Active | Temazepam Related Compound A (15 mg) (5-chloro-2-methylaminobenzophenone) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1644364 | Active | Temazepam Related Compound F (15 mg) (7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1646375 | Active | Temazepam Related Compound G (15 mg) (7-Chloro-1,4-dimethyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1643554 | Active | Temozolomide Related Compound A (15 mg) (4-diazo-4H-imidazole-5-carboxamide) | Reference Standard | Impurity | Oncology | Enquire
|
| 1643565 | Active | Temozolomide Related Compound B (15 mg) (3-methyl-1,1-diphenylurea) | Reference Standard | Impurity | Oncology | Enquire
|
| 1643576 | Active | Temozolomide Related Compound C (15 mg) (diphenylcarbamic chloride) | Reference Standard | Impurity | Oncology | Enquire
|
| 1643747 | Active | Teniposide Related Compound A (10 mg) (4'-Demethylepipodophyllotoxin) | Reference Standard | Impurity | Oncology | Enquire
|
| 1612719 | Active | Tenivastatin Calcium (2 x 15 mg) (COLD SHIPMENT REQUIRED) (Calcium (3R,5R)-7-{(1S,2S,6R,8S,8aR)-8-[(2,2-dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl}-3,5-dihydroxyheptanoate (1:2) monohydrate) | Reference Standard | Impurity | Antihyperlipidemics | Enquire
|
| 1643612 | Active | Tenofovir Disoproxil Related Compound A (10 mg) (O,O-Bis(isopropoxycarbonyloxymethyl) (S)-[1-(6-amino-9H-purin-9-yl)prop-2-yloxy]methylphosphonate fumarate) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1643623 | Active | Tenofovir Disoproxil Related Compound B (10 mg) ((E)-9-(Prop-1-enyl)-9H-purin-6-amine) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1643678 | Active | Tenofovir Disoproxil Related Compound G (15 mg) (O-(Isopropoxycarbonyloxymethyl)-O-isopropyl-{(R)-[1-(6-amino-9H-purin-9-yl)propan-2-yloxy]}methylphosphonate) fumarate) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1643714 | Active | Tenofovir Disoproxil Related Compound J (15 mg) (O-(N,N-Diethylaminocarbonyloxymethyl)-O-(isopropoxycarbonyloxymethyl)-(R)-[1-(6-amino-9H-purin-9-yl)propan-2-yloxy]methylphosphonate oxalate) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1643725 | Active | Tenofovir Disoproxil Related Compound K (15 mg) (O-(Isopropoxycarbonyloxymethyl)-O-(propoxycarbonyloxymethyl)-(R)-[1-(6-amino-9H-purin-9-yl)propan-2-yloxy]methylphosphonate fumarate) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1643463 | Active | Terazosin Related Compound A (50 mg) (6,7-Dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine dihydrochloride) | Reference Standard | Impurity | Renal | Enquire
|
| 1643474 | Active | Terazosin Related Compound B (50 mg) (1-(4-Hydroxy-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine) | Reference Standard | Impurity | Renal | Enquire
|
| 1643485 | Active | Terazosin Related Compound C (25 mg) (1,4-Bis(4-amino-6,7-dimethoxy-2-quinazolinyl)piperazine, dihydrochloride) | Reference Standard | Impurity | Renal | Enquire
|
| 1424608 | Active | Terbinafine Related Compound A (25 mg) (N-methyl-C-(naphthalen-1-yl)methanamine hydrochloride) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1643532 | Active | Terbinafine Related Compound B (25 mg) ((2Z)-N,6,6-Trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine hydrochloride) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1353215 | Active | Terbinafine Related Compound C (25 mg) ((2E)-N,6,6-Trimethyl-N-(naphthalen-2-ylmethyl)hept-2-en-4-yn-1-amine hydrochloride) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1437701 | Active | Terbinafine Related Compound D (25 mg) ((2E)-N,6,6-trimethyl-N-[(4-methylnaphthalen-1-yl)methyl]hept-2-en-4-yn-1-amine hydrochloride) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1643510 | Active | Terbutaline Related Compound A (50 mg) (2-(tert-Butylamino)-1-(3,5-dihydroxyphenyl)ethan-1-one sulfate) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1643521 | Active | Terbutaline Related Compound D (25 mg) (2-[Benzyl(tert-butyl)amino]-1-(3,5-dihydroxyphenyl)ethan-1-one) (COLD SHIPMENT REQUIRED) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1357089 | Active | Teriflunomide Related Compound B (25 mg) (2-Cyano-N-(4-(trifluoromethyl)phenyl)acetamide) | Reference Standard | Impurity | Immunosuppresants | Enquire
|
| 1647012 | Active | Testosterone Cypionate Related Compound A (25 mg) (Androst-4-en-3,6-dione-17Beta-yl 3-cyclopentylpropanoate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1647023 | Active | Testosterone Cypionate Related Compound B (40 mg) (Androst-4,6-dien-3-one-17 Beta-yl 3-cyclopentylpropanoate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1648026 | Active | Testosterone Enanthate Related Compound B CIII (50 mg) (Androst-4-en-3-one-17beta-yl hexanoate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1646042 | Active | Testosterone Enanthate Related Compound F (50 mg) (Androst-4,6-dien-3-one-17Beta-yl heptanoate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1646053 | Active | Testosterone Enanthate Related Compound G (50 mg) (Androst-4,9(11)-dien-3-one-17Beta-yl heptanoate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1648081 | Active | Testosterone Enanthate Related Compound H CIII (25 mg) (Androst-5-ene-3Beta,17Beta-diyl diheptanoate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1646010 | Active | Testosterone Related Compound A CIII (20 mg) (Androst-4-ene-3,17-dione) | Reference Standard | Impurity | Steroids | Enquire
|
| 1646031 | Active | Testosterone Related Compound C (15 mg) (17alpha-Hydroxyandrost-4-en-3-one) | Reference Standard | Impurity | Steroids | Enquire
|
| 1646097 | Active | Testosterone Related Compound I (15 mg) (17beta-Hydroxyandrosta-4,6-dien-3-one) | Reference Standard | Impurity | Steroids | Enquire
|
| 1649812 | Active | Tetrabenazine Related Compound C (25 mg) ((3RS,11bRS)-3-Butyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1650017 | Active | Tetracaine Related Compound B (25 mg) (4-(Butylamino)benzoic acid) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1650028 | Active | Tetracaine Related Compound C (25 mg) (Methyl 4-(butylamino)benzoate) | Reference Standard | Impurity | Anaesthetics | Enquire
|
| 1652012 | Active | Tetrahydrozoline Related Compound A (50 mg) (1,2,3,4-Tetrahydronaphthalene-1-carbonitrile) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1652023 | Active | Tetrahydrozoline Related Compound B (25 mg) (2-(1,2,3,4-Tetrahydronaphthalen-1-yl)-1H-imidazole) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1652034 | Active | Tetrahydrozoline Related Compound C (25 mg) (1,2,3,4-Tetrahydronaphthalene-1-carboxylic acid) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1652045 | Active | Tetrahydrozoline Related Compound D (25 mg) (2-(Naphthalen-1-yl)-4,5-dihydro-1H-imidazole hydrochloride) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1652056 | Active | Tetrahydrozoline Related Compound E (25 mg) (N-(2-Aminoethyl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1652169 | Active | Tetraxetan Related Compound A (25 mg) (2,2',2"-[10-(2-Ethoxy-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetic acid) | Reference Standard | Impurity | Oncology | Enquire
|
| 1653026 | Active | Theophylline Related Compound B (25 mg) (3-Methyl-1H-purine-2,6-dione) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1653037 | Active | Theophylline Related Compound C (25 mg) (N-(6-Amino-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)formamide) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1653048 | Active | Theophylline Related Compound D (30 mg) (N-Methyl-5-(methylamino)-1H-imidazole-4-carboxamide hydrochloride monohydrate) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1653060 | Active | Theophylline Related Compound F (25 mg) (7-(2-Hydroxyethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1659001 | Active | Thimerosal Related Compound A (50 mg) (2,2'-Disulfanediyldibenzoic acid) | Reference Standard | Impurity | Antiseptics | Enquire
|
| 1663063 | Active | Thioridazine Related Compound F (20 mg) (2-(Methylthio)-10-[2-(piperidin-2-yl)ethyl]-10H-phenothiazine hydrochloride) (DISCONTINUED) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1667122 | Active | Tiagabine Isomer (25 mg) (1-(4,4-Bis(4-methylthiophen-2-yl)but-3-en-1-yl)piperidine-3-carboxylic acid) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1667224 | Active | Tiagabine Related Compound A (15 mg) ((R)-ethyl 1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylate, hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1667337 | Active | Tiamulin Related Compound A (50 mg) (Tosyl pleuromutilin) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1667188 | Active | Ticagrelor Related Compound A (25 mg) ((1R,2S)-2-(3,4-difluorophenyl)cyclopropan-1-amine (R)-mandelate) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1667133 | Active | Ticagrelor Related Compound B (25 mg) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1667155 | Active | Ticlopidine Related Compound A (20 mg) (4-oxo-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1667166 | Active | Ticlopidine Related Compound B (20 mg) (5-(2-chlorobenzyl)-4-oxo-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1667665 | Active | Tigecycline Related Compound B (25 mg) ((4S,4aS,5aR,12aS)-9-Amino-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2- carboxamide hydrochloride (1:x)) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1667381 | Active | Timolol Related Compound A (20 mg) ((R)-1-(tert-Butylamino)-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy)propan-2-ol maleate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1667315 | Active | Timolol Related Compound B (20 mg) (3-(tert-Butylamino)-2-(4-morpholino-1,2,5-thiadiazol-3-yloxy)propan-1-ol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1667326 | Active | Timolol Related Compound C (20 mg) (N-(tert-Butyl)-2,3-bis(4-morpholino-1,2,5-thiadiazol-3-yloxy)propan-1-amine maleate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1667369 | Active | Timolol Related Compound D (20 mg) (4-Morpholino-1,2,5-thiadiazol-3-ol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1667443 | Active | Timolol Related Compound E (20 mg) ((S,Z)-4-({1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-yl}oxy)-4-oxobut-2-enoic acid maleate salt (1:1)) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1667348 | Active | Timolol Related Compound F (20 mg) (3-Chloro-4-morpholino-1,2,5-thiadiazol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1667530 | Active | Tinidazole Related Compound A (100 mg) (2-methyl-5-nitroimidazole) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1667541 | Active | Tinidazole Related Compound B (20 mg) (1-(2-ethyl-sulfonylethyl)-2-methyl-4-nitroimidazole) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1667450 | Active | Tioconazole Related Compound A (25 mg) (1-[2,4-Dichloro-Beta-[(3-thenyl)-oxy]phenethyl]imidazole hydrochloride) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1667461 | Active | Tioconazole Related Compound B (25 mg) (1-[2,4-Dichloro-beta-[(2,5-dichloro-3-thenyl)oxy]phenethyl]imidazole hydrochloride) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1667472 | Active | Tioconazole Related Compound C (25 mg) (1-[2,4-Dichloro-beta-[(5-bromo-2-chloro-3-thenyl)-oxy]-phenethyl]imidazole hydrochloride) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1667619 | Active | Tiotropium Related Compound C (25 mg) ((1R,3s,5S)-3-[2-Hydroxy-2,2-di(thiophen-2-yl)acetoxy]-8,8-dimethyl-8-azabicyclo[3.2.1]oct-6-en-8-ium bromide) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1667621 | Active | Tiotropium Related Compound G (50 mg) ((1R,2R,4S,5S,7s)-7-Hydroxy-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1667632 | Active | Tiotropium Related Compound H (50 mg) ((2RS,3aSR,5RS,6RS,6aRS)-6-Hydroxy-4,4-dimethylhexahydro-2H-2,5-methanofuro[3,2-b]pyrrol-4-ium bromide) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1667916 | Active | Tizanidine Related Compound A (50 mg) (4-amino-5-chloro-2,1,3-benzothiadiazole) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1667924 | Active | Tizanidine Related Compound B (50 mg) (N-acetyltizanidine) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1667938 | Active | Tizanidine Related Compound C (50 mg) (1-acetylimidazolidine-2-thione) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1670218 | Active | Tolcapone Related Compound A (25 mg) (4'-methyl-3,4-dihydroxybenzophenone) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1670229 | Active | Tolcapone Related Compound B (25 mg) (4-hydroxy-3-methoxy-4'-methyl-5-nitrobenzophenone) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1671040 | Active | Tolnaftate Related Compound D (100 mg) (N,3-Dimethylaniline) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1671468 | Active | Tolterodine S-Enantiomer (15 mg) ((S)-2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol tartrate) | Reference Standard | Impurity | Renal | Enquire
|
| 1672210 | Active | Topiramate Related Compound A (25 mg) (2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1672268 | Active | Topotecan Related Compound A (25 mg) ((S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-8-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione) | Reference Standard | Impurity | Oncology | Enquire
|
| 1672280 | Active | Topotecan Related Compound C (25 mg) ((S)-4-Ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione) | Reference Standard | Impurity | Oncology | Enquire
|
| 1672315 | Active | Torsemide Related Compound A (75 mg) (4-[(3-methylphenyl)amino]-3-pyridinesulfonamide) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1672326 | Active | Torsemide Related Compound B (50 mg) (N-[(n-butylamino)carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1672337 | Active | Torsemide Related Compound C (30 mg) (N-[(ethylamino)carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1672359 | Active | Torsemide Related Compound E (20 mg) (4-(3-Tolyl)-2H-pyrido[4,3-e][1,2,4]thiadiazin-3(4H)-one 1,1-dioxide) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1672610 | Active | Tramadol Related Compound A CIV (25 mg) ((RS,SR)-1-(3-Methoxyphenyl)-2-(dimethylaminomethyl)cyclohexanol hydrochloride) | Reference Standard | Impurity | Opioids | Enquire
|
| 1672621 | Active | Tramadol Related Compound B (25 mg) (2-[(Dimethylamino)methyl]cyclohexanone hydrochloride) | Reference Standard | Impurity | Opioids | Enquire
|
| 1672698 | Active | Trandolapril Related Compound A (25 mg) ((2S,3aR,7aS)-1-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]hexahydro-2-indolinecarboxylic acid 1-methyl ester) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1672701 | Active | Trandolapril Related Compound C (25 mg) ((2S, 3aR, 7aS)-1-[N-[(S)-1-Carboxy-3-cyclohexylpropyl]-L-alanyl]hexahydro-2-indolinecarboxylic acid 1-ethyl ester hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1672712 | Active | Trandolapril Related Compound D (25 mg) ((S)-ethyl 2-[(3S, 5aS, 9aR, 10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl]-4-phenylbutanoate) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1672723 | Active | Trandolapril Related Compound E (25 mg) ((2S,3aR,7aS)-1-[N-[(S)-1-Carboxy-3-phenylpropyl]-L-alanyl]hexahydro-2-indolinecarboxylic acid) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1672756 | Active | Tranexamic Acid Related Compound C (15 mg) ((RS)-4-(Aminomethyl)cyclohex-1-enecarboxylic acid hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1672803 | Active | Transplatin (25 mg) | Reference Standard | Impurity | Oncology | Enquire
|
| 1672916 | Active | Tranylcypromine Related Compound A (40 mg) ((+/-)-cis-2-phenylcyclopropanamine hydrochloride; cis-tranylcypromine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1672927 | Active | Tranylcypromine Related Compound B (40 mg) ((E)-3-Phenylallylamine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1673012 | Active | Travoprost Related Compound A (1.5 mL) ((Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-{(R,E)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl}cyclopentyl)hept-5-enoic acid) (COLD SHIPMENT REQUIRED) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1673533 | Active | Trazodone Related Compound C (20 mg) (2-{3-[4-(4-Chlorophenyl)piperazin-1-yl]propyl}-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1673544 | Active | Trazodone Related Compound D (20 mg) (2-{3-[4-(3-Bromophenyl)piperazin-1-yl]propyl}-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1673566 | Active | Trazodone Related Compound F (25 mg) (1-(3-chlorophenyl)-4-(3-chloropropyl)piperazine hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1679020 | Active | Triamcinolone Acetonide Related Compound B (15 mg) (9-Fluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-(11beta,16alpha)-pregna-1,4,14-triene-3,20-dione) | Reference Standard | Impurity | Steroids | Enquire
|
| 1679037 | Active | Triamcinolone Acetonide Related Compound C (15 mg) (9-Fluoro-11,21,21-trihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-(11beta,16alpha)-pregna-1,4-diene-3,20-dione) | Reference Standard | Impurity | Steroids | Enquire
|
| 1680018 | Active | Triamterene Related Compound A (50 mg) (2,4,6-triamino-5-nitrosopyrimidine) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1680029 | Active | Triamterene Related Compound B (50 mg) (2,7-diamino-4-hydroxy-6-phenylpteridine) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1680030 | Active | Triamterene Related Compound C (50 mg) (2,4-diamino-7-hydroxy-6-phenylpteridine) | Reference Standard | Impurity | Diuretics | Enquire
|
| 1681622 | Active | Triclabendazole Related Compound A (15 mg) (5-Chloro-6-(2,3-dichlorophenoxy)-2-(methylsulfinyl)-1H-benzimidazole) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1681633 | Active | Triclabendazole Related Compound B (15 mg) (5-Chloro-6-(2,3-dichlorophenoxy)-1,3-dihydro-2H-benzimidazole-2-thione) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1681655 | Active | Triclabendazole Related Compound D (15 mg) (4-Chloro-5-(2,3-dichlorophenoxy)-2-nitroaniline) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1681815 | Active | Triclocarban Related Compound A (15 mg) (1,3-Bis(4-chlorophenyl)urea) | Reference Standard | Impurity | Antiseptics | Enquire
|
| 1681845 | Active | Triclocarban Related Compound C (15 mg) (1,3-Bis(3,4-dichlorophenyl)urea) | Reference Standard | Impurity | Antiseptics | Enquire
|
| 1681856 | Active | Triclocarban Related Compound D Mixture (15 mg) (Mixture of 3,5-Bis(4-chlorophenyl)-1-(3,4-dichlorophenyl)biuret and 1,5-Bis(4-chlorophenyl)-3-(3,4-dichlorophenyl)biuret) | Reference Standard | Impurity | Antiseptics | Enquire
|
| 1682217 | Active | Triclosan Related Compounds Mixture A (1.2 mL/ampule; 3 ampules) | Reference Standard | Impurity | Antiseptics | Enquire
|
| 1683559 | Active | Triethylamine (2 mL/ampule; 4 ampules) (N,N-diethylethanamine) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1686310 | Active | Trifluridine Related Compound A (10 mg) (5-Carboxy-2'-deoxyuridine) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1687017 | Active | Trihexyphenidyl Related Compound A (20 mg) (1-Phenyl-3-(piperidin-1-yl)propan-1-one hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1692516 | Active | Trimethoprim Related Compound A (25 mg) (4-amino-5-(3,4,5-trimethoxybenzyl)pyrimidin-2-ol) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1692527 | Active | Trimethoprim Related Compound B (25 mg) ((2,4-diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone) | Reference Standard | Impurity | Antibiotics | Enquire
|
| 1692710 | Active | Trimipramine Related Compound A (25 mg) (3-(5H-Dibenzo[b,f]azepin-5-yl)-N,N,2-trimethylpropan-1-amine) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1695343 | Active | Triphenylmethanol (50 mg) | Reference Standard | Impurity | Others-Chemical Medicines | Enquire
|
| 1696109 | Active | Triprolidine Hydrochloride Z-Isomer (50 mg) | Reference Standard | Impurity | Antihistamines | Enquire
|
| 1696200 | Active | Trisalicylic Acid (100 mg) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1699016 | Active | Tropicamide Related Compound A (100 mg) (N-(pyridin-4-ylmethyl)ethanamine) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1699027 | Active | Tropicamide Related Compound B (50 mg) (N-ethyl-2-phenyl-N-(pyridin-4-ylmethyl)acrylamide) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1699038 | Active | Tropicamide Related Compound C (25 mg) (3-hydroxy-2-phenylpropionic acid) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1699049 | Active | Tropicamide Related Compound D (15 mg) (List Chemical) (2-phenylacetic acid) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1699311 | Active | Trospium Chloride Related Compound A (20 mg) (Benzilic Acid) (International Restricted Sales Item) | Reference Standard | Impurity | Renal | Enquire
|
| 1699322 | Active | Trospium Chloride Related Compound B (20 mg) ((1R,3r,5S)-8-azabicyclo[3.2.1]octan-3-yl hydroxydiphenylacetate hydrochloride) | Reference Standard | Impurity | Renal | Enquire
|
| 1699333 | Active | Trospium Chloride Related Compound C (20 mg) ((1R, 3r, 5S)-3-Hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8, 1'-pyrrolidinium]chloride) | Reference Standard | Impurity | Renal | Enquire
|
| 1705378 | Active | Ulipristal Acetate Related Compound A (25 mg) (11Beta-[4-(Dimethylamino)phenyl]-5alpha-hydroxy-20-oxospiro{19-norpregna-9-en-3,2'-[1,3]dioxolan}-17-yl acetate) | Reference Standard | Impurity | Steroids | Enquire
|
| 1705753 | Active | Uracil (15 mg) | Reference Standard | Impurity | Oncology | Enquire
|
| 1705800 | Active | Uracil Arabinoside (50 mg) | Reference Standard | Impurity | Oncology | Enquire
|
| 1706698 | Active | Urea (200 mg) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1706712 | Active | Urea Related Compound A (15 mg) (Dicarbonimidic diamide) | Reference Standard | Impurity | Dermatology | Enquire
|
| 1707114 | Active | Uridine (30 mg) (1-Beta-D-Ribofuranosylpyrimidine-2,4(1H,3H)-dione) | Reference Standard | Impurity | Oncology | Enquire
|
| 1707792 | Active | Ursodiol Related Compound H (25 mg) (3Beta, 7Beta-Dihydroxy-5Beta-cholan-24-oic acid) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1707855 | Active | Valacyclovir Related Compound C (10 mg) (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-methyl-L-valinate hydrochloride) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1707861 | Active | Valacyclovir Related Compound D (15 mg) (2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9yl)methoxy]ethyl N-ethyl-L-valinate) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1707872 | Active | Valacyclovir Related Compound E (25 mg) (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-[(benzyloxy)carbonyl]-L-valinate) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1707883 | Active | Valacyclovir Related Compound F (25 mg) (2-hydroxyethyl valinate para-toluenesulfonate salt) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1707894 | Active | Valacyclovir Related Compound G (50 mg) (N,N-dimethylpyridin-4-amine) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1707828 | Active | Valacyclovir Related Compound M (15 mg) (9-[(2-Hydroxyethoxy)methyl]guanine N-formyl-l-valinate) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1708729 | Active | Valproic Acid Related Compound A (0.25 mL) (2-allylpent-4-enoic acid) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1708718 | Active | Valproic Acid Related Compound B (50 mg) ((2RS)-2-(1-methylethyl)pentanoic acid) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1708650 | Active | Valproic Acid Related Compound K (25 mg) (2-Ethyl-2-methylpentanoic acid) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1708773 | Active | Valsartan Related Compound A (10 mg) (N-Valeryl-N-{[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}D-valine) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1708784 | Active | Valsartan Related Compound B (10 mg) (N-butyryl-N-{[2'-(1H-tetrazole-5-yl)-biphenyl-4-yl]methyl}-L-valine) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1708795 | Active | Valsartan Related Compound C (10 mg) (N-Valeryl-N-{[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}-L-valine benzyl ester) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1708810 | Active | Valsartan Related Compound E (15 mg) (N-valeryl-N-{[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}-L-valine methyl ester) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1711064 | Active | Vardenafil Related Compound D (25 mg) (2-{2-Ethoxy-5-[(4-ethyl-4-oxidopiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propyl-imidazo[5,1-f][1,2,4]triazin-4(3H)-one) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1711075 | Active | Vardenafil Related Compound E (25 mg) (2-[2-Ethoxy-5-(piperazin-1-ylsulfonyl)phenyl]-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(3H)-one) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1711166 | Active | Vecuronium Bromide Related Compound A (25 mg) (3alpha,17Beta-diacetyl-oxy-2Beta, 16Beta-bispiperidinyl-5alpha-androstan) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1711177 | Active | Vecuronium Bromide Related Compound B (15 mg) (Piperidinium, 1-[(2beta, 3alpha, 5alpha, 16beta, 17beta)-3-acetyloxy-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1711188 | Active | Vecuronium Bromide Related Compound C (15 mg) (Piperidinium, 1-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-dihydroxy-2-(1-piperidinyl) androstan-16-yl]-1-methyl bromide) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1711224 | Active | Vecuronium Bromide Related Compound F (15 mg) (Piperidinium,1-[(2beta,3alpha,5alpha,16beta,17beta)-17-acetyloxy-3-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide) | Reference Standard | Impurity | Muscle Relaxants | Enquire
|
| 1711279 | Active | Venlafaxine Related Compound A (10 mg) (1-(1-(4-Methoxyphenyl)-2-(methylamino)ethyl)cyclohexanol hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1711304 | Active | Verapamil Related Compound A (50 mg) (3,4-Dimethoxy-alpha-[3-(methylamino)propyl]-alpha-(1-methylethyl)-benzeneacetonitrile monohydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1711406 | Active | Verapamil Related Compound B (50 mg) (4-[(3,4-Dimethoxyphenethyl)(methyl)amino]-2-(3,4-dimethoxyphenyl)-2-isopropylbutanenitrile hydrochloride) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1711439 | Active | Verapamil Related Compound E (50 mg) (3,4-dimethoxybenzaldehyde) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1711440 | Active | Verapamil Related Compound F (150 mg) ((3,4-Dimethoxyphenyl)methanol) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1711472 | Active | Verteporfin Related Compound A (50 mg) ((+/-)18-Ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-23H,25H-benzo[b]prophine-9,13-dipropanoic acid) | Reference Standard | Impurity | Ophthamology | Enquire
|
| 1712012 | Active | Vigabatrin Related Compound A (50 mg) (5-vinylpyrrolidin-2-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1712023 | Active | Vigabatrin Related Compound B (30 mg) ((E)-2-(2-aminoethyl)but-2-enoic acid hydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1712045 | Active | Vigabatrin Related Compound E (30 mg) (2-(2-Aminobut-3-enyl)malonic acid) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1714528 | Active | Vinorelbine Related Compound A (25 mg) (4-O-Deacetylvinorelbine tartrate) | Reference Standard | Impurity | Oncology | Enquire
|
| 1718019 | Active | Voriconazole Related Compound A (10 mg) ((2RS, 3RS)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1718020 | Active | Voriconazole Related Compound B (10 mg) ((2S, 3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1718039 | Active | Voriconazole Related Compound C (10 mg) (1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1718041 | Active | Voriconazole Related Compound D (10 mg) ((2RS,3SR)-2-(2,4-difluorophenyl)-3-(pyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1718063 | Active | Voriconazole Related Compound F (50 mg) ({(1RS,4SR)-7,7-Dimethyl-2-oxobicyclo[2.2.1]hept-1-yl}methanesulfonic acid) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1719102 | Active | Warfarin Related Compound A (50 mg) (3-(o-hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one) | Reference Standard | Impurity | Anticoagulants & Antiplatelets | Enquire
|
| 1720000 | Active | Xanthanoic Acid (100 mg) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1720203 | Active | Xanthone (100 mg) | Reference Standard | Impurity | Gastrointestinal | Enquire
|
| 1721013 | Active | Xylometazoline Related Compound A (25 mg) (N-(2-Aminoethyl)-2-[4-(tert-butyl)-2,6-dimethylphenyl]acetamide) | Reference Standard | Impurity | Cough and Cold | Enquire
|
| 1724361 | Active | Zaleplon Related Compound A (15 mg) ((E)-N-(3-[3-(dimethylamino)acryloyl]phenyl)-N-ethylacetamide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1724372 | Active | Zaleplon Related Compound B (15 mg) (N-[3-(3-Cyanopyrazolo[1,5-alpha]pyrimidin-5-yl)phenyl]-N-ethylacetamide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1724383 | Active | Zaleplon Related Compound C (25 mg) (7-[3-(N-ethylacetamido)phenyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1724077 | Active | Zanamivir Related Compounds Mixture (2.5 mg) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1724521 | Active | Zidovudine Related Compound B (25 mg) (3'-chloro-3'-deoxythymidine) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1724532 | Active | Zidovudine Related Compound C (100 mg) (thymine) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1724543 | Active | Zidovudine Related Compound D (50 mg) ([1-(2-Deoxy-beta-D-ribofuranosyl)]thymine) | Reference Standard | Impurity | Antivirals | Enquire
|
| 1724667 | Active | Zileuton Related Compound A (50 mg) (N-(1-Benzo[b]thien-2-ylethyl) urea) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1724678 | Active | Zileuton Related Compound B (50 mg) (2-(Benzo[b]thien-2-oyl)benzo[b]thiophene) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1724689 | Active | Zileuton Related Compound C (50 mg) (1-(Benzo[b]thiophen-2-yl)ethan-1-one) | Reference Standard | Impurity | Pulmonary | Enquire
|
| 1724419 | Active | Ziprasidone Related Compound A (10 mg) (3-(Piperazin-1-yl)benzo[d]isothiazole monohydrochloride) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1724420 | Active | Ziprasidone Related Compound B (10 mg) (5-{2-[4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloroindoline-2,3-dione) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1724441 | Active | Ziprasidone Related Compound C (10 mg) (5,5'-Bis(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6,6'-dichloro-3-hydroxy-3,3'-biindoline-2,2'-dione) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1724452 | Active | Ziprasidone Related Compound D (10 mg) (3-(Benzo[d]isothiazol-3-yl)-5-{2-[4-(benzo[d]isothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloroindolin-2-one) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1724474 | Active | Ziprasidone Related Compound F (15 mg) (Sodium 2-(2-amino-5-{2-[4-(benzo[d]isothiazol-3-yl)piperazin-1-yl]ethyl}-4-chlorophenyl)acetate monohydrate) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1724838 | Active | Zoledronic Acid Related Compound A (30 mg) (2-(1H-Imidazol-1-yl)acetic acid) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1724849 | Active | Zoledronic Acid Related Compound B (COLD SHIPMENT REQUIRED) (30 mg) (1-Hydroxy-2-[1-(2-hydroxy-2,2-diphosphonoethyl)-1H-imidazol-3-ium-3-yl]-1-phosphonoethylphosphonate) | Reference Standard | Impurity | Endocrine | Enquire
|
| 1727018 | Active | Zolmitriptan R-Isomer (20 mg) ((R)-4-({3-[2-(Dimethylamino)ethyl]indol-5-yl}methyl)oxazolidin-2-one) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1727020 | Active | Zolmitriptan Related Compound A (20 mg) ((S)-4-({3-[2-(Methylamino)ethyl]-1H-indol-5-yl}methyl)oxazolidin-2-one) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1727031 | Active | Zolmitriptan Related Compound B (20 mg) ((S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1727064 | Active | Zolmitriptan Related Compound E (25 mg) ((S)-N,N-dimethyl-2-{5-[(2-oxooxazolidin-4-yl)methyl]-1H-indol-3-yl}ethanamine oxide) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1727075 | Active | Zolmitriptan Related Compound F (25 mg) (2,2'-[4-(Dimethylamino)butane-1,1-diyl]bis{5-[(S)-(2-oxooxazolidin-4-yl)methyl]-3-(2-dimethylaminoethyl)indole}) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1727086 | Active | Zolmitriptan Related Compound G (25 mg) ((S)-4-(4-Aminobenzyl)oxazolidin-2-one) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1727097 | Active | Zolmitriptan Related Compound H (50 mg) (4,4-Diethoxy-N,N-dimethylbutan-1-amine) | Reference Standard | Impurity | Analgesics | Enquire
|
| 1724951 | Active | Zolpidem Impurities Mixture CIV (15 mg) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1724918 | Active | Zolpidem Related Compound A (15 mg) (N,N-Dimethyl-2-[7-methyl-2-p-tolylimidazo[1,2-a]pyridin-3-yl]acetamide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1725014 | Active | Zonisamide Related Compound A (20 mg) (1,2-benzisoxazole-3-methanesulfonic acid sodium salt) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1725036 | Active | Zonisamide Related Compound C (20 mg) (N'-(benzisoxazol-3-ylmethylsulfonyl)-N,N-dimethylformimidamide) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1729118 | Active | Zopiclone R-Isomer CIV (10 mg) ((-)-(5R)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate) | Reference Standard | Impurity | Psychiatrics | Enquire
|
| 1026004 | Active | m-Aminophenol (300 mg) | Reference Standard | Impurity | Antimicrobials | Enquire
|
| 1285862 | Active | o-Flutamide (50 mg) | Reference Standard | Impurity | Oncology | Enquire
|
| 1344305 | Active | o-Iodohippuric Acid (100 mg) | Reference Standard | Impurity | Radiopharmaceuticals | Enquire
|
| 1598733 | Active | p-Ranolazine (25 mg) (N-(2,6-Dimethylphenyl)-2-{4-[2-hydroxy-3-(4-methoxyphenoxy)propyl]piperazin-1-yl}acetamide) | Reference Standard | Impurity | Cardiovascular | Enquire
|
| 1672053 | Active | p-Toluidine (50 mg) (COLD SHIPMENT REQUIRED) | Reference Standard | Impurity | Dermatology | Enquire
|
